"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. . "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. calcium carbonate. this classification denotes a nutritional supplement with the molecular formula co3.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h0g9379fgk, chemically known as carbonic acid, calcium salt (1:1) but generally known as calcium carbonate, which bears us nih compound identifier 10112. european medicines agency schedules calcium carbonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13166mig. world health organization schedules calcium carbonate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, calcium carbonate remains the us fda preferred term for this commodity. calcium carbonate bears us nlm identifiers umls id c0006681 and nci concept code c332. smiles: c(=o)([o-])[o-].[ca+2].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. magaldrate. this classification denotes an anti-ulcer agent with the molecular formula 5al.10mg.2o4s.31ho.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6v88e24n5t, chemically known as aluminum magnesium hydroxide sulfate, hydrate but generally known as magaldrate, which bears us nih compound identifier 3086011. european medicines agency schedules magaldrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08636mig. the term magaldrate is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules magaldrate in its anatomical therapeutic chemical (atc) classification. magaldrate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule magaldrate under hs 28429080 and sitc 52389. as of q4 2014, magaldrate remains the us fda preferred term for this commodity. magaldrate bears us nlm identifiers umls id c0065512 and nci concept code c95958. smiles: [oh-].[o-]s(=o)(=o)[o-].[mg+2].[al].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. simethicone. this classification denotes an antacid preparation with the molecular formula c6h18o4si3, chemically known as dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane but generally known as simethicone, which bears us nih compound identifier 6433516. european medicines agency schedules simethicone in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub45207 and sub04403mig. simethicone bears us nlm identifiers umls id c0037138 and nci concept code c29453. smiles: co[si](c)(c)o[si](c)(c)c.o=[si]=o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. hydrotalcite. this classification denotes an antacid preparation with the molecular formula ch7almgo10-4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 17432cg1ku, chemically known as aluminum;magnesium;carbonate;heptahydroxide but generally known as hydrotalcite, which bears us nih compound identifier 24838866. european medicines agency schedules hydrotalcite in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08071mig. world health organization schedules hydrotalcite in its anatomical therapeutic chemical (atc) classification. hydrotalcite is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydrotalcite under hs 28429080 and sitc 52389. as of q4 2014, hydrotalcite remains the us fda preferred term for this commodity. smiles: c(=o)([o-])[o-].[oh-].[oh-].[oh-].[oh-].[oh-].[oh-].[oh-].[mg+2].[al+3].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. magnesium carbonate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0e53j927na. european medicines agency schedules magnesia carbonica in its extended eudravigilance medicinal product dictionary or xevmpd under index sub34276. magnesium carbonate generally arises in the molecular formula co3.mg.h2o. the term magnesium carbonate is a united states homeopathic pharmacopoeia name designation. as of q4 2014, magnesium carbonate remains the us fda preferred term for this commodity. magnesium carbonate bears us nlm identifiers umls id c0065517 and nci concept code c66048. smiles: oc(=o)o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. magnesium trisilicate. this classification denotes an antacid preparation, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c2e1ci501t. european medicines agency schedules magnesium trisilicate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14451mig. magnesium trisilicate generally arises in the molecular formula 2mg.o8si3.h2o. the term magnesium trisilicate is a european pharmacopoeia designation. as of q4 2014, magnesium trisilicate remains the us fda preferred term for this commodity. magnesium trisilicate bears us nlm identifiers umls id c0065533 and nci concept code c66052. smiles: [o-][si](=o)o[si]([o-])([o-])o[si](=o)[o-].[mg+2].[mg+2].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. algeldrate or aluminium hydroxide. this classification denotes a vaccine adjuvant with the molecular formula al.3ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5qb0t2iun0, chemically known as aluminum hydroxide, dried (jp15/usp) but generally known as aluminium hydroxide, which bears us nih compound identifier 6328211. european medicines agency schedules aluminium hydroxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11700mig. world health organization schedules aluminium hydroxide in its anatomical therapeutic chemical (atc) classification. most nations schedule aluminium hydroxide under hs 28183000 and sitc 52266. smiles: o.o.o.[al].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. dihydroxyaluminum sodium carbonate. this classification denotes an anti-ulcer agent with the molecular formula co3.al.na.2ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84h8z9550j. european medicines agency schedules dihydroxyaluminum sodium carbonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13596mig. as of q4 2014, dihydroxyaluminum sodium carbonate remains the us fda preferred term for this commodity. dihydroxyaluminum sodium carbonate bears us nlm identifiers umls id c0058135 and nci concept code c76484. smiles: c(=o)([o-])o[al].o.o.[na+].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. bismuth subnitrate. this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h19j064ba5. european medicines agency schedules bismuth subnitrate, heavy in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11748mig. bismuth subnitrate generally arises in the molecular formula 5bi.4no3.o.9ho. the term bismuth subnitrate is a european pharmacopoeia designation. as of q4 2014, bismuth subnitrate remains the us fda preferred term for this commodity. bismuth subnitrate bears us nlm identifiers umls id c0053791 and nci concept code c76481. smiles: [nh+](o)([o-])o[bi](o[n+](=o)[o-])o[n+](=o)[o-].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. aluminum carbonate. this classification denotes an antacid with the molecular formula 3co3.2al, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1ga689n629, chemically known as carbonic acid, aluminum salt (3:2) but generally known as aluminum carbonate, which bears us nih compound identifier 16205141. as of q4 2014, aluminum carbonate remains the us fda preferred term for this commodity. smiles: c(=o)([o-])[o-].c(=o)([o-])[o-].c(=o)([o-])[o-].[al+3].[al+3].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. almagate. this classification denotes a pharmacologic substance and antacid with the molecular formula co3.al.3mg.7ho.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 568z59h7zj, chemically known as magnesium, (carbonato(2-))heptahydroxy(aluminum)tri-, dihydrate but generally known as almagate, which bears us nih compound identifier 71749. european medicines agency schedules almagate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05343mig. the term almagate is an international non-proprietary name. world health organization schedules almagate in its anatomical therapeutic chemical (atc) classification. almagate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule almagate under hs 28429080 and sitc 52389. as of q4 2014, almagate remains the us fda preferred term for this commodity. smiles: [alh3].[mg].[mg].[mg].oc(=o)o.o.o.o.o.o.o.o.o.o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. almasilate. this classification denotes an aluminum silicates and antacid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ozq8o62h53. european medicines agency schedules almasilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05344mig. almasilate generally arises in the molecular formula 2al.mg.8o.2si.h2o. the term almasilate is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20.) almasilate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule almasilate under hs 28421000 and sitc 52389. as of q4 2014, almasilate remains the us fda preferred term for this commodity. smiles: o.o[si](=o)o.o[si](=o)o.[mg+2].[al+3].[al+3].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. aluminium glycinate or dihydroxyaluminum aminoacetate. this classification denotes an anti-ulcer agent with the molecular formula c2h4no2.al.2ho.(h2o)mix, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier do250mg0w6, chemically known as (glycinato-n,o)dihydroxyaluminum but generally known as aluminium glycinate, which bears us nih compound identifier 16683036. european medicines agency schedules aluminium glycinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12823mig. world health organization schedules aluminium glycinate in its anatomical therapeutic chemical (atc) classification. aluminium glycinate or dihydroxyaluminum aminoacetate bears us nlm identifiers umls id c0058134 and nci concept code c81600. smiles: [al](oc(=o)cn)([oh2])[oh2].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. attapulgite. this classification denotes an antidiarrheal agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6v729apam. european medicines agency schedules attapulgite in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12962mig. attapulgite generally arises in the molecular formula al.mg.10o.4si.ho.4h2o. the term attapulgite is an fda designation. as of q4 2014, attapulgite remains the us fda preferred term for this commodity. attapulgite bears us nlm identifiers umls id c0052657 and nci concept code c28841. smiles: o.o.o.o.o.o.o.o.o.o.o.o.o.o.[oh-].[mg].[mg].[al].[al].[si].[si].[si].[si]. .. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. bismuth aluminate or aluminum bismuth oxide. this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jb5y63jdhj. european medicines agency schedules bismuth aluminate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13079mig. bismuth aluminate generally arises in the molecular formula al6bi2o12. the term bismuth aluminate is a united states adopted name designation.this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jb5y63jdhj. european medicines agency schedules bismuth aluminate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13079mig. bismuth aluminate generally arises in the molecular formula al6bi2o12. the term bismuth aluminate is a united states adopted name designation. smiles: [o-][al]=o.[o-][al]=o.[o-][al]=o.[bi+3].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. calcarea silicata. this classification denotes an industrial aid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s4255p4g5m. european medicines agency schedules calcium silicate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12473mig. calcium silicate generally arises in the molecular formula ca.h2o3si. the term calcium silicate is a united states homeopathic pharmacopoeia name designation. smiles: [ca].[ca].[si](o)(o)(o)o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. calcium lactate. this classification denotes a nutritional supplement with the molecular formula 2c3h5o3.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2urq2n32w3, chemically known as propanoic acid, 2-hydroxy-, calcium salt (2:1) but generally known as calcium lactate, which bears us nih compound identifier 13144. european medicines agency schedules calcium lactate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13184mig. world health organization schedules calcium lactate in its anatomical therapeutic chemical (atc) classification. most nations schedule calcium lactate under hs 29181100 and sitc 51391. as of q4 2014, calcium lactate remains the us fda preferred term for this commodity. calcium lactate bears us nlm identifiers umls id c0108121 and nci concept code c76830. smiles: cc(c(=o)[o-])o.cc(c(=o)[o-])o.[ca+2].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. carbaldrate. this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6931e8lh07. european medicines agency schedules carbaldrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06112mig. carbaldrate generally arises in the molecular formula co3.al.na.2ho.h2o. the term carbaldrate is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) carbaldrate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbaldrate under hs 28429080 and sitc 52389. as of q4 2014, carbaldrate remains the us fda preferred term for this commodity. carbaldrate bears us nlm identifiers umls id c2827103 and nci concept code c83588. smiles: [alh3].[na].oc(=o)o.o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. dihydroxyaluminum aminoacetate or aluminium glycinate. this classification denotes an anti-ulcer agent with the molecular formula c2h4no2.al.2ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1k713c615k. european medicines agency schedules dihydroxyaluminum aminoacetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20302. the term dihydroxyaluminum aminoacetate is a u.s. pharmacopeial convention designation. smiles: [al](oc(=o)cn)([oh2])[oh2].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. magnesium oxide. this classification denotes a nutritional supplement and laxative, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3a3u0gi71g, chemically known as oxomagnesium, but generally known as magnesium oxide, which bears us nih compound identifier 14792. european medicines agency schedules magnesium oxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14436mig. magnesium oxide generally arises in the molecular formula mgo. the term magnesium oxide is a united states homeopathic pharmacopoeia name designation. as of q4 2014, magnesium oxide remains the us fda preferred term for this commodity. magnesium oxide bears us nlm identifiers umls id c0024477 and nci concept code c29242. smiles: o=[mg].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. troxipide. this classification denotes a piperidine with the molecular formula c15h22n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w6qjx1q00z, chemically known as 3,4,5-trimethoxy-n-(3-piperidyl)benzamide but generally known as troxipide, which bears us nih compound identifier 5597. european medicines agency schedules troxipide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11353mig. world health organization schedules troxipide in its anatomical therapeutic chemical (atc) classification. troxipide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule troxipide under hs 29333999 and sitc 51574. as of q4 2014, troxipide remains the us fda preferred term for this commodity. smiles: o=c(nc1cccnc1)c1cc(oc)c(oc)c(oc)c1.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. betaine. this classification denotes a nutritional supplement with the molecular formula c5h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3scv180c9w, chemically known as 2-(trimethylammonio)ethanoic acid, hydroxide, inner salt but generally known as betaine, which bears us nih compound identifier 247. betaine comes in many forms, including base, aldehyde, aldehyde chloride, aldehyde hydrate, alpha-d-glucofuranuronate, amide, aspartate, cephaloridine, chloride, choline citrate, citrate, d-galacturonate, d-gluconate, hydrate, hydrazide hydrochloride, hydrochloride, l-ascorbate, lauryldimethylaminoacetate, methyl ester, monohydrate, nicotinate, solution, and tartrate. european medicines agency schedules betaine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13055mig. world health organization schedules betaine in its anatomical therapeutic chemical (atc) classification. most nations schedule betaine under hs 29239000 and sitc 51481. as of q4 2014, betaine remains the us fda preferred term for this commodity. betaine bears us nlm identifiers umls id c1166065 and nci concept code c81038. smiles: c[n+](c)(c)cc(=o)[o-].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. betaine anhydrous. this classification denotes a nutritional supplement with the molecular formula c5h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3scv180c9w, chemically known as 2-(trimethylammonio)ethanoic acid, hydroxide, inner salt but more generally known as betaine, which bears us nih compound identifier 247. betaine comes in many forms, including base, aldehyde, aldehyde chloride, aldehyde hydrate, alpha-d-glucofuranuronate, amide, aspartate, cephaloridine, chloride, choline citrate, citrate, d-galacturonate, d-gluconate, hydrate, hydrazide hydrochloride, hydrochloride, l-ascorbate, lauryldimethylaminoacetate, methyl ester, monohydrate, nicotinate, solution, and tartrate. european medicines agency schedules betaine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13055mig. world health organization schedules betaine in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule betaine anhydrous under hs 29239000. smiles: c[n+](c)(c)cc(=o)[o-].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. betaine hydrate. this classification denotes a nutritional supplement with the molecular formula c5h11no2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tpu0itr2br, chemically known as 1-carboxy-n,n,n-trimethylmethanaminium, chloride but more generally known as betaine hydrate, which bears us nih compound identifier 248. the base compound, betaine, comes in many forms, including base, aldehyde, aldehyde chloride, aldehyde hydrate, alpha-d-glucofuranuronate, amide, aspartate, cephaloridine, chloride, choline citrate, citrate, d-galacturonate, d-gluconate, hydrate, hydrazide hydrochloride, hydrochloride, l-ascorbate, lauryldimethylaminoacetate, methyl ester, monohydrate, nicotinate, solution, and tartrate. most nations, for tariff and trade purposes, schedule betaine hydrate under hs 29239000. as of q4 2014, betaine hydrate remains us fdas preferred term for this commodity. smiles: c[n+](c)(c)cc(=o)[o-].o.. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. betaine hydrochloride. this classification denotes a nutritional supplement with the molecular formula c5h12no2.cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jk8u8k4d6k, chemically known as 1-carboxy-n,n,n-trimethylmethanaminium, chloride but more generally known as betaine hydrochloride, which bears us nih compound identifier 248. the base compound, betaine, comes in many forms, including base, aldehyde, aldehyde chloride, aldehyde hydrate, alpha-d-glucofuranuronate, amide, aspartate, cephaloridine, chloride, choline citrate, citrate, d-galacturonate, d-gluconate, hydrate, hydrazide hydrochloride, hydrochloride, l-ascorbate, lauryldimethylaminoacetate, methyl ester, monohydrate, nicotinate, solution, and tartrate. european medicines agency schedules betaine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13059mig. world health organization schedules betaine hydrochloride in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule betaine hydrochloride under hs 29239000 and sitc 51481. as of q4 2014, betaine hydrochloride remains us fdas preferred term for this commodity. betaine hydrochloride bears us nlm identifiers umls id c0282072 and nci concept code c82301. smiles: c[n+](c)(c)cc(=o)o.[cl-].. "
"antacids and antiflatulents. this classification denotes a) substances that counteract or neutralize gastrointestinal tract acidity; or b) agents used to prevent the formation of foam or to treat flatulence or bloat.. aluminium phosphate. this classification denotes an industrial aid, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier f92v3s521o. european medicines agency schedules aluminium phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12462mig. aluminium phosphate generally arises in the molecular formula al.o4p. the term aluminium phosphate is a u.s. pharmacopeial convention designation.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. . "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. docusate calcium. this classification denotes a stool softener, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f05q2t2ja0. european medicines agency schedules docusate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06348mig. docusate sodium generally arises in the molecular formula c20h37nao7s. the term docusate sodium is an international nomenclature of cosmetic ingredients designation. as of q4 2014, docusate calcium remains the us fda preferred term for this commodity. docusate calcium bears us nlm identifiers umls id c0282140 and nci concept code c28999. smiles: s(=o)(=o)(o)c(cc(=o)occ(cccc)cc)c(=o)occ(cccc)cc.[na].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. docusate potassium. this classification denotes a stool softener with the molecular formula c20h37o7s.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cik9f54zhr, chemically known as potassium 1,4-bis(2-ethylhexyl) sulfosuccinate but generally known as docusate potassium, which bears us nih compound identifier 24097. european medicines agency schedules docusate potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01807mig. as of q4 2014, docusate potassium remains the us fda preferred term for this commodity. docusate potassium bears us nlm identifiers umls id c0282141 and nci concept code c76971. smiles: ccccc(cc)coc(=o)cc(c(=o)occ(cc)cccc)s(=o)(=o)[o-].[k+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. lactulose. this classification denotes a laxative and disaccharide, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9u7d5qh5ae. european medicines agency schedules lactulose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08386mig. lactulose generally arises in the molecular formula c12h22o11. the term lactulose is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) lactulose is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lactulose under hs 29400000 and sitc 51692. as of q4 2014, lactulose remains the us fda preferred term for this commodity. lactulose bears us nlm identifiers umls id c0022957 and nci concept code c29148. smiles: c(c1c(c(c(c(o1)oc2c(oc(c2o)(co)o)co)o)o)o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. psyllium hydrophilic muciloid. this classification denotes a natural product which us fda regulates as an active ingredient or moiety under unique ingredient identifier ud50rby30f, which the integrated taxonomic information system classifies under taxonomic serial number 504438 as a member of kingdom plantae, subkingdom viridaeplantae, infrakingdom streptophyta, division tracheophyta, subdivision spermatophytina, infradivision angiospermae, class magnoliopsida, superorder asteranae, order lamiales, family plantaginaceae, genus plantago l. (indianwheat, plantain), species plantago ovata forssk., commonly known as desert indianwheat or as here, psyllium. plantago bears the usda plants database identifier plov. european medicines agency schedules psyllium (as plantago ovata) in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub12088mig, sub14285mig, and sub14286mig. this classification concerns the outer shell or coating of the plantago, or psyllium husk or psyllium husk. which fda generically classifies under unique ingredient identifier 9c60y73166 (base) and ud50rby30f (ovata). smiles: none.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. glycerine. this classification denotes a laxative with the molecular formula c3h8o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pdc6a3c0ox, chemically known as 1,2,3-trihydroxypropanol but generally known as glycerine, which bears us nih compound identifier 753. european medicines agency schedules glycerine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22395. smiles: oc(co)co.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. senna glycosides or sennosides. this classification denotes a laxative, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3fyp5m0ijx. european medicines agency schedules sennosides in its extended eudravigilance medicinal product dictionary or xevmpd under index sub40994. sennosides generally arises in the molecular formula c42h38o20. the term sennosides is a u.s. pharmacopeial convention designation. senna glycosides or sennosides bears us nlm identifiers umls id c0074332 and nci concept code c29448. smiles: c1=cc2=c(c(=c1)oc3c(c(c(c(o3)co)o)o)o)c(=o)c4=c(c2c5c6=c(c(=cc=c6)oc7c(c(c(c(o7)co)o)o)o)c(=o)c8=c5c=c(c=c8o)c(=o)o)c=c(c=c4o)c(=o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. aloin. this classification denotes a laxative with the molecular formula c21h22o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w41h6s09f4, chemically known as 1,8-dihydroxy-3-hydroxymethyl-10-(6-hydroxymethyl-3,4,5-trihydroxy-2-pyranyl)anthrone but generally known as aloin, which bears us nih compound identifier 14989. european medicines agency schedules aloin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12795mig. most nations schedule aloin under hs 29389000 and sitc 54161. as of q4 2014, aloin remains the us fda preferred term for this commodity. aloin bears us nlm identifiers umls id c0051209 and nci concept code c76760. smiles: o1c(c2c3c(c(=o)c4c2cccc4o)c(o)cc(c3)co)c(o)c(o)c(o)c1co.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. bisacodyl. this classification denotes a laxative with the molecular formula c22h19no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10x0709y6i, chemically known as 4,4-diacetoxydiphenylpyridyl-2-methane but generally known as bisacodyl, which bears us nih compound identifier 2391. bisacodyl most often comes in base and tannex forms. european medicines agency schedules bisacodyl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05846mig. the term bisacodyl is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules bisacodyl in its anatomical therapeutic chemical (atc) classification. bisacodyl is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bisacodyl under hs 29333999 and sitc 51574. as of q4 2014, bisacodyl remains the us fda preferred term for this commodity. bisacodyl bears us nlm identifiers umls id c0005632 and nci concept code c28870. smiles: o(c1ccc(c(c2ccc(oc(=o)c)cc2)c2ncccc2)cc1)c(=o)c.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. calcium polycarbophil or polycarbophil calcium. this classification denotes a synthetic polymer, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w25lm17a4w. european medicines agency schedules polycarbophil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03927mig. polycarbophil generally arises in the molecular formula (c6h10o2)n.(c3h4o2)n. the term polycarbophil is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) polycarbophil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, calcium polycarbophil remains the us fda preferred term for this commodity. calcium polycarbophil bears us nlm identifiers umls id c0054480 and nci concept code c28902. smiles: none.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. casanthranol. this classification denotes a laxative with the molecular formula c21h22o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3sj3u7j6v2, chemically known as (10r)-1,8-dihydroxy-3-(hydroxymethyl)-10-[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-10h-anthracen-9-one but generally known as casanthranol, which bears us nih compound identifier 51371307. european medicines agency schedules casanthranol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13254mig. as of q4 2014, casanthranol remains the us fda preferred term for this commodity. casanthranol bears us nlm identifiers umls id c0205705 and nci concept code c28907. smiles: c1=cc2=c(c(=c1)o)c(=o)c3=c(c=c(c=c3c2oc4c(c(c(c(o4)co)o)o)o)co)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. castor oil. this classification denotes a natural product, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d5340y2i9g. european medicines agency schedules castor oil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13263mig. castor oil generally arises in the molecular formula c57h104o9. the term castor oil is a united states homeopathic pharmacopoeia name designation. as of q4 2014, castor oil remains the us fda preferred term for this commodity. castor oil bears us nlm identifiers umls id c0007343 and nci concept code c80990. smiles: none.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. sodium phosphate. this classification denotes an electrolyte replacement agent with the molecular formula nah2po4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier se337svy37, more generally known as sodium phosphate. european medicines agency schedules sodium phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12587mig. the term sodium phosphate is an international non-proprietary name or inn. see who inn reference publication, volume 25 , no. 10 1971, list 11. most nations schedule sodium phosphate under hs 28444030 and sitc 52519. as of q4 2014, sodium phosphate remains the us fda preferred term for this commodity. sodium phosphate bears us nlm identifiers umls id c0074757 and nci concept code c29459. smiles: [o-]p(=o)([o-])[o-].[na+].[na+].[na+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. phenolphthalein. this classification denotes an organic carcinogen with the molecular formula c20h14o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6qk969r2if, chemically known as 3,3-bis(p-hydroxyphenyl)phthalide but generally known as phenolphthalein, which bears us nih compound identifier 4764. european medicines agency schedules phenolphthalein in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09773mig. the term phenolphthalein is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules phenolphthalein in its anatomical therapeutic chemical (atc) classification. phenolphthalein is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, phenolphthalein remains the us fda preferred term for this commodity. phenolphthalein bears us nlm identifiers umls id c0600489 and nci concept code c29359. smiles: o1c(c2c(c1=o)cccc2)(c1ccc(o)cc1)c1ccc(o)cc1.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. potassium sodium tartrate. this classification denotes a laxative with the molecular formula c4h4o6.k.na.4h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qh257bpv3j, chemically known as 2,3-dihydroxybutanedioic acid, monopotassium monosodium salt but generally known as potassium sodium tartrate, which bears us nih compound identifier 9357. european medicines agency schedules potassium sodium tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12561mig. as of q4 2014, potassium sodium tartrate remains the us fda preferred term for this commodity. potassium sodium tartrate bears us nlm identifiers umls id c0770985 and nci concept code c80954. smiles: [c@@h]([c@h](c(=o)[o-])o)(c(=o)[o-])o.[na+].[k+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. potassium phosphate. this classification denotes an electrolyte replacement agent with the molecular formula 2k.ho4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ci71s98n1z, chemically known as potassium phosphate, monobasic (jan/nf) but generally known as potassium phosphate, which bears us nih compound identifier 24506. european medicines agency schedules potassium phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21612. potassium phosphate bears us nlm identifiers umls id c0071778 and nci concept code c29373. smiles: op(=o)(o)[o-].[k+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. sodium sulfate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0ypr65r21j. european medicines agency schedules sodium sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15325mig. sodium sulfate generally arises in the molecular formula na2o4s. the term sodium sulfate is a united states homeopathic pharmacopoeia name designation. as of q4 2014, sodium sulfate remains the us fda preferred term for this commodity. sodium sulfate bears us nlm identifiers umls id c0074769 and nci concept code c47727. smiles: s(=o)(=o)(o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. macrogol or polyethylene glycol. this classification denotes a synthetic polymer with the molecular formula c2h6o2(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b697894sgq. european medicines agency schedules polyethylene glycol 400 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16380mig. the term polyethylene glycol 400 is an international nomenclature of cosmetic ingredients designation. european medicines agency schedules polyethylene glycol 400 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16380mig. macrogol or polyethylene glycol bears us nlm identifiers umls id c0032483 and nci concept code c762. smiles: coccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccocco.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. lubiprostone. this classification denotes a prostaglandin analogue with the molecular formula c20h32f2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7662kg2r6k, chemically known as prostan-1-oic acid, 16,16-difluoro-11-hydroxy-9,15-dioxo-, (11alpha)- but generally known as lubiprostone, which bears us nih compound identifier 157920. european medicines agency schedules lubiprostone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32077. the term lubiprostone is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 2, 2003, list 49). world health organization schedules lubiprostone in its anatomical therapeutic chemical (atc) classification. most nations schedule lubiprostone under hs 29375000 and sitc 54156. as of q4 2014, lubiprostone remains the us fda preferred term for this commodity. lubiprostone bears us nlm identifiers umls id c1684405 and nci concept code c66040. smiles: fc(f)(c1(oc2c(c(c(=o)c2)ccccccc(=o)o)cc1)o)cccc.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. alvimopan. this classification denotes an opiate antagonist with the molecular formula c25h32n2o4.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 677c126aet, chemically known as glycine, n-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate but generally known as alvimopan, which bears us nih compound identifier 5488547. alvimopan most often comes in simple, anhydrous, and hyrdate forms. european medicines agency schedules alvimopan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20585. world health organization schedules alvimopan in its anatomical therapeutic chemical (atc) classification. most nations schedule alvimopan under hs 29333999 and sitc 51574. as of q4 2014, alvimopan remains the us fda preferred term for this commodity. alvimopan bears us nlm identifiers umls id c1508750 and nci concept code c49096. smiles: oc1cc(c2(c(cn(cc2)cc(cc2ccccc2)c(=o)ncc(=o)o)c)c)ccc1.o.o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. bisoxatin. this classification denotes an oxazine with the molecular formula c20h15no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7c75n0l7fp, chemically known as 2,2-bis(p-hydroxyphenyl)-3-oxo-dihydrobenzoxazin-(1,4) but generally known as bisoxatin, which bears us nih compound identifier 28689. bisoxatin most often comes in base and acetate forms. european medicines agency schedules bisoxatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05856mig. world health organization schedules bisoxatin in its anatomical therapeutic chemical (atc) classification. bisoxatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bisoxatin under hs 29349990 and sitc 51579. as of q4 2014, bisoxatin remains the us fda preferred term for this commodity. smiles: o1c(c2ccc(o)cc2)(c2ccc(o)cc2)c(=o)nc2c1cccc2.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. danthron or dantron. this classification denotes a carcinogenic anthraquinone with the molecular formula c14h8o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z4xe6ibf3v, chemically known as 1,4,5,8-tetroxyantraquinone but generally known as danthron, which bears us nih compound identifier 2950. european medicines agency schedules danthron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06904mig. the term dantron is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules danthron in its anatomical therapeutic chemical (atc) classification. danthron or dantron bears us nlm identifiers umls id c0057135 and nci concept code c44363. smiles: o=c1c2c(c(=o)c3c1c(o)ccc3)cccc2o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. lactitol. this classification denotes an artificial sweetener with the molecular formula c12h24o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l2b0wjf7zy, chemically known as d-glucitol, 4-o-beta-d-galactopyranosyl- but generally known as lactitol, which bears us nih compound identifier 91476. european medicines agency schedules lactitol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08385mig. the term lactitol is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules lactitol in its anatomical therapeutic chemical (atc) classification. lactitol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lactitol under hs 29400000 and sitc 51692. as of q4 2014, lactitol remains the us fda preferred term for this commodity. lactitol bears us nlm identifiers umls id c0064585 and nci concept code c81025. smiles: o1c(oc(c(o)c(o)co)c(o)co)c(o)c(o)c(o)c1co.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. methylnaltrexone. this classification denotes an opiate antagonist with the moleculat formula c21h26no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0rk7m7iabe. european medicines agency schedules methylnaltrexone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33963. the term methylnaltrexone is a european medicines agency european public assessment report system designation. as of q4 2014, methylnaltrexone remains the us fda preferred term for this commodity. methylnaltrexone bears us nlm identifiers umls id c0066411 and nci concept code c48403. smiles: c[n+]1(ccc23c4c(=o)ccc2(c1cc5=c3c(=c(c=c5)o)o4)o)cc6cc6.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. oxyphenisatin or oxyphenisatine. this classification denotes a laxative with the molecular formula c20h15no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3bt0vqg2gq, chemically known as 4,4-dihydroxydiphenylisatin but generally known as oxyphenisatin, which bears us nih compound identifier 31315. european medicines agency schedules oxyphenisatine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09574mig. the term oxyphenisatine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules oxyphenisatin in its anatomical therapeutic chemical (atc) classification. oxyphenisatin or oxyphenisatine bears us nlm identifiers umls id c0031422 and nci concept code c80953. smiles: c1=cc=c2c(=c1)c(c(=o)n2)(c3=cc=c(c=c3)o)c4=cc=c(c=c4)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. picosulfate. this classification denotes a laxative with the molecular formula c18h13no8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lr57574hn8, chemically known as 4,4-(2-pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) but generally known as picosulfate, which bears us nih compound identifier 68654. european medicines agency schedules picosulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10569mig. the term picosulfate is an international non-proprietary name. world health organization schedules picosulfate in its anatomical therapeutic chemical (atc) classification. smiles: c1=cc=nc(=c1)c(c2=cc=c(c=c2)os(=o)(=o)[o-])c3=cc=c(c=c3)os(=o)(=o)[o-].[na+].[na+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. polyethylene glycol. this classification denotes a synthetic polymer with the molecular formula c2h6o2(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b697894sgq. european medicines agency schedules polyethylene glycol 400 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16380mig. the term polyethylene glycol 400 is an international nomenclature of cosmetic ingredients designation. european medicines agency schedules polyethylene glycol 400 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16380mig. polyethylene glycol bears us nlm identifiers umls id c0032483 and nci concept code c762. smiles: coccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccoccocco.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. prucalopride. this classification denotes a serotonin agonist with the molecular formula c18h26cln3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0a09iuw5tp, chemically known as 4-amino-5-chloro-2,3-dihydro-n-(1-(3-methoxypropyl)-4-piperidyl)-7-benzofurancarboxamide but generally known as prucalopride, which bears us nih compound identifier 3052762. european medicines agency schedules prucalopride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10155mig. the term prucalopride is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules prucalopride in its anatomical therapeutic chemical (atc) classification. prucalopride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prucalopride under hs 29349990 and sitc 51579. as of q4 2014, prucalopride remains the us fda preferred term for this commodity. prucalopride bears us nlm identifiers umls id c0913506 and nci concept code c74386. smiles: clc1cc(c(=o)nc2ccn(cc2)cccoc)c2occc2c1n.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. methylcellulose. this classification denotes a laxative with the molecular formula c29h54o16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o0gn6f9b2y, chemically known as (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3, 4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5, 6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane but generally known as methylcellulose, which bears us nih compound identifier 44263857. european medicines agency schedules methylcellulose in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub45349, sub45348, sub45347, sub43175, sub45344, sub60089, and sub03240mig.. most nations schedule methylcellulose under hs 39123980 and sitc 57554. methylcellulose bears us nlm identifiers umls id c0025729 and nci concept code c29253. smiles: cocc1c(c(c(c(o1)oc2c(oc(c(c2oc)oc)oc3c(oc(c(c3oc)oc)oc)coc)coc)oc)oc)oc.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. sulisatin. this classification denotes a laxative with the molecular formula c21h17no9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5eog8kqt0y, chemically known as 3,3-bis(4-hydroxyphenyl)-7-methyl-2-indolinone, disodium salt of sulfuric acid diester but generally known as sulisatin, which bears us nih compound identifier 41237. european medicines agency schedules sulisatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10745mig. the term sulisatin is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). sulisatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulisatin under hs 29337900 and sitc 51561. as of q4 2014, sulisatin remains the us fda preferred term for this commodity. sulisatin bears us nlm identifiers umls id c0075617 and nci concept code c74275. smiles: s(=o)(=o)(oc1ccc(c2(c3c(nc2=o)c(ccc3)c)c2ccc(os(=o)(=o)o)cc2)cc1)o.[na].[na].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. polyethylene glycol 400. this classification denotes a synthetic polymer with the molecular formula c2h6o2(c2h4o)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b697894sgq. european medicines agency schedules polyethylene glycol 400 in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16380mig. the term polyethylene glycol 400 is an international nomenclature of cosmetic ingredients designation. as of q4 2014, polyethylene glycol 400 remains the us fda preferred term for this commodity.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. alvimopan anhydrous. this classification denotes the anhydrous form of an opiate antagonist with the molecular formula c25h32n2o4.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 677c126aet, chemically known as glycine, n-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate but more generally known as alvimopan, which bears us nih compound identifier 5488547. alvimopan most often comes in simple, anhydrous, and hyrdate forms. european medicines agency schedules alvimopan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20585. world health organization schedules alvimopan in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule alvimopan anhydrous under hs 29333999. as of q4 2014, alvimopan anhydrous remains us fdas preferred term for this commodity. alvimopan anhydrous bears us nlm identifiers umls id c2698078 and nci concept code c77377. smiles: c[c@h]1cn(cc[c@@]1(c)c2cccc(c2)o)c[c@h](cc3ccccc3)c(=o)ncc(=o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. bisacodyl tannex. this classification denotes a laxative c76h52o46.c22h19no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t0i8l1b7j6, chemically known as er-soluble complex of bisacodyl and tannic acid. (1) phenol, 4,4-(2-pyridinylmethylene)bis-, diacetate (ester), complex with tannic acid, but more generally known as bisacodyl tannex, which bears us nih compound identifier 2391. most nations, for tariff and trade purposes, schedule bisacodyl tannex under hs 29333999 and sitc 51574. smiles: as of q4 2014, bisacodyl tannex remains us fdas preferred term for this commodity.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. bisoxatin acetate. this classification denotes an oxazine c24h19no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 79w5lfs83k, chemically known as 2h-1,4-benzoxazin-3(4h)-one, 2,2-bis(4-(acetyloxy)phenyl)-, but more generally known as bisoxatin acetate, which bears us nih compound identifier 26391. european medicines agency schedules bisoxatin acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00833mig. most nations, for tariff and trade purposes, schedule bisoxatin acetate under hs 29349990 and sitc 51579. as of q4 2014, bisoxatin acetate remains us fdas preferred term for this commodity. smiles: cc(=o)oc1ccc(cc1)c2(c(=o)nc3ccccc3o2)c4ccc(cc4)oc(=o)c.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. lactitol dihydrate. this classification denotes an artificial sweetener with the molecular formula c12h24o11.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1f5s85f60b, chemically known as d-glucitol, 4-o-.beta.-d-galactopyranosyl-, dihydrate, but more generally known as lactitol dihydrate, which bears us nih compound identifier 157354. european medicines agency schedules lactitol dihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08385mig. most nations, for tariff purposes, schedule lactitol dihydrate under hs 29400000. smiles: c([c@@h]1[c@@h]([c@@h]([c@h]([c@@h](o1)o[c@h]([c@@h](co)o)[c@@h]([c@h](co)o)o)o)o)o)o.o.o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. lactitol monohydrate. this classification denotes an artificial sweetener c12h24o11.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uh2k6w1y64, chemically known as d-glucitol, 4-o-.beta.-d-galactopyranosyl-, monohydrate, but more generally known as lactitol monohydrate, which bears us nih compound identifier 3067270. european medicines agency schedules lactitol monohydrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12097mig. most nations, for tariff and trade purposes, schedule lactitol monohydrate under hs 29400000 and sitc 51692. as of q4 2014, lactitol monohydrate remains us fdas preferred term for this commodity. lactitol monohydrate bears us nlm identifiers umls id c2697878 and nci concept code c77137. smiles: c([c@@h]1[c@@h]([c@@h]([c@h]([c@@h](o1)o[c@h]([c@@h](co)o)[c@@h]([c@h](co)o)o)o)o)o)o.o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. phenolphthalein glucuronide. this classification denotes an organic carcinogen with the molecular formula c26h22o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0s390i6642, chemically known as .beta.-d-glucopyranosiduronic acid, 4-(1,3-dihydro-1-(4-hydroxyphenyl)-3-oxo-1-isobenzofuranyl)phenyl, but more generally known as phenolphthalein glucuronide, which bears us nih compound identifier 3032634. european medicines agency schedules phenolphthalein glucuronide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09773mig. most nations, for tariff purposes, schedule phenolphthalein glucuronide under hs 29322910. smiles: c1ccc2c(c1)c(=o)oc2(c3ccc(cc3)o)c4ccc(cc4)o[c@h]5[c@@h]([c@h]([c@@h]([c@h](o5)c(=o)o)o)o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. prucalopride hydrochloride. this classification denotes a serotonin agonist c18h26cln3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m8iyx9z79v, chemically known as 4-amino-5-chloro-2,3-dihydro-n-(1-(3-methoxypropyl)-4-piperidinyl)-7-benzofurancarboxamide hydrochloride, but more generally known as prucalopride hydrochloride, which bears us nih compound identifier 9931054. most nations, for tariff and trade purposes, schedule prucalopride hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, prucalopride hydrochloride remains us fdas preferred term for this commodity. smiles: cocccn1ccc(cc1)nc(=o)c2cc(c(c3c2occ3)n)cl.cl.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. prucalopride succinate. this classification denotes a serotonin agonist with the molecular formula c18h26cln3o3.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4v2g75e1ck. european medicines agency schedules prucalopride succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub28850. the term prucalopride succinate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule prucalopride succinate under hs 29349990 and sitc 51579. as of q4 2014, prucalopride succinate remains us fdas preferred term for this commodity. smiles: cocccn1ccc(cc1)nc(=o)c2cc(c(c3c2occ3)n)cl.c(cc(=o)o)c(=o)o.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. sulisatin sodium. this classification denotes a laxative c21h15no9s2.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7s636l78gu, chemically known as 2h-indol-2-one, 1,3-dihydro-7-methyl-3,3-bis(4-(sulfooxy)phenyl)-, sodium salt (1:2), but more generally known as sulisatin sodium, which bears us nih compound identifier 41237. european medicines agency schedules sulisatin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04641mig. most nations, for tariff and trade purposes, schedule sulisatin sodium under hs 29337900 and sitc 51561. as of q4 2014, sulisatin sodium remains us fdas preferred term for this commodity. smiles: cc1cccc2c1nc(=o)c2(c3ccc(cc3)os(=o)(=o)[o-])c4ccc(cc4)os(=o)(=o)[o-].[na+].[na+].. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. sodium picosulfate. this classification denotes a laxative with the molecular formula c18h13no8s2.2na, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier lr57574hn8, chemically known as 4,4-(2-pyridylmethylene)diphenolbis(hydrogen sulfate) (ester) disodium salt but more generally known as picosulfate sodium, which bears u.s. nih compound identifier 68654. european medicines agency schedules picosulfate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10569mig. the term picosulfate sodium is an international non-proprietary name. world health organization schedules picosulfate sodium in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary.. "
"laxatives. this classification denotes agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation.. docusate sodium. this classification denotes a stool softener, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier f05q2t2ja0. european medicines agency schedules docusate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06348mig. docusate sodium generally arises in the molecular formula c20h37nao7s. the term docusate sodium is an international nomenclature of cosmetic ingredients designation.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. . "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. difenoxin. this classification denotes an antidiarrheal agent with the molecular formula c28h28n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3zz5bj9f2q, chemically known as 4-piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl- but generally known as difenoxin, which bears us nih compound identifier 34328. european medicines agency schedules difenoxin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07123mig. the term difenoxin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules difenoxin in its anatomical therapeutic chemical (atc) classification. difenoxin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule difenoxin under hs 29333300 and sitc 51574. as of q4 2014, difenoxin remains the us fda preferred term for this commodity. difenoxin bears us nlm identifiers umls id c0057981 and nci concept code c65381. smiles: oc(=o)c1(ccn(cc1)ccc(c1ccccc1)(c1ccccc1)c#n)c1ccccc1.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. loperamide. this classification denotes an opioid and antidiarrheal agent with the molecular formula c29h33cln2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6x9oc3h4ii, chemically known as 4-(4-chlorophenyl)-n,n-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide but generally known as loperamide, which bears us nih compound identifier 3955. european medicines agency schedules loperamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08572mig. the term loperamide is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules loperamide in its anatomical therapeutic chemical (atc) classification. loperamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule loperamide under hs 29333999 and sitc 51574. as of q4 2014, loperamide remains the us fda preferred term for this commodity. loperamide bears us nlm identifiers umls id c0023992 and nci concept code c618. smiles: clc1ccc(c2(o)ccn(cc2)ccc(c2ccccc2)(c2ccccc2)c(=o)n(c)c)cc1.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. paregoric. this classification denotes an opioid and antidiarrheal agent.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. nifuroxazide. this classification denotes a topical anti-infective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pm5li0p38j. european medicines agency schedules nifuroxazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09271mig. nifuroxazide generally arises in the molecular formula c12h9n3o5. the term nifuroxazide is an international non-proprietary name or inn. nifuroxazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifuroxazide under hs 29321900 and sitc 51569. as of q4 2014, nifuroxazide remains the us fda preferred term for this commodity. nifuroxazide bears us nlm identifiers umls id c0068742 and nci concept code c90982. smiles: o1c(ccc1[n](=o)o)/c=n/nc(=o)c1ccc(o)cc1.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. diphenoxylate. this classification denotes an antidiarrheal agent with the molecular formula c30h32n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 73312p173g, chemically known as 2,2-diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile but generally known as diphenoxylate, which bears us nih compound identifier 13505. european medicines agency schedules diphenoxylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07212mig. world health organization schedules diphenoxylate in its anatomical therapeutic chemical (atc) classification. diphenoxylate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diphenoxylate under hs 29333300 and sitc 51574. as of q4 2014, diphenoxylate remains the us fda preferred term for this commodity. diphenoxylate bears us nlm identifiers umls id c0012525 and nci concept code c62024. smiles: o(c(=o)c1(ccn(cc1)ccc(c1ccccc1)(c1ccccc1)c#n)c1ccccc1)cc.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. saccharomyces boulardii. this classification denotes a natural antidiarrheal agent.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. alosetron. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c17h18n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 13z9hth115, chemically known as 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1h-imidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one but generally known as alosetron, which bears us nih compound identifier 2099. alosetron comes in base and hydrochloride forms. european medicines agency schedules alosetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05358mig. the term alosetron is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules alosetron in its anatomical therapeutic chemical (atc) classification. alosetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alosetron under hs 29337900 and sitc 51561. as of q4 2014, alosetron remains the us fda preferred term for this commodity. alosetron bears us nlm identifiers umls id c0291772 and nci concept code c73100. smiles: o=c1n(ccc2n(c3c(c12)cccc3)c)cc1nc[nh]c1c.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. purified pectin with acidophilus. this classification denotes an opioid and antidiarrheal agent with the molecular formula c6h10o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89na02m4rx, chemically known as (2s,3r,4s,5r,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid but generally known as pectin, which bears us nih compound identifier 441476. european medicines agency schedules loperamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14786mig. world health organization schedules pectin in its anatomical therapeutic chemical (atc) classification. smiles: c1(c(c(oc(c1o)o)c(=o)o)o)o.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. bismuth subcarbonate. this classification denotes an anti-ulcer agent with the molecular formula co3.2bi.2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m41l2in55t, chemically known as carbonic acid, bismuth salt but generally known as bismuth carbonate, which bears us nih compound identifier 161253. european medicines agency schedules bismuth carbonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13088mig. as of q4 2014, bismuth subcarbonate remains the us fda preferred term for this commodity. bismuth subcarbonate bears us nlm identifiers umls id c0053789 and nci concept code c76480. smiles: c(=o)(o[bi]=o)o[bi]=o.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. racecadotril. this classification denotes a protease inhibitor and antidiarrheal agent with the molecular formula c21h23no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 76k53xp4to, chemically known as glycine, n-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester but generally known as racecadotril, which bears us nih compound identifier 107751. european medicines agency schedules racecadotril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12435mig. the term racecadotril is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). racecadotril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule racecadotril under hs 29309085 and sitc 51549. as of q4 2014, racecadotril remains the us fda preferred term for this commodity. racecadotril bears us nlm identifiers umls id c0050461 and nci concept code c66503. smiles: s(cc(cc1ccccc1)c(=o)ncc(=o)occ1ccccc1)c(=o)c.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. bismuth subgallate. this classification denotes a topical anti-infective agent with the molecular formula c7h4o5.bi.ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yiw503mi7v, chemically known as 1,3,2-benzodioxabismole-5-carboxylic acid, 2,7-dihydroxy- but generally known as bismuth subgallate, which bears us nih compound identifier 16682999. european medicines agency schedules bismuth subgallate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13091mig. as of q4 2014, bismuth subgallate remains the us fda preferred term for this commodity. bismuth subgallate bears us nlm identifiers umls id c0053790 and nci concept code c77029. smiles: [bi]1(oc2c(o1)cc(cc2o)c(=o)o)[oh2].. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. lidamidine. this classification denotes an antidiarrheal agent with the molecular formula c11h16n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q8x04w8418, chemically known as urea, n-(2,6-dimethylphenyl)-n-(imino(methylamino)methyl)- but generally known as lidamidine, which bears us nih compound identifier 47510. european medicines agency schedules lidamidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08504mig. the term lidamidine is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). lidamidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lidamidine under hs 29252900 and sitc 51482. as of q4 2014, lidamidine remains the us fda preferred term for this commodity. lidamidine bears us nlm identifiers umls id c0064961 and nci concept code c82240. smiles: cc1=c(c(=cc=c1)c)nc(=o)nc(=nc)n.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. mebiquine. this classification denotes an antidiarrheal agent with the molecular formula c10h10bino3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dbe10q8qf6, chemically known as quinoline, 8-((dihydroxybismuthino)oxy)-6-methyl- but generally known as mebiquine, which bears us nih compound identifier 16683098. european medicines agency schedules mebiquine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08665mig. the term mebiquine is an international non-proprietary name. mebiquine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mebiquine under hs 29334990 and sitc 51575. as of q4 2014, mebiquine remains the us fda preferred term for this commodity. mebiquine bears us nlm identifiers umls id c1881637 and nci concept code c66060. smiles: cc1=cc(=c2c(=c1)c=cc=n2)o[bi].o.o.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. rolgamidine. this classification denotes an antidiarrheal agent with the molecular formula c9h16n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2m3ng13839, chemically known as 1h-pyrrole-1-acetamide, n-(aminoiminomethyl)-2,5-dihydro-2,5-dimethyl-, trans but generally known as rolgamidine, which bears us nih compound identifier 3055175. european medicines agency schedules rolgamidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10364mig. the term rolgamidine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). rolgamidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rolgamidine under hs 29339990 and sitc 51577. as of q4 2014, rolgamidine remains the us fda preferred term for this commodity. rolgamidine bears us nlm identifiers umls id c2699094 and nci concept code c75194. smiles: o=c(/n=c(/n)n)cn1c(c=cc1c)c.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. zaldaride. this classification denotes an antidiarrheal agent with the molecular formula c26h28n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gh66pet6s3, chemically known as (+-)-1-(1-((4-methyl-4h,6h-pyrrolo(1,2-a)(4,1)benzoxazepin-4-yl)methyl)-4-piperidyl)-2-benzimidazolinone but generally known as zaldaride, which bears us nih compound identifier 65909. european medicines agency schedules zaldaride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00131mig. the term zaldaride is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). zaldaride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zaldaride under hs 29349990 and sitc 51579. as of q4 2014, zaldaride remains the us fda preferred term for this commodity. zaldaride bears us nlm identifiers umls id c1883594 and nci concept code c66680. smiles: o1c(cn2ccc(n3c4c([nh]c3=o)cccc4)cc2)(c2n(c3c(c1)cccc3)ccc2)c.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. alosetron hydrochloride. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c17h18n4o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2f5r1a46yw, chemically known as 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1h-pyrido(4,3-b)indol-1-one monohydrochloride but more generally known as alosetron hydrochloride, which bears us nih compound identifier 60758. the base compound, alosetron, comes in base and hydrochloride forms. european medicines agency schedules alosetron hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12461mig. most nations, for tariff and trade purposes, schedule alosetron hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, alosetron hydrochloride remains us fdas preferred term for this commodity. alosetron hydrochloride bears us nlm identifiers umls id c0291771 and nci concept code c47386. smiles: cc1c(nc[nh]1)cn2ccc3c(c4ccccc4n3c)c2=o.cl.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. difenoxin hydrochloride. this classification denotes an antidiarrheal agent with the molecular formula c28h28n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vqz63k01iw, chemically known as 4-piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, monohydrochloride but more generally known as difenoxin hydrochloride, which bears us nih compound identifier 37193. european medicines agency schedules difenoxin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01691mig. most nations, for tariff and trade purposes, schedule difenoxin hydrochloride under hs 29333300 and sitc 51574. as of q4 2014, difenoxin hydrochloride remains us fdas preferred term for this commodity. difenoxin hydrochloride bears us nlm identifiers umls id c0770333 and nci concept code c47487. smiles: c1ccc(cc1)c2(ccn(cc2)ccc(c#n)(c3ccccc3)c4ccccc4)c(=o)o.cl.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. diphenoxylate hydrochloride. this classification denotes an opioid analgesic and antidiarrheal with the molecular formula c30h32n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w24od7yw48, chemically known as 2,2-diphenyl-4-(4-carbethoxy-4-phenylpiperidino)butyronitrile but more generally known as diphenoxylate hydrochloride, which bears us nih compound identifier 13505. european medicines agency schedules diphenoxylate hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01776mig. most nations, for tariff and trade purposes, schedule diphenoxylate hydrochloride under hs 29333300 and sitc 51574. as of q4 2014, diphenoxylate hydrochloride remains us fdas preferred term for this commodity. diphenoxylate hydrochloride bears us nlm identifiers umls id c0282145 and nci concept code c28995. smiles: ccoc(=o)c1(ccn(cc1)ccc(c#n)(c2ccccc2)c3ccccc3)c4ccccc4.cl.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. lidamidine hydrochloride. this classification denotes an antidiarrheal agent with the molecular formula c11h16n4o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3q1q4qjv3v, chemically known as 1-(methylamidino)-3-(2,6-xylyl)urea monohydrochloride but more generally known as lidamidine hydrochloride, which bears us nih compound identifier 47509. european medicines agency schedules lidamidine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35843. most nations, for tariff and trade purposes, schedule lidamidine hydrochloride under hs 29252900 and sitc 51482. as of q4 2014, lidamidine hydrochloride remains us fdas preferred term for this commodity. lidamidine hydrochloride bears us nlm identifiers umls id c0771745 and nci concept code c82241. smiles: cc1cccc(c1nc(=o)nc(=n)nc)c.cl.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. loperamide hydrochloride. this classification denotes an antidiarrheal agent with the molecular formula c29h33cln2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 77ti35393c, chemically known as 4-(p-chlorophenyl)-4-hydroxy-n,n-dimethyl-alpha,alpha-diphenyl-1-piperidinebutyramide monohydrochloride but more generally known as loperamide hydrochloride, which bears us nih compound identifier 71420. european medicines agency schedules loperamide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02969mig. most nations, for tariff and trade purposes, schedule loperamide hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, loperamide hydrochloride remains us fdas preferred term for this commodity. loperamide hydrochloride bears us nlm identifiers umls id c0282221 and nci concept code c1584. smiles: cn(c)c(=o)c(ccn1ccc(cc1)(c2ccc(cc2)cl)o)(c3ccccc3)c4ccccc4.cl.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. loperamide oxide monohydrate. this classification denotes an opioid and antidiarrheal agent with the molecular formula c29h33cln2o3.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h3vot77de1, chemically known as 1-piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-n,n-dimethyl-alpha,alpha-diphenyl-, 1-oxide, (e)- but more generally known as loperamide oxide, which bears us nih compound identifier 71421. european medicines agency schedules loperamide oxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08573mig. world health organization schedules loperamide oxide in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule loperamide oxide monohydrate under hs 29333999. as of q4 2014, loperamide oxide monohydrate remains us fdas preferred term for this commodity. smiles: cn(c(=o)c(c1ccccc1)(c2ccccc2)cc[n@+]3(cc[c@](cc3)(o)c4ccc(cc4)cl)[o-])c.o.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. zaldaride maleate. this classification denotes an antidiarrheal agent with the molecular formula c26h28n4o2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k7sg01p7nj, chemically known as 1,3-dihydro-1-(1-((4-methyl-4h,6h-pyrrolo(1,2-a)(4,1)benzoxazepin-4-yl)methyl)-4-piperidinyl)-2h-benzimidazol-2-one maleate, but more generally known as zaldaride maleate, which bears us nih compound identifier 6450522. european medicines agency schedules zaldaride maleate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00131mig. most nations, for tariff purposes, schedule zaldaride maleate under hs 29349990. smiles: cc1(c2cccn2-c3ccccc3co1)cn4ccc(cc4)n5c6ccccc6[nh]c5=o.c(=c\\c(=o)o)\\c(=o)o.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. eluxadoline. a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowelsyndrome with diarrhea.. "
"antidiarrheals. this classification denotes miscellaneous agents found useful in the symptomatic treatment of increased liquidity or decreased consistency of feces, such as running stool. i.e., diarrhea. they have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition.. fecal microbiota transplant preparation. fecal microbiota transplant involves restoration of the colon microflora by introducing healthy bacterial flora through infusion of stool, e.g by colonoscopy,  enema, orogastric tube, or by mouthin the form of a capsule containing freeze-dried material.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. . "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. trimethobenzamide. this classification denotes an antiemetic agent with the molecular formula c21h28n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w2x096qy97, chemically known as 4-(2-dimethylaminoethoxy)-n-(3,4,5-trimethoxybenzoyl)benzylamine but generally known as trimethobenzamide, which bears us nih compound identifier 5577. european medicines agency schedules trimethobenzamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11309mig. the term trimethobenzamide is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). trimethobenzamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trimethobenzamide under hs 29242995 and sitc 51479. as of q4 2014, trimethobenzamide remains the us fda preferred term for this commodity. trimethobenzamide bears us nlm identifiers umls id c0077163 and nci concept code c61989. smiles: o(ccn(c)c)c1ccc(cnc(=o)c2cc(oc)c(oc)c(oc)c2)cc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. metoclopramide. this classification denotes an antiemetic agent with the molecular formula c14h22cln3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l4yeb44i46, chemically known as 2-methoxy-4-amino-5-chloro-n,n-dimethylaminoethyl)benzamide but generally known as metoclopramide, which bears us nih compound identifier 4168. european medicines agency schedules metoclopramide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08902mig. the term metoclopramide is an international non-proprietary name. world health organization schedules metoclopramide in its anatomical therapeutic chemical (atc) classification. metoclopramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metoclopramide under hs 29242995 and sitc 51479. as of q4 2014, metoclopramide remains the us fda preferred term for this commodity. metoclopramide bears us nlm identifiers umls id c0025853 and nci concept code c62046. smiles: clc1cc(c(=o)nccn(cc)cc)c(oc)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. cinnarizine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c26h28n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3di2e1x18l, chemically known as piperazine, 1- (diphenylmethyl)-4-(3-phenyl-2-propenyl)-, (e)- but generally known as cinnarizine, which bears us nih compound identifier 2761. european medicines agency schedules cinnarizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06302mig. the term cinnarizine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules cinnarizine in its anatomical therapeutic chemical (atc) classification. cinnarizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cinnarizine under hs 29335995 and sitc 51576. as of q4 2014, cinnarizine remains the us fda preferred term for this commodity. cinnarizine bears us nlm identifiers umls id c0008803 and nci concept code c76060. smiles: n1(ccn(cc1)c/c=c/c1ccccc1)c(c1ccccc1)c1ccccc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. difenidol or diphenidol. this classification denotes an antiemetic agent with the molecular formula c21h27no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nqo8r319ly, chemically known as 1,1-diphenyl-4-(1-piperidyl)butan-1-ol but generally known as difenidol, which bears us nih compound identifier 3055. european medicines agency schedules difenidol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07121mig. the term difenidol is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). difenidol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. difenidol or diphenidol bears us nlm identifiers umls id c0058371 and nci concept code c65421. smiles: c1ccn(cc1)cccc(c2=cc=cc=c2)(c3=cc=cc=c3)o.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. cyclizine. this classification denotes an antiemetic agent with the molecular formula c18h22n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qrw9fcr9p2, chemically known as piperazine, 1- (diphenylmethyl)-4-methyl-, monohydrochloride but generally known as cyclizine, which bears us nih compound identifier 6726. european medicines agency schedules cyclizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06847mig. the term cyclizine is an international non-proprietary name. world health organization schedules cyclizine in its anatomical therapeutic chemical (atc) classification. cyclizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyclizine under hs 29335995 and sitc 51576. as of q4 2014, cyclizine remains the us fda preferred term for this commodity. cyclizine bears us nlm identifiers umls id c0010547 and nci concept code c65356. smiles: n1(ccn(cc1)c)c(c1ccccc1)c1ccccc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. combinational fructose dextrose and phosphoric acid. this classification denotes a combination drug and antiemetic preparation. the first component of this combination drug is a hexose, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6yss42vsev. european medicines agency schedules fructose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13925mig. fructose generally arises in the molecular formula c6h12o6. the term fructose is an fda designation. smiles: c(c1c(c(c(o1)(co)o)o)o)o. the second component of this combination drug is a hexose with the molecular formula c6h12o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5sl0g7r0ok, chemically known as sugar, grape but generally known as anhydrous dextrose, which bears us nih compound identifier 5793. european medicines agency schedules glucose in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13981mig. world health organization schedules anhydrous dextrose in its anatomical therapeutic chemical (atc) classification. smiles: o1c(c(o)c(o)c(o)c1o)co. the third component of this combination drug is an acid with the molecular formula h3o4p, chemically known as phosphoric acid, and which bears us nih compound identifier 1004. european medicines agency schedules phosphoric acid in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub12212mig, sub12213mig, sub14854mig, sub22394, sub22400, sub29997, sub35788, sub36455, sub37010, and sub42701.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. prochlorperazine. this classification denotes a phenothiazine with the molecular formula c20h24cln3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yhp6ylt61t, chemically known as 10h-phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)- but generally known as prochlorperazine, which bears us nih compound identifier 4917. european medicines agency schedules prochlorperazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10059mig. the term prochlorperazine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules prochlorperazine in its anatomical therapeutic chemical (atc) classification. prochlorperazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prochlorperazine under hs 29343090 and sitc 51578. as of q4 2014, prochlorperazine remains the us fda preferred term for this commodity. prochlorperazine bears us nlm identifiers umls id c0033229 and nci concept code c774. smiles: clc1cc2n(cccn3ccn(cc3)c)c3c(sc2cc1)cccc3.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. metopimazine. this classification denotes an antiemetic agent with the molecular formula c22h27n3o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 238s75v9av, chemically known as 4-piperidinecarboxamide, 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)- but generally known as metopimazine, which bears us nih compound identifier 26388. european medicines agency schedules metopimazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08908mig. the term metopimazine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules metopimazine in its anatomical therapeutic chemical (atc) classification. metopimazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metopimazine under hs 29343090 and sitc 51578. as of q4 2014, metopimazine remains the us fda preferred term for this commodity. metopimazine bears us nlm identifiers umls id c0066469 and nci concept code c81497. smiles: s1c2c(n(cccn3ccc(cc3)c(=o)n)c3c1cccc3)cc(s(=o)(=o)c)cc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. dolasetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 82wi2l7q6e. european medicines agency schedules dolasetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06352mig. dolasetron generally arises in the molecular formula c19h20n2o3. the term dolasetron is an international non-proprietary name or inn. dolasetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dolasetron under hs 29339990 and sitc 51577. as of q4 2014, dolasetron remains the us fda preferred term for this commodity. dolasetron bears us nlm identifiers umls id c0209210 and nci concept code c61735. smiles: o(c1cc2n3c(cc(c2)c(=o)c3)c1)c(=o)c1c2c([nh]c1)cccc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. ondansetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula c18h19n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4af302esos, chemically known as 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one but generally known as ondansetron, which bears us nih compound identifier 4595. european medicines agency schedules ondansetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09445mig. the term ondansetron is an international non-proprietary name. world health organization schedules ondansetron in its anatomical therapeutic chemical (atc) classification. ondansetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ondansetron under hs 29332990 and sitc 51573. as of q4 2014, ondansetron remains the us fda preferred term for this commodity. ondansetron bears us nlm identifiers umls id c0061851 and nci concept code c1119. smiles: o=c1c(ccc2n(c3c(c12)cccc3)c)cn1c(ncc1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. thiethylperazine. this classification denotes an antiemetic agent with the molecular formula c22h29n3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8etk1waf6r, chemically known as 10h-phenothiazine, 2-(ethylthio)-10-(3-(4-methyl-1-piperazinyl)propyl)- but generally known as thiethylperazine, which bears us nih compound identifier 5440. european medicines agency schedules thiethylperazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10973mig. the term thiethylperazine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules thiethylperazine in its anatomical therapeutic chemical (atc) classification. thiethylperazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule thiethylperazine under hs 29343010 and sitc 51578. as of q4 2014, thiethylperazine remains the us fda preferred term for this commodity. thiethylperazine bears us nlm identifiers umls id c0039865 and nci concept code c62081. smiles: s1c2c(n(cccn3ccn(cc3)c)c3c1cccc3)cc(scc)cc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. dimenhydrinate. this classification denotes an antimuscarinic agent and antiemetic agent with the molecular formula c17h21no.c7h7cln4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jb937per5c, chemically known as 8-chlorotheophylline, compound with 2-(diphenylmethoxy)-n,n-dimethylethylamine (1:1) but generally known as dimenhydrinate, which bears us nih compound identifier 10660. european medicines agency schedules dimenhydrinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07159mig. the term dimenhydrinate is an international non-proprietary name. dimenhydrinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimenhydrinate under hs 29395900 and sitc 54145. as of q4 2014, dimenhydrinate remains the us fda preferred term for this commodity. dimenhydrinate bears us nlm identifiers umls id c0012381 and nci concept code c28992. smiles: clc1[nh]c2c(n(c(=o)n(c2=o)c)c)n1.o(c(c1ccccc1)c1ccccc1)ccn(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. palonosetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula c19h24n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5d06587d6r, chemically known as 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1h-benz(de)isoquinolin-1-one but generally known as palonosetron, which bears us nih compound identifier 148211. european medicines agency schedules palonosetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09593mig. the term palonosetron is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules palonosetron in its anatomical therapeutic chemical (atc) classification. palonosetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule palonosetron under hs 29337900 and sitc 51561. as of q4 2014, palonosetron remains the us fda preferred term for this commodity. palonosetron bears us nlm identifiers umls id c0220578 and nci concept code c61874. smiles: o=c1n(c2c3ccn(c2)cc3)cc2c3c1cccc3ccc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. granisetron. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c18h24n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wzg3j2mcol, chemically known as 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, endo- but generally known as granisetron, which bears us nih compound identifier 3510. european medicines agency schedules granisetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07964mig. the term granisetron is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules granisetron in its anatomical therapeutic chemical (atc) classification. most nations schedule granisetron under hs 29399900 and sitc 54149. as of q4 2014, granisetron remains the us fda preferred term for this commodity. granisetron bears us nlm identifiers umls id c0061863 and nci concept code c62031. smiles: o=c(nc1cc2n(c(c1)ccc2)c)c1nn(c2c1cccc2)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. bemesetron. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c15h17cl2no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o98t3677pa, chemically known as 3-tropanyl-3,5-dichlorobenzoate but generally known as bemesetron, which bears us nih compound identifier 1683. european medicines agency schedules bemesetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05692mig. the term bemesetron is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). bemesetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bemesetron under hs 29399900 and sitc 54149. as of q4 2014, bemesetron remains the us fda preferred term for this commodity. bemesetron bears us nlm identifiers umls id c0164151 and nci concept code c80766. smiles: clc1cc(c(=o)oc2cc3n(c(cc3)c2)c)cc(cl)c1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. acotiamide. this classification denotes an antiemetic agent with the molecular formula c21h30n4o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d42owk5383. the term acotiamide is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53. ). most nations schedule acotiamide under hs 29341000 and sitc 51579. as of q4 2014, acotiamide remains the us fda preferred term for this commodity. acotiamide bears us nlm identifiers umls id c1879544 and nci concept code c65214. smiles: cc(c)n(ccnc(=o)c1=csc(=n1)nc(=o)c2=cc(=c(c=c2o)oc)oc)c(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. alepride. this classification denotes an antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r6g1m06tpo. european medicines agency schedules alepride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05309mig. alepride generally arises in the molecular formula c22h30cln3o2. the term alepride is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) alepride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alepride under hs 29333999 and sitc 51574. as of q4 2014, alepride remains the us fda preferred term for this commodity. alepride bears us nlm identifiers umls id c2697984 and nci concept code c74450. smiles: clc1cc(c(=o)nc2ccn(cc3ccc=cc3)cc2)c(occ=c)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. alizapride. this classification denotes an antiemetic agent with the molecular formula c16h21n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p55703zrzy, chemically known as 1h-benzotriazole-5-carboxamide, 6-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)- but generally known as alizapride, which bears us nih compound identifier 43008. alizapride most often comes in base and hydrochloride forms. european medicines agency schedules alizapride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05332mig. the term alizapride is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules alizapride in its anatomical therapeutic chemical (atc) classification. alizapride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alizapride under hs 29339990 and sitc 51577. as of q4 2014, alizapride remains the us fda preferred term for this commodity. alizapride bears us nlm identifiers umls id c0051162 and nci concept code c995. smiles: o=c(ncc1n(ccc1)cc=c)c1c(oc)cc2n[nh]nc2c1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. azasetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula c17h20cln3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 77hc7urr9z, chemically known as 2h-1,4-benzoxazine-8-carboxamide, n-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, monohydrochloride but generally known as azasetron, which bears us nih compound identifier 2264. azasetron most often comes in base and hydrochloride forms. european medicines agency schedules azasetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05642mig. the term azasetron is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). azasetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azasetron under hs 29349990 and sitc 51579. as of q4 2014, azasetron remains the us fda preferred term for this commodity. azasetron bears us nlm identifiers umls id c0378974 and nci concept code c73101. smiles: clc1cc(c(=o)nc2c3ccn(c2)cc3)c2occ(=o)n(c2c1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. azasetron hydrochloride. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c17h20cln3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2bss7xl60s, chemically known as 2h-1,4-benzoxazine-8-carboxamide, n-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, monohydrochloride but generally known as azasetron hydrochloride, which bears us nih compound identifier 115000. european medicines agency schedules azasetron hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00639mig. most nations schedule azasetron hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, azasetron hydrochloride remains the us fda preferred term for this commodity. azasetron hydrochloride bears us nlm identifiers umls id c2698288 and nci concept code c77260. smiles: clc1cc(c(=o)nc2c3ccn(c2)cc3)c2occ(=o)n(c2c1)c.cl.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. batanopride. this classification denotes an antiemetic agent with the molecular formula c17h26cln3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1at99k728n, chemically known as benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-(1-methyl-2-oxopropoxy)- but generally known as batanopride, which bears us nih compound identifier 59692. batanopride most often comes in base and hydrochloride forms. european medicines agency schedules batanopride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06108mig. the term batanopride is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). batanopride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule batanopride under hs 29242995 and sitc 51479. as of q4 2014, batanopride remains the us fda preferred term for this commodity. batanopride bears us nlm identifiers umls id c0053879 and nci concept code c1021. smiles: clc1cc(c(=o)nccn(cc)cc)c(oc(c)c(=o)c)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. cipropride. this classification denotes an antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0d2vuo6dcn. european medicines agency schedules cipropride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07472mig. cipropride generally arises in the molecular formula c17h25n3o4s. the term cipropride is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) cipropride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cipropride under hs 29350090 and sitc 51580. as of q4 2014, cipropride remains the us fda preferred term for this commodity. cipropride bears us nlm identifiers umls id c0055777 and nci concept code c78026. smiles: s(=o)(=o)(n)c1cc(c(=o)ncc2n(cc3cc3)ccc2)c(oc)cc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. benzquinamide. this classification denotes an antiemetic agent with the molecular formula c22h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0475ea27q3, chemically known as 3-diethylcarbamoyl-2,3,4,6,7,11b-hexahydro-9,10-dimethoxy-1h-benzo(a)chinolizin-2-yl acetat but generally known as benzquinamide, which bears us nih compound identifier 2342. benzquinamide most often comes in base and hydrochloride forms. european medicines agency schedules benzquinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05768mig. the term benzquinamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). benzquinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benzquinamide under hs 29339990 and sitc 51577. as of q4 2014, benzquinamide remains the us fda preferred term for this commodity. benzquinamide bears us nlm identifiers umls id c0053284 and nci concept code c65253. smiles: o(c1c(cn2c(c1)c1c(cc2)cc(oc)c(oc)c1)c(=o)n(cc)cc)c(=o)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. bromopride. this classification denotes a dopamine antagonist and antiemetic agent with the molecular formula c14h22brn3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 75473v2yzk, chemically known as o-anisamide, 4-amino-5-bromo-n-(2-(diethylamino)ethyl)- but generally known as bromopride, which bears us nih compound identifier 2446. bromopride most often comes in base and hydrochloride forms. european medicines agency schedules bromopride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05921mig. the term bromopride is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules bromopride in its anatomical therapeutic chemical (atc) classification. bromopride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bromopride under hs 29242995 and sitc 51479. as of q4 2014, bromopride remains the us fda preferred term for this commodity. bromopride bears us nlm identifiers umls id c0054129 and nci concept code c73035. smiles: brc1cc(c(=o)nccn(cc)cc)c(oc)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. cannabinol or nabiximols or tetrahydrocannabinol. this classification denotes an antiemetic agent with the molecular formula c21h26o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7uyp6mc9gh, chemically known as 6,6,9-trimethyl-3-pentyl-6h-dibenzo(b,d)pyran-1-ol but generally known as cannabinol, which bears us nih compound identifier 2543. cannabinol most often comes in base, methyl, and tert-butyldimethylsilyl ether forms. european medicines agency schedules cannabinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06074mig. the term cannabinol is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). cannabinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cannabinol under hs 29329985 and sitc 51569. as of q4 2014, cannabinol remains the us fda preferred term for this commodity. cannabinol bears us nlm identifiers umls id c0006865 and nci concept code c84510. smiles: o1c(c2c(c3c1cc(ccccc)cc3o)cc(cc2)c)(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. casopitant. this classification denotes an antidepressant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3b03kpm27l. european medicines agency schedules casopitant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32122. casopitant generally arises in the molecular formula c30h35f7n4o2. the term casopitant is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56.) most nations schedule casopitant under hs 29335990 and sitc 51576. as of q4 2014, casopitant remains the us fda preferred term for this commodity. casopitant bears us nlm identifiers umls id c2347566 and nci concept code c71635. smiles: cc1cc(ccc1[c@h]2c[c@h](ccn2c(=o)n(c)[c@h](c)c3cc(cc(c3)c(f)(f)f)c(f)(f)f)n4ccn(cc4)c(=o)c)f.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. cilansetron. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c20h21n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2j6dq1u5b5, chemically known as 4h-pyrido(3,2,1-jk)carbazol-11(8h)-one, 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-, (r)- but generally known as cilansetron, which bears us nih compound identifier 65939. european medicines agency schedules cilansetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06263mig. the term cilansetron is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). world health organization schedules cilansetron in its anatomical therapeutic chemical (atc) classification. most nations schedule cilansetron under hs 29332990 and sitc 51573. as of q4 2014, cilansetron remains the us fda preferred term for this commodity. cilansetron bears us nlm identifiers umls id c0249289 and nci concept code c76106. smiles: o=c1c(ccc2n3c4c(c12)cccc4ccc3)cn1c(ncc1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. flumeridone. this classification denotes an antiemetic agent with the molecular formula c22h23clfn5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7zzn46qu1n, chemically known as 2h-benzimidazol-2-one, 1-(3-(4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1-piperidinyl)propyl)-5-fluoro-1,3-dihydro- but generally known as flumeridone, which bears us nih compound identifier 71758. european medicines agency schedules flumeridone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07697mig. the term flumeridone is an international non-proprietary name. flumeridone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flumeridone under hs 29333999 and sitc 51574. as of q4 2014, flumeridone remains the us fda preferred term for this commodity. flumeridone bears us nlm identifiers umls id c1880808 and nci concept code c65716. smiles: clc1cc2[nh]c(=o)n(c3ccn(cc3)cccn3c4c([nh]c3=o)cc(f)cc4)c2cc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. fosaprepitant or ivemend. this classification denotes an antiemetic agent with the molecular formula c23h22f7n4o6p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6l8of9xrdc. european medicines agency schedules fosaprepitant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25384. the term fosaprepitant is an international non-proprietary name. fosaprepitant or ivemend bears us nlm identifiers umls id c2349941 and nci concept code c72787. smiles: cc(c1=cc(=cc(=c1)c(f)(f)f)c(f)(f)f)oc2c(n(cco2)cc3=nc(=o)n(n3)p(=o)(o)o)c4=cc=c(c=c4)f.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. hydroxyzine. this classification denotes a histamine-1 receptor antagonist with the molecular formula c21h27cln2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30s50ym8og, chemically known as ethanol, 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)- but generally known as hydroxyzine, which bears us nih compound identifier 3658. european medicines agency schedules hydroxyzine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08088mig. the term hydroxyzine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules hydroxyzine in its anatomical therapeutic chemical (atc) classification. hydroxyzine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydroxyzine under hs 29335995 and sitc 51576. as of q4 2014, hydroxyzine remains the us fda preferred term for this commodity. hydroxyzine bears us nlm identifiers umls id c0020404 and nci concept code c29103. smiles: clc1ccc(c(n2ccn(cc2)ccocco)c2ccccc2)cc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. hyoscine or levo-duboisine or scopolamine. this classification denotes a mydriatic agent and antimuscarinic agent with the molecular formula c17h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dl48g20x8x, chemically known as 1.alpha.h, 5.alpha.h-tropan-3.alpha.-ol, 6.beta.,7.beta.-epoxy-, (-)-tropate (ester), hydrobromide but generally known as hyoscine, which bears us nih compound identifier 5184. european medicines agency schedules hyoscine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14152mig. world health organization schedules hyoscine in its anatomical therapeutic chemical (atc) classification. smiles: o1c2c1c1n(c2cc(oc(=o)c(co)c2ccccc2)c1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. iprozilamine. this classification denotes an antiemetic agent with the molecular formula c13h22cln5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8wtg4rsp9y, chemically known as pyrimidine, 4-chloro-2-isopropylamino-6-(4-methylpiperazino)-5-methylthio- but generally known as iprozilamine, which bears us nih compound identifier 68725. european medicines agency schedules iprozilamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08288mig. the term iprozilamine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). iprozilamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule iprozilamine under hs 29335995 and sitc 51576. as of q4 2014, iprozilamine remains the us fda preferred term for this commodity. iprozilamine bears us nlm identifiers umls id c1881265 and nci concept code c65958. smiles: clc1nc(nc(n2ccn(cc2)c)c1sc)nc(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. denipride. this classification denotes an antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t5ibt2zqs3. european medicines agency schedules denipride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06976mig. denipride generally arises in the molecular formula c18h26n4o5. the term denipride is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) denipride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule denipride under hs 29349990 and sitc 51579. as of q4 2014, denipride remains the us fda preferred term for this commodity. denipride bears us nlm identifiers umls id c2699588 and nci concept code c78027. smiles: o1c(cn2ccc(nc(=o)c3c(oc)cc(n)c([n](=o)o)c3)cc2)ccc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. maropitant. this classification denotes an antiemetic agent with the molecular formula c32h40n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4xe2t9h4dh, chemically known as (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine but generally known as maropitant, which bears us nih compound identifier 204108. the term maropitant is an international non-proprietary name or inn. most nations schedule maropitant under hs 29333999 and sitc 51574. as of q4 2014, maropitant remains the us fda preferred term for this commodity. maropitant bears us nlm identifiers umls id c1871004 and nci concept code c81500. smiles: cc(c)(c)c1=cc(=c(c=c1)oc)cnc2c3ccn(c2c(c4=cc=cc=c4)c5=cc=cc=c5)cc3.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. nabilone. this classification denotes an antiemetic agent with the molecular formula c24h36o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2n4o9l084n, chemically known as 9h-dibenzo(b,d)pyran-9-one, 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-, trans-(.+/-.)- but generally known as nabilone, which bears us nih compound identifier 39860. european medicines agency schedules nabilone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09104mig. the term nabilone is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules nabilone in its anatomical therapeutic chemical (atc) classification. nabilone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nabilone under hs 29329985 and sitc 51569. as of q4 2014, nabilone remains the us fda preferred term for this commodity. nabilone bears us nlm identifiers umls id c1263104 and nci concept code c1171. smiles: o1c(c2c(cc(=o)cc2)c2c1cc(c(cccccc)(c)c)cc2o)(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. nantradol. this classification denotes an analgesic agent with the molecular formula c27h35no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9kb5wi7mq6, chemically known as 1,9-phenanthridinediol, 5,6,6a,7,8,9,10, 10a-octahydro-6-methyl-3-(1-methyl-4-phenylbutoxy)-, 1-acetate, hydrochloride, (6a,6a.alpha.,9.alpha.,10a.beta.)- but generally known as nantradol, which bears us nih compound identifier 107822. european medicines agency schedules nantradol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09151mig. the term nantradol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). nantradol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nantradol under hs 29339990 and sitc 51577. as of q4 2014, nantradol remains the us fda preferred term for this commodity. nantradol bears us nlm identifiers umls id c0068401 and nci concept code c83983. smiles: oc1cc2c(cc1)c(nc1c2c(oc(=o)c)cc(oc(cccc2ccccc2)c)c1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. nonabine. this classification denotes an antiemetic agent and antidepressant agent with the molecular formula c25h33no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 77duk856j7, chemically known as 7-(1,2-dimethylheptyl)-2,2-dimethyl-4-(4-pyridyl)-2h-1-benzopyran-5-ol but generally known as nonabine, which bears us nih compound identifier 71885. european medicines agency schedules nonabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09348mig. the term nonabine is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). nonabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nonabine under hs 29349990 and sitc 51579. as of q4 2014, nonabine remains the us fda preferred term for this commodity. nonabine bears us nlm identifiers umls id c0132764 and nci concept code c72950. smiles: o1c(c=c(c2c1cc(c(c(ccccc)c)c)cc2o)c1ccncc1)(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. pancopride. this classification denotes a serotonin antagonist with the molecular formula c18h24cln3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w80hw6q65o, chemically known as benzamide, 4-amino-n-1-azabicyclo(2.2.2)oct-3-yl-5-chloro-2-(cyclopropylmethoxy)-, (+-)- but generally known as pancopride, which bears us nih compound identifier 71342. european medicines agency schedules pancopride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09602mig. the term pancopride is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). pancopride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pancopride under hs 29333999 and sitc 51574. as of q4 2014, pancopride remains the us fda preferred term for this commodity. pancopride bears us nlm identifiers umls id c0210840 and nci concept code c87213. smiles: clc1cc(c(=o)nc2c3ccn(c2)cc3)c(occ2cc2)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. pipamazine. this classification denotes an antiemetic agent with the molecular formula c21h24cln3os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 653552fh1n, chemically known as isonipecotamide, 1-(3-(2-chlorophenothiazin-10-yl)propyl)- but generally known as pipamazine, which bears us nih compound identifier 6761. european medicines agency schedules pipamazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09859mig. the term pipamazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). pipamazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pipamazine under hs 29343090 and sitc 51578. as of q4 2014, pipamazine remains the us fda preferred term for this commodity. pipamazine bears us nlm identifiers umls id c0301468 and nci concept code c81501. smiles: clc1cc2n(cccn3ccc(cc3)c(=o)n)c3c(sc2cc1)cccc3.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. levonantradol. this classification denotes an antiemetic agent with the molecular formula c27h35no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 03s640adsk, chemically known as 1,9-phenanthridinediol, 5,6,6a,7,8,9,10,10a-octahydro-6-methyl-3-((1r)-1-methyl-4-phenylbutoxy)-, 1-acetate, (6s,6ar,9r,10ar)- but generally known as levonantradol, which bears us nih compound identifier 5361881. european medicines agency schedules levonantradol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08482mig. the term levonantradol is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). levonantradol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levonantradol under hs 29339990 and sitc 51577. as of q4 2014, levonantradol remains the us fda preferred term for this commodity. levonantradol bears us nlm identifiers umls id c0125660 and nci concept code c1385. smiles: oc1cc2c(cc1)c(nc1c2c(oc(=o)c)cc(oc(cccc2ccccc2)c)c1)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. prochlorperazine mesilate. this classification denotes a phenothiazine with the molecular formula c20h24cln3s.2ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 531sh87h9n, chemically known as piperazine, 1-methyl-4-(3-(2-chloro-phenothiazin-10-yl)propyl)-, hydrogen methanesulfonate but generally known as prochlorperazine mesilate, which bears us nih compound identifier 94252. european medicines agency schedules prochlorperazine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04053mig. most nations schedule prochlorperazine mesilate under hs 29343090 and sitc 51578. smiles: clc1cc2n(cccn3ccn(cc3)c)c3c(sc2cc1)cccc3.s(=o)(=o)(o)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. ricasetron. this classification denotes a 5-ht3 receptor antagonist with the molecular formula c19h27n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r92jb88o88, chemically known as 3,3-dimethyl-n-1alphah,5alphah-tropan-3alpha-yl-1-indolinecarboxamide but generally known as ricasetron, which bears us nih compound identifier 71785. european medicines agency schedules ricasetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10301mig. the term ricasetron is an international non-proprietary name. most nations schedule ricasetron under hs 29399900 and sitc 54149. as of q4 2014, ricasetron remains the us fda preferred term for this commodity. ricasetron bears us nlm identifiers umls id c2699081 and nci concept code c77263. smiles: o=c(nc1cc2n(c(c1)cc2)c)n1cc(c2c1cccc2)(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. tinisulpride. this classification denotes an antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 037s03tj5m. european medicines agency schedules tinisulpride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11075mig. tinisulpride generally arises in the molecular formula c20h29n3o4s. the term tinisulpride is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21.) tinisulpride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tinisulpride under hs 29350090 and sitc 51580. as of q4 2014, tinisulpride remains the us fda preferred term for this commodity. tinisulpride bears us nlm identifiers umls id c2699949 and nci concept code c74451. smiles: s(=o)(=o)(nc(c)(c)c#c)c1cc(c(=o)ncc2n(ccc2)cc)c(oc)cc1.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. tropisetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula c17h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6i819nik1w, chemically known as 1h-indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo- but generally known as tropisetron, which bears us nih compound identifier 72165. european medicines agency schedules tropisetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11345mig. the term tropisetron is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules tropisetron in its anatomical therapeutic chemical (atc) classification. tropisetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tropisetron under hs 29399900 and sitc 54149. as of q4 2014, tropisetron remains the us fda preferred term for this commodity. tropisetron bears us nlm identifiers umls id c0063322 and nci concept code c1131. smiles: o(c1cc2n(c(cc2)c1)c)c(=o)c1c2c([nh]c1)cccc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. ramosetron. this classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula c17h17n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7zro0sc54y, chemically known as (-)-(r)-1-methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl ketone. but generally known as ramosetron, which bears us nih compound identifier 108000. european medicines agency schedules ramosetron in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10254mig. the term ramosetron is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). ramosetron is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ramosetron under hs 29339990 and sitc 51577. as of q4 2014, ramosetron remains the us fda preferred term for this commodity. ramosetron bears us nlm identifiers umls id c0526950 and nci concept code c61921. smiles: o=c(c1ccc2nc[nh]c2c1)c1c2c(n(c1)c)cccc2.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. clebopride. this classification denotes a dopamine antagonist with the molecular formula c20h24cln3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i0a84520y9, chemically known as benzamide, 4-amino-5-chloro-2-methoxy-n-(1-(phenylmethyl)-4-piperidinyl)- but generally known as clebopride, which bears us nih compound identifier 2780. european medicines agency schedules clebopride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06646mig. the term clebopride is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules clebopride in its anatomical therapeutic chemical (atc) classification. clebopride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clebopride under hs 29333999 and sitc 51574. as of q4 2014, clebopride remains the us fda preferred term for this commodity. clebopride bears us nlm identifiers umls id c0055869 and nci concept code c83627. smiles: clc1cc(c(=o)nc2ccn(cc2)cc2ccccc2)c(oc)cc1n.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. acetylleucine. this classification denotes an amino acid derivative with the molecular formula c8h15no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k76s41v71x, chemically known as (r,s)-n-acetylleucin but generally known as acetylleucine, which bears us nih compound identifier 1995. european medicines agency schedules acetylleucine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05231mig. the term acetylleucine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules acetylleucine in its anatomical therapeutic chemical (atc) classification. acetylleucine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acetylleucine under hs 29241900 and sitc 51471. as of q4 2014, acetylleucine remains the us fda preferred term for this commodity. acetylleucine bears us nlm identifiers umls id c0256552 and nci concept code c72679. smiles: oc(=o)c(nc(=o)c)cc(c)c.. "
"antiemetics and antinauseants and antivertigo agents. this classification denotes drugs used to prevent nausea or vomiting. antiemetics act by a wide range of mechanisms. some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors.. fludorex. this classification denotes an antiemetic agent and anorexiant with the molecular formula c11h14f3no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 346fqp00bi, chemically known as benzeneethanamine, beta-methoxy-n-methyl-3-(trifluoromethyl)- but generally known as fludorex, which bears us nih compound identifier 27139. european medicines agency schedules fludorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07682mig. the term fludorex is an international non-proprietary name. fludorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fludorex under hs 29221980 and sitc 51461. as of q4 2014, fludorex remains the us fda preferred term for this commodity. fludorex bears us nlm identifiers umls id c2983802 and nci concept code c90617. smiles: cncc(c1cccc(c1)c(f)(f)f)oc.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. . "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. cimetidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c10h16n6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 80061l1wgd, chemically known as guanidine, n-cyano-n-methyl-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)- but generally known as cimetidine, which bears us nih compound identifier 2756. european medicines agency schedules cimetidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06279mig. the term cimetidine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules cimetidine in its anatomical therapeutic chemical (atc) classification. cimetidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cimetidine under hs 29332990 and sitc 51573. as of q4 2014, cimetidine remains the us fda preferred term for this commodity. cimetidine bears us nlm identifiers umls id c0008783 and nci concept code c374. smiles: cc1=c(n=cn1)csccnc(=nc)nc#n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. famotidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c8h15n7o2s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5qzo15j2z8, chemically known as propanimidamide, n-(aminosulfonyl)-3-(((2-((diaminomethylene)amino)-4-thiazoly)methyl)thio)- but generally known as famotidine, which bears us nih compound identifier 3325. european medicines agency schedules famotidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07503mig. the term famotidine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules famotidine in its anatomical therapeutic chemical (atc) classification. famotidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule famotidine under hs 29341000 and sitc 51579. as of q4 2014, famotidine remains the us fda preferred term for this commodity. famotidine bears us nlm identifiers umls id c0015620 and nci concept code c29045. smiles: s(ccc(=n\\s(=o)(=o)n)\\n)cc1nc(sc1)/n=c(/n)n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. nizatidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c12h21n5o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p41pml4ghr, chemically known as 1,1-ethenediamine, n-(2-(((2-((dimethylamino)methyl)-4-thiazoly)methyl)thio)ethyl)-n-methyl-2-nitro- but generally known as nizatidine, which bears us nih compound identifier 3033637. european medicines agency schedules nizatidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09335mig. the term nizatidine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules nizatidine in its anatomical therapeutic chemical (atc) classification. nizatidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nizatidine under hs 29341000 and sitc 51579. as of q4 2014, nizatidine remains the us fda preferred term for this commodity. nizatidine bears us nlm identifiers umls id c0085154 and nci concept code c29295. smiles: s(ccn/c(=c/[n](=o)o)nc)cc1nc(sc1)cn(c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. cisapride. this classification denotes an antiemetic agent with the molecular formula c23h29clfn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uvl329170w, chemically known as benzamide, 4-amino-5-chloro-n-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis- but generally known as cisapride, which bears us nih compound identifier 2769. european medicines agency schedules cisapride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07479mig. the term cisapride is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules cisapride in its anatomical therapeutic chemical (atc) classification. cisapride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cisapride under hs 29333999 and sitc 51574. as of q4 2014, cisapride remains the us fda preferred term for this commodity. cisapride bears us nlm identifiers umls id c0072916 and nci concept code c1210. smiles: clc1cc(c(=o)nc2c(oc)cn(cc2)cccoc2ccc(f)cc2)c(oc)cc1n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. lansoprazole. this classification denotes a proton pump inhibitor with the molecular formula c16h14f3n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0k5c5t2qpg, chemically known as 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as lansoprazole, which bears us nih compound identifier 3883. european medicines agency schedules lansoprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08403mig. the term lansoprazole is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules lansoprazole in its anatomical therapeutic chemical (atc) classification. lansoprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lansoprazole under hs 29333999 and sitc 51574. as of q4 2014, lansoprazole remains the us fda preferred term for this commodity. lansoprazole bears us nlm identifiers umls id c0286036 and nci concept code c29150. smiles: s(=o)(cc1nccc(occ(f)(f)f)c1c)c1[nh]c2c(n1)cccc2.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. esomeprazole or omeprazole. this classification denotes a proton pump inhibitor with the molecular formula c17h19n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kg60484qx9, chemically known as 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as omeprazole, which bears us nih compound identifier 4594. european medicines agency schedules omeprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09439mig. the term omeprazole is an international non-proprietary name. world health organization schedules omeprazole in its anatomical therapeutic chemical (atc) classification. omeprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. esomeprazole or omeprazole bears us nlm identifiers umls id c0028978 and nci concept code c716. smiles: s(=o)(cc1ncc(c(oc)c1c)c)c1[nh]c2c(n1)ccc(oc)c2.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pancreatin. this classification denotes a gastrointestinal drug and bile, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fq3drg0n5k.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. sucralfate. this classification denotes a radioprotective agent and cytoprotective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xx73205dh5. european medicines agency schedules sucralfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04613mig. sucralfate generally arises in the molecular formula c12h54al16o75s8. the term sucralfate is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10.) sucralfate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sucralfate under hs 29400000 and sitc 51692. as of q4 2014, sucralfate remains the us fda preferred term for this commodity. sucralfate bears us nlm identifiers umls id c0038633 and nci concept code c848. smiles: s(=o)(=o)(oc1c(oc2oc(c(os(=o)(=o)o)c(os(=o)(=o)o)c2os(=o)(=o)o)cos(=o)(=o)o)(oc(os(=o)(=o)o)c1os(=o)(=o)o)cos(=o)(=o)o)o.[al]([oh2])([oh2])[oh2].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pantoprazole. this classification denotes a proton pump inhibitor with the molecular formula c16h15f2n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d8tst4o562, chemically known as 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as pantoprazole, which bears us nih compound identifier 4679. european medicines agency schedules pantoprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09608mig. the term pantoprazole is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules pantoprazole in its anatomical therapeutic chemical (atc) classification. pantoprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pantoprazole under hs 29333999 and sitc 51574. as of q4 2014, pantoprazole remains the us fda preferred term for this commodity. pantoprazole bears us nlm identifiers umls id c0081876 and nci concept code c29346. smiles: s(=o)(c1[nh]c2c(n1)ccc(oc(f)f)c2)cc1nccc(oc)c1oc.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. rabeprazole sodium. this classification denotes a proton pump inhibitor with the molecular formula c18h21n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 32828355ll, chemically known as 1h-benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)- but generally known as rabeprazole, which bears us nih compound identifier 5029. european medicines agency schedules rabeprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10229mig. the term rabeprazole is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules rabeprazole in its anatomical therapeutic chemical (atc) classification. rabeprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rabeprazole sodium under hs 29333999 and sitc 51574. as of q4 2014, rabeprazole sodium remains the us fda preferred term for this commodity. rabeprazole sodium bears us nlm identifiers umls id c0732569 and nci concept code c80692. smiles: s(=o)(cc1nccc(occcoc)c1c)c1[nh]c2c(n1)cccc2.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ranitidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c19h27bin4o10s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7aj51i17kg, chemically known as bismuth;(e)-1-n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-n-methyl-2-nitroethene-1,1-diamine;2-hydroxypropane-1,2,3-tricarboxylate but generally known as ranitidine bismuth citrate, which bears us nih compound identifier 3033887. european medicines agency schedules ranitidine bismuth citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15106mig. the term ranitidine is an international non-proprietary name. world health organization schedules ranitidine in its anatomical therapeutic chemical (atc) classification. ranitidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ranitidine under hs 29321900 and sitc 51569. as of q4 2014, ranitidine remains the us fda preferred term for this commodity. ranitidine bears us nlm identifiers umls id c0034665 and nci concept code c29412. smiles: cnc(=c[n+](=o)[o-])nccscc1=cc=c(o1)cn(c)c.c(c(=o)[o-])c(cc(=o)[o-])(c(=o)[o-])o.[bi+3].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. tegaserod. this classification denotes a serotonin antagonist with the molecular formula c16h23n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 458vc51857, chemically known as hydrazinecarboximidamide, 2-((5-methoxy-1h-indol-3-yl)methylene)-n-pentyl- but generally known as tegaserod, which bears us nih compound identifier 5487301. european medicines agency schedules tegaserod in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04713mig. the term tegaserod is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 1, 1999, list 41). world health organization schedules tegaserod in its anatomical therapeutic chemical (atc) classification. most nations schedule tegaserod under hs 29339990 and sitc 51577. as of q4 2014, tegaserod remains the us fda preferred term for this commodity. tegaserod bears us nlm identifiers umls id c0537147 and nci concept code c66583. smiles: occ1cc2c(n=cc\\2=c/nn/c(=n/ccccc)n)cc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. rebamipide. this classification denotes an anti-ulcer agent with the molecular formula c19h15cln2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lr583v32zr, chemically known as 4-quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)- but generally known as rebamipide, which bears us nih compound identifier 5042. european medicines agency schedules rebamipide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10267mig. the term rebamipide is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). rebamipide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rebamipide under hs 29337900 and sitc 51561. as of q4 2014, rebamipide remains the us fda preferred term for this commodity. rebamipide bears us nlm identifiers umls id c0069562 and nci concept code c29852. smiles: clc1ccc(c(=o)nc(cc2c3c([nh]c(=o)c2)cccc3)c(=o)o)cc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. sevelamer. this classification denotes a polyamine compound with the molecular formula (c9h18n2o)n.(c3h7n)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 941n5duu5c, chemically known as 2-propen-1-amine polymer with (chloromethyl)oxirane, hydrochloride but generally known as sevelamer, which bears us nih compound identifier 159247. european medicines agency schedules sevelamer in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04381mig. the term sevelamer is an international non-proprietary name. world health organization schedules sevelamer in its anatomical therapeutic chemical (atc) classification. sevelamer is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sevelamer under hs 39119099 and sitc 57596. as of q4 2014, sevelamer remains the us fda preferred term for this commodity. sevelamer bears us nlm identifiers umls id c0718050 and nci concept code c84172. smiles: c=ccn.c1c(o1)ccl.cl.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. acetoxolone. this classification denotes a peptic ulcer drug with the molecular formula c32h48o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cww961q19k, chemically known as acetylglycyrrhetic acid or (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-acetoxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylic acid, and which bears us nih compound identifier 94320. european medicines agency schedules acetoxolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21866. as of q4 2014, acetoxolone remains the us fda preferred term for this commodity. acetoxolone bears us nlm identifiers umls id c0050521 and nci concept code c98247. smiles: cc(=o)oc1ccc2(c(c1(c)c)ccc3(c2c(=o)c=c4c3(ccc5(c4cc(cc5)(c)c(=o)o)c)c)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. bismuth subcitrate. this classification denotes a cytoprotective agent and anti-ulcer agent with the molecular formula 2c6h5o7.bi.3k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hs813p8qpx, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt (2:1:3) but generally known as bismuth subcitrate, which bears us nih compound identifier 6335486. european medicines agency schedules bismuth subcitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13089mig. world health organization schedules bismuth subcitrate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, bismuth subcitrate remains the us fda preferred term for this commodity. bismuth subcitrate bears us nlm identifiers umls id c0106556 and nci concept code c1351. smiles: c(c(=o)[o-])c(cc(=o)[o-])(c(=o)[o-])o.[bi+3].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. bismuth tripotassium dicitrate. this classification denotes a cytoprotective agent and anti-ulcer agent with the molecular formula 2c6h5o7.bi.3k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hs813p8qpx, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt (2:1:3) but generally known as bismuth subcitrate, which bears us nih compound identifier 6335486. european medicines agency schedules bismuth subcitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13089mig. world health organization schedules bismuth subcitrate in its anatomical therapeutic chemical (atc) classification. smiles: c(c(=o)o)c(cc(=o)[o-])(c(=o)o)o.c(c(=o)o)c(cc(=o)[o-])(c(=o)o)[o-].[k].[k].[k].[bi+3].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. candoxatril or candoxatrilat. this classification denotes an antihypertensive agent with the molecular formula c29h41no7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier acp75508ee, chemically known as (.alpha.s)-1-((cis-4-carboxycyclohexyl)carbamoyl)-.alpha.-((2-methoxyethoxy)methyl)cyclopentanepropionic acid, .alpha.-5-indanyl ester, but generally known as candoxatril, which bears us nih compound identifier 5362417. european medicines agency schedules candoxatril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06072mig. candoxatril or candoxatrilat bears us nlm identifiers umls id c0077780 and nci concept code c77602. smiles: coccocc(cc1(cccc1)c(=o)nc2ccc(cc2)c(=o)o)c(=o)oc3=cc4=c(ccc4)c=c3.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. cetraxate. this classification denotes an anxiolytic with the molecular formula c17h23no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5vpa8cpf0n, chemically known as hydrocinnamic acid, p-hydroxy-, 4-(aminomethyl)cyclohexanecarboxylate, trans- but generally known as cetraxate, which bears us nih compound identifier 2680. european medicines agency schedules cetraxate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07457mig. the term cetraxate is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). cetraxate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cetraxate under hs 29224995 and sitc 51465. as of q4 2014, cetraxate remains the us fda preferred term for this commodity. cetraxate bears us nlm identifiers umls id c0055150 and nci concept code c79885. smiles: o(c(=o)c1ccc(cc1)cn)c1ccc(cc1)ccc(=o)o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. cinitapride. this classification denotes a serotonin antagonist and serotonin agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r8i97i2l24. european medicines agency schedules cinitapride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06298mig. cinitapride generally arises in the molecular formula c21h30n4o4. the term cinitapride is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) cinitapride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cinitapride under hs 29333999 and sitc 51574. as of q4 2014, cinitapride remains the us fda preferred term for this commodity. cinitapride bears us nlm identifiers umls id c0055747 and nci concept code c77257. smiles: o=c(nc1ccn(cc2ccc=cc2)cc1)c1c(occ)cc(n)c([n](=o)o)c1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. colloidal bismuth subcitrate. this classification denotes a cytoprotective agent and anti-ulcer agent with the molecular formula 2c6h5o7.bi.3k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hs813p8qpx, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3+) potassium salt (2:1:3) but generally known as bismuth subcitrate, which bears us nih compound identifier 6335486. european medicines agency schedules bismuth subcitrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13089mig. world health organization schedules bismuth subcitrate in its anatomical therapeutic chemical (atc) classification. smiles: c(c(=o)[o-])c(cc(=o)[o-])(c(=o)[o-])o.[bi+3].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. deboxamet. this classification denotes an anti-ulcer agent with the molecular formula c12h14n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qjh0xa6aw9, chemically known as 1h-indole-3-acetamide, n-hydroxy-5-methoxy-2-methyl- but generally known as deboxamet, which bears us nih compound identifier 36660. european medicines agency schedules deboxamet in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06927mig. the term deboxamet is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). deboxamet is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule deboxamet under hs 29339990 and sitc 51577. as of q4 2014, deboxamet remains the us fda preferred term for this commodity. deboxamet bears us nlm identifiers umls id c0636219 and nci concept code c76483. smiles: cc1=c(c2=c(n1)c=cc(=c2)oc)cc(=o)no.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. dexlansoprazole. this classification denotes a proton pump inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uye4t5i70x. european medicines agency schedules dexlansoprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31929. dexlansoprazole generally arises in the molecular formula c16h14f3n3o2s. the term dexlansoprazole is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55.) dexlansoprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dexlansoprazole under hs 29333999 and sitc 51574. as of q4 2014, dexlansoprazole remains the us fda preferred term for this commodity. dexlansoprazole bears us nlm identifiers umls id c2607263 and nci concept code c73192. smiles: cc1=c(c=cn=c1cs(=o)c2=nc3=cc=cc=c3n2)occ(f)(f)f.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. disuprazole. this classification denotes a proton pump inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v81j4oo2ot. european medicines agency schedules disuprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06327mig. disuprazole generally arises in the molecular formula c16h17n3os2. the term disuprazole is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27.) disuprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule disuprazole under hs 29333999 and sitc 51574. as of q4 2014, disuprazole remains the us fda preferred term for this commodity. disuprazole bears us nlm identifiers umls id c1880366 and nci concept code c65441. smiles: s(=o)(cc1nccc(scc)c1c)c1[nh]c2c(n1)cccc2.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ebrotidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c14h17brn6o2s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tmz3ibw2ow, chemically known as benzenesulfonamide, n-(((2-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)ethyl)amino)methylene)-4-bromo-, (e)- but generally known as ebrotidine, which bears us nih compound identifier 65869. european medicines agency schedules ebrotidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06438mig. the term ebrotidine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). most nations schedule ebrotidine under hs 29350090 and sitc 51580. as of q4 2014, ebrotidine remains the us fda preferred term for this commodity. ebrotidine bears us nlm identifiers umls id c0169307 and nci concept code c77440. smiles: brc1ccc(s(=o)(=o)n/c=n/ccscc2nc(sc2)/n=c(/n)n)cc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. enprostil. this classification denotes an anti-ulcer agents and prostaglandins e, synthetic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j4ip5z9dau. european medicines agency schedules enprostil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06549mig. enprostil generally arises in the molecular formula c23h28o6. the term enprostil is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) enprostil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enprostil under hs 29375000 and sitc 54156. as of q4 2014, enprostil remains the us fda preferred term for this commodity. smiles: oc1c(c(c(=o)c1)cc=c=cccc(=o)oc)/c=c/c(o)coc1ccccc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. esaprazole. this classification denotes an anti-ulcer agent with the molecular formula c12h23n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 38qsu0ib5l, chemically known as 1-piperazineacetamide, n-cyclohexyl- but generally known as esaprazole, which bears us nih compound identifier 68835. european medicines agency schedules esaprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06607mig. the term esaprazole is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). esaprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule esaprazole under hs 29335995 and sitc 51576. as of q4 2014, esaprazole remains the us fda preferred term for this commodity. esaprazole bears us nlm identifiers umls id c0059583 and nci concept code c65535. smiles: o=c(nc1ccccc1)cn1ccncc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. fenoctimine. this classification denotes an anti-ulcer agent with the molecular formula c27h38n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, b45cf873f8 chemically known as 4-(diphenylmethyl)-1-(n-octylformimidoyl)piperidine, hemihydrate but generally known as fenoctimine, which bears us nih compound identifier 50455. european medicines agency schedules fenoctimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07575mig. the term fenoctimine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). most nations schedule fenoctimine under hs 29333999 and sitc 51574. as of q4 2014, fenoctimine remains the us fda preferred term for this commodity. fenoctimine bears us nlm identifiers umls id c0060178 and nci concept code c76485. smiles: ccccccccn=cn1ccc(cc1)c(c2=cc=cc=c2)c3=cc=cc=c3.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. metiamide. this classification denotes a histamine-2 receptor antagonist with the molecular formula c9h16n4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3k7670861m, chemically known as urea, 1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-2-thio- but generally known as metiamide, which bears us nih compound identifier 1548992. european medicines agency schedules metiamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08881mig. the term metiamide is an international non-proprietary name. metiamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metiamide under hs 29332990 and sitc 51573. as of q4 2014, metiamide remains the us fda preferred term for this commodity. metiamide bears us nlm identifiers umls id c0025845 and nci concept code c90862. smiles: s(cc1nc[nh]c1c)ccnc(=s)nc.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. gefarnate. this classification denotes an antispasmotic agent with the molecular formula c27h44o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1ise2y6ula, chemically known as 5,9,13-trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester but generally known as gefarnate, which bears us nih compound identifier 5282182. european medicines agency schedules gefarnate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07889mig. the term gefarnate is an international non-proprietary name. world health organization schedules gefarnate in its anatomical therapeutic chemical (atc) classification. gefarnate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gefarnate under hs 29161970 and sitc 51379. as of q4 2014, gefarnate remains the us fda preferred term for this commodity. gefarnate bears us nlm identifiers umls id c0017226 and nci concept code c73187. smiles: o(c(=o)cc/c=c(/cc/c=c(/cc/c=c(/c)c)c)c)c/c=c(/cc/c=c(/c)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. glaziovine. this classification denotes an anti-ulcer agent with the molecular formula c18h19no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ke7j8a65p6, chemically known as spiro(2,5-cyclohexadiene-1,7(1h)-cyclopent(ij)isoquinolin)-4-one, 2,3,8,8a-tetrahydro-6-hydroxy-5-methoxy-1-methyl-, (+-)- (9ci) but generally known as glaziovine, which bears us nih compound identifier 65631. european medicines agency schedules glaziovine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07911mig. the term glaziovine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). glaziovine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule glaziovine under hs 29399900 and sitc 54149. as of q4 2014, glaziovine remains the us fda preferred term for this commodity. glaziovine bears us nlm identifiers umls id c0061303 and nci concept code c73193. smiles: oc1c2c3(cc4n(ccc(c24)cc1oc)c)c=cc(=o)c=c3.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. irsogladine. this classification denotes an anti-ulcer agent with the molecular formula c9h7cl2n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qbx79nzc1d, chemically known as 1,3,5-triazine-2,4-diamine, 6-(2,5-dichlorophenyl)- but generally known as irsogladine, which bears us nih compound identifier 3752. european medicines agency schedules irsogladine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08299mig. the term irsogladine is an international non-proprietary name. irsogladine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule irsogladine under hs 29336980 and sitc 51576. as of q4 2014, irsogladine remains the us fda preferred term for this commodity. irsogladine bears us nlm identifiers umls id c0063879 and nci concept code c65964. smiles: clc1c(c2nc(nc(n2)n)n)cc(cl)cc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. isotiquimide. this classification denotes an anti-ulcer agent with the molecular formula c11h14n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ex1nd80x1i, chemically known as 8-quinolinecarbothioamide, 5,6,7,8-tetrahydro-4-methyl-,( -); but generally known as isotiquimide, which bears us nih compound identifier 3037235. european medicines agency schedules isotiquimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08340mig. the term isotiquimide is an international non-proprietary name. isotiquimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isotiquimide under hs 29334990 and sitc 51575. as of q4 2014, isotiquimide remains the us fda preferred term for this commodity. isotiquimide bears us nlm identifiers umls id c1881281 and nci concept code c65984. smiles: cc1=c2cccc(c2=nc=c1)c(=s)n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. lafutidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c22h29n3o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 49s4o7adlc, chemically known as acetamide, 2-((2-furanylmethyl)sulfinyl)-n-(4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)-, (z)- but generally known as lafutidine, which bears us nih compound identifier 5282136. european medicines agency schedules lafutidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08388mig. the term lafutidine is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules lafutidine in its anatomical therapeutic chemical (atc) classification. lafutidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lafutidine under hs 29349990 and sitc 51579. as of q4 2014, lafutidine remains the us fda preferred term for this commodity. lafutidine bears us nlm identifiers umls id c0172827 and nci concept code c79117. smiles: s(=o)(cc1occc1)cc(=o)nc/c=c\\coc1nccc(cn2ccccc2)c1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. lamtidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c18h28n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bo55z3jl5k, chemically known as 1-(m-(3-((3-amino-1-methyl-1h-1,2,4-triazol-5-yl)amino)propoxy)benzyl)piperidine but generally known as lamtidine, which bears us nih compound identifier 71988. european medicines agency schedules lamtidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08394mig. the term lamtidine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). lamtidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lamtidine under hs 29333999 and sitc 51574. as of q4 2014, lamtidine remains the us fda preferred term for this commodity. lamtidine bears us nlm identifiers umls id c0064637 and nci concept code c79118. smiles: o(c1cc(cn2ccccc2)ccc1)cccnc1n(nc(n1)n)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. lozilurea. this classification denotes an anti-ulcer agent with the molecular formula c10h13cln2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 677ayv0r9n, chemically known as urea, n-(m-chlorobenzyl)-n-ethyl- but generally known as lozilurea, which bears us nih compound identifier 68907. european medicines agency schedules lozilurea in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08611mig. the term lozilurea is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). lozilurea is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lozilurea under hs 29242190 and sitc 51473. as of q4 2014, lozilurea remains the us fda preferred term for this commodity. lozilurea bears us nlm identifiers umls id c0620245 and nci concept code c66039. smiles: ccnc(=o)ncc1=cc(=cc=c1)cl.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pirenzepine. this classification denotes an antimuscarinic agent with the molecular formula c19h21n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3g0285n20n, chemically known as 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one but generally known as pirenzepine, which bears us nih compound identifier 4848. european medicines agency schedules pirenzepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09904mig. the term pirenzepine is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules pirenzepine in its anatomical therapeutic chemical (atc) classification. pirenzepine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pirenzepine under hs 29335995 and sitc 51576. as of q4 2014, pirenzepine remains the us fda preferred term for this commodity. pirenzepine bears us nlm identifiers umls id c0031978 and nci concept code c76002. smiles: o=c(n1c2c(c(=o)[nh]c3c1nccc3)cccc2)cn1ccn(cc1)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. molfarnate. this classification denotes an anti-ulcer agent with the molecular formula c31h50o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5288i2k01s, chemically known as 3,7,11-trimethyl-2,6,10-dodecatrienyl 4,8,12-trimethyl-3,7,11-tridecatrienoate. but generally known as molfarnate, which bears us nih compound identifier 6446651. european medicines agency schedules molfarnate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09039mig. the term molfarnate is an international non-proprietary name. molfarnate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule molfarnate under hs 29161970 and sitc 51379. as of q4 2014, molfarnate remains the us fda preferred term for this commodity. molfarnate bears us nlm identifiers umls id c2825700 and nci concept code c81598. smiles: o(c/c=c(/cc/c=c(/cc/c=c(/c)c)c)c)c(=o)c/c=c(/cc/c=c(/cc/c=c(/c)c)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. niperotidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c20h26n4o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 12jbd7u72k, chemically known as 1,1-ethenediamine, n-(1,3-benzodioxol-5-ylmethyl)-n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-2-nitro- but generally known as niperotidine, which bears us nih compound identifier 3033952. european medicines agency schedules niperotidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09301mig. the term niperotidine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules niperotidine in its anatomical therapeutic chemical (atc) classification. niperotidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule niperotidine under hs 29321900 and sitc 51569. as of q4 2014, niperotidine remains the us fda preferred term for this commodity. niperotidine bears us nlm identifiers umls id c0650638 and nci concept code c90863. smiles: s(cc1oc(cn(c)c)cc1)ccnc(=c\\[n](=o)o)/ncc1cc2ococ2cc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. nolinium. this classification denotes an antiulcerative with the molecular formula c15h11cl2n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n018s592lp, chemically known as 2-(3,4-dichloroanilino)quinolizinium but generally known as nolinium, which bears us nih compound identifier 38666. the term nolinium is an international non-proprietary name or inn. european medicines agency schedules nolinium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09343mig. as of q4 2014, nolinium remains the us fda preferred term for this commodity. smiles: c1=cc=[n+]2c=cc(=cc2=c1)nc3=cc(=c(c=c3)cl)cl.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pibutidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c19h24n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4xrl9pl02y, chemically known as 3-cyclobutene-1,2-dione, 3-amino-4-((4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)amino)-, (z)- but generally known as pibutidine, which bears us nih compound identifier 5282450. european medicines agency schedules pibutidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09805mig. the term pibutidine is an international non-proprietary name. pibutidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pibutidine under hs 29333999 and sitc 51574. as of q4 2014, pibutidine remains the us fda preferred term for this commodity. pibutidine bears us nlm identifiers umls id c2825480 and nci concept code c81156. smiles: o(c1nccc(cn2ccccc2)c1)c/c=c\\cnc1=c(n)c(=o)c1=o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pifarnine. this classification denotes an anti-ulcer agent with the molecular formula c27h40n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3w85193gz4, chemically known as 4-farnesyl-1-(3,4-methylenedioxybenzyl)piperazine but generally known as pifarnine, which bears us nih compound identifier 6436032. european medicines agency schedules pifarnine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09827mig. the term pifarnine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). pifarnine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pifarnine under hs 29349990 and sitc 51579. as of q4 2014, pifarnine remains the us fda preferred term for this commodity. pifarnine bears us nlm identifiers umls id c0071052 and nci concept code c76487. smiles: o1c2cc(cn3ccn(cc3)c/c=c(/cc/c=c(/cc/c=c(/c)c)c)c)ccc2oc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. roxatidine. this classification denotes an anti-ulcer agent and histamine h2 antagonist with the molecular formula c17h26n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier iv9vht3yum, chemically known as acetamide, 2-hydroxy-n-(3-(3-(1-piperidinylmethyl)phenoxy)propyl)- but generally known as roxatidine, which bears us nih compound identifier 91276. european medicines agency schedules roxatidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10396mig. world health organization schedules roxatidine in its anatomical therapeutic chemical (atc) classification. roxatidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule roxatidine under hs 29333999 and sitc 51574. as of q4 2014, roxatidine remains the us fda preferred term for this commodity. smiles: o(c1cc(cn2ccccc2)ccc1)cccnc(=o)co.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. plaunotol. this classification denotes an anti-ulcer agent with the molecular formula c20h34o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mv715x4634, chemically known as 2,6,10,14-hexadecatetraen-1-ol, 7-(hydroxymethyl)-3,11,15-trimethyl-, (e,z,e)- but generally known as plaunotol, which bears us nih compound identifier 5282197. european medicines agency schedules plaunotol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09956mig. the term plaunotol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). plaunotol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule plaunotol under hs 29053985 and sitc 51229. as of q4 2014, plaunotol remains the us fda preferred term for this commodity. plaunotol bears us nlm identifiers umls id c0071276 and nci concept code c66446. smiles: occ(=c\\cc/c(=c/co)c)/cc/c=c(/cc/c=c(/c)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. proglumide. this classification denotes an anti-ulcer agent with the molecular formula c18h26n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier epl8w5565d, chemically known as 2,5-diamino-5-oxopentanoic acid but generally known as proglumide, which bears us nih compound identifier 738. european medicines agency schedules proglumide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10078mig. the term proglumide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules proglumide in its anatomical therapeutic chemical (atc) classification. proglumide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule proglumide under hs 29242995 and sitc 51479. as of q4 2014, proglumide remains the us fda preferred term for this commodity. proglumide bears us nlm identifiers umls id c0033321 and nci concept code c81916. smiles: oc(=o)c(n)ccc(=o)n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. propinetidine. this classification denotes a histamine-2 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70qv580pa4. european medicines agency schedules propinetidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10108mig. propinetidine generally arises in the molecular formula c19h25no2. the term propinetidine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) most nations schedule propinetidine under hs 29333999 and sitc 51574. as of q4 2014, propinetidine remains the us fda preferred term for this commodity. propinetidine bears us nlm identifiers umls id c1882491 and nci concept code c66484. smiles: o(c1(ccn(cc1)ccc1ccccc1)cc#c)c(=o)cc.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. proxazole. this classification denotes an antispasmotic agent with the molecular formula c17h25n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fd72t13m0k, chemically known as 1,2,4-oxadiazole-5-ethanamine, n,n-diethyl-3-(1-phenylpropyl)-, (+)- (9ci) but generally known as proxazole, which bears us nih compound identifier 8590. european medicines agency schedules proxazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10146mig. the term proxazole is an international non-proprietary name. world health organization schedules proxazole in its anatomical therapeutic chemical (atc) classification. proxazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule proxazole under hs 29349990 and sitc 51579. as of q4 2014, proxazole remains the us fda preferred term for this commodity. proxazole bears us nlm identifiers umls id c0072507 and nci concept code c74176. smiles: o1nc(nc1ccn(cc)cc)c(cc)c1ccccc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ramixotidine. this classification denotes a histamine-2 receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 957w618927. european medicines agency schedules ramixotidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10250mig. ramixotidine generally arises in the molecular formula c16h21n3o3s. the term ramixotidine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26.) ramixotidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ramixotidine under hs 29349990 and sitc 51579. as of q4 2014, ramixotidine remains the us fda preferred term for this commodity. ramixotidine bears us nlm identifiers umls id c0139912 and nci concept code c76679. smiles: s(cc1oc(cn(c)c)cc1)ccnc(=o)c1c[n](o)ccc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. rotraxate. this classification denotes an anti-ulcer agent with the molecular formula c17h23no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier krn50n3y2t, chemically known as benzenepropanoic acid, 4-((4-(aminomethyl)cyclohexyl)carbonyl)-, trans- but generally known as rotraxate, which bears us nih compound identifier 65829. european medicines agency schedules rotraxate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10393mig. the term rotraxate is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). rotraxate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rotraxate under hs 29225000 and sitc 51467. as of q4 2014, rotraxate remains the us fda preferred term for this commodity. rotraxate bears us nlm identifiers umls id c2699113 and nci concept code c76490. smiles: o=c(c1ccc(cc1)cn)c1ccc(cc1)ccc(=o)o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ursodeoxycholic acid or ursodiol. this classification denotes a protein kinase c inhibitor and anti-lipidemic agent with the molecular formula c24h40o4, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 724l30y2qr, chemically known as cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)- but more generally known as ursodeoxycholic acid, which bears us nih compound identifier 5645. european medicines agency schedules ursodeoxycholic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11389mig. the term ursodeoxycholic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules ursodeoxycholic acid in its anatomical therapeutic chemical (atc) classification. ursodiol bears us nlm identifiers umls id c0042105 and nci concept code c1818. smiles: oc1c2c3c(c(cc3)c(ccc(=o)o)c)(ccc2c2(c(c1)cc(o)cc2)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. spizofurone. this classification denotes an anti-ulcer agent with the molecular formula c12h10o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 94f21t5g3c, chemically known as 5-acetylspiro(benzofuran-2(3h),1-cyclopropan)-3-one but generally known as spizofurone, which bears us nih compound identifier 71755. european medicines agency schedules spizofurone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10637mig. the term spizofurone is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). spizofurone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spizofurone under hs 29329985 and sitc 51569. as of q4 2014, spizofurone remains the us fda preferred term for this commodity. spizofurone bears us nlm identifiers umls id c0075027 and nci concept code c73190. smiles: cc(=o)c1=cc2=c(c=c1)oc3(c2=o)cc3.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. sufotidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c20h31n5o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56b0591y76, chemically known as 1-(m-(3-((1-methyl-3-((methylsulfonyl)methyl)-1h-1,2,4-triazol-5-yl)amino)propoxy)benzyl)piperidine but generally known as sufotidine, which bears us nih compound identifier 71763. european medicines agency schedules sufotidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10673mig. the term sufotidine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). sufotidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sufotidine under hs 29333999 and sitc 51574. as of q4 2014, sufotidine remains the us fda preferred term for this commodity. sufotidine bears us nlm identifiers umls id c0075495 and nci concept code c73217. smiles: s(=o)(=o)(cc1nc(ncccoc2cc(cn3ccccc3)ccc2)n(n1)c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. benatoprazole or tenatoprazole. this classification denotes a proton pump inhibitor with the molecular formula c16h18n4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier re0689tx2k, chemically known as 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-imidazo(4,5-b)pyridine but generally known as tenatoprazole, which bears us nih compound identifier 636411. european medicines agency schedules tenatoprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04717mig. the term tenatoprazole is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). benatoprazole or tenatoprazole bears us nlm identifiers umls id c1455363 and nci concept code c90934. smiles: s(=o)(cc1ncc(c(oc)c1c)c)c1[nh]c2c(n1)nc(oc)cc2.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. geranylgeranylacetone or teprenone. this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s8s8451a4o. european medicines agency schedules teprenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15486mig. teprenone generally arises in the molecular formula c23h38o. the term teprenone is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) teprenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. geranylgeranylacetone or teprenone bears us nlm identifiers umls id c0061231 and nci concept code c66587. smiles: cc(=ccc/c(=c/cc/c(=c/cc/c(=c/ccc(=o)c)/c)/c)/c)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. timoprazole. this classification denotes a proton pump inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95h6s1x9cc. european medicines agency schedules timoprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11071mig. timoprazole generally arises in the molecular formula c13h11n3os. the term timoprazole is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16.) timoprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule timoprazole under hs 29333999 and sitc 51574. as of q4 2014, timoprazole remains the us fda preferred term for this commodity. timoprazole bears us nlm identifiers umls id c0076690 and nci concept code c80634. smiles: s(=o)(c1[nh]c2c(n1)cccc2)cc1ncccc1.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. tiquinamide. this classification denotes an anti-ulcer agent with the molecular formula c11h14n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51o951x8v9, chemically known as 5,6,7,8-tetrahydro-3-methyl-8-quinolinecarbothioamide but generally known as tiquinamide, which bears us nih compound identifier 3003921. european medicines agency schedules tiquinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11112mig. the term tiquinamide is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). tiquinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiquinamide under hs 29334990 and sitc 51575. as of q4 2014, tiquinamide remains the us fda preferred term for this commodity. tiquinamide bears us nlm identifiers umls id c0076720 and nci concept code c90778. smiles: cc1=cn=c2c(cccc2=c1)c(=s)n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. tuvatidine. this classification denotes a histamine-2 receptor antagonist with the molecular formula c10h17n9o2s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier twn203tlyt, chemically known as guanidine, (4-(((2-((5-amino-4-methyl-4h-1,2,4,6-thiatriazin-3-yl)amino)ethyl)thio)methyl)-2-thiazolyl)-, s,s-dioxide but generally known as tuvatidine, which bears us nih compound identifier 65826. european medicines agency schedules tuvatidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11368mig. the term tuvatidine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). tuvatidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tuvatidine under hs 29341000 and sitc 51579. as of q4 2014, tuvatidine remains the us fda preferred term for this commodity. tuvatidine bears us nlm identifiers umls id c2348828 and nci concept code c73216. smiles: cn1c(=ns(=o)(=o)n=c1nccscc2=csc(=n2)n=c(n)n)n.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. zolenzepine. this classification denotes an anti-ulcer agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o0xj4l38z3. european medicines agency schedules zolenzepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00177mig. zolenzepine generally arises in the molecular formula c19h24n6o2. the term zolenzepine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) zolenzepine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolenzepine under hs 29335995 and sitc 51576. as of q4 2014, zolenzepine remains the us fda preferred term for this commodity. zolenzepine bears us nlm identifiers umls id c1883608 and nci concept code c66704. smiles: o=c(n1c2c(n(nc2c)c)c(=o)[nh]c2c1cccc2)cn1ccn(cc1)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. zolimidine. this classification denotes an anti-ulcer agent with the molecular formula c14h12n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ycf001n8qb, chemically known as 2-(p-(methylsulfonyl)phenyl)imidazol(1,2-a)pyridine but generally known as zolimidine, which bears us nih compound identifier 14652. european medicines agency schedules zolimidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00179mig. the term zolimidine is an international non-proprietary name. world health organization schedules zolimidine in its anatomical therapeutic chemical (atc) classification. zolimidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolimidine under hs 29339990 and sitc 51577. as of q4 2014, zolimidine remains the us fda preferred term for this commodity. zolimidine bears us nlm identifiers umls id c0650163 and nci concept code c66705. smiles: s(=o)(=o)(c1ccc(c2nc3n(c2)cccc3)cc1)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. alglucerase. this classification denotes an enzyme replacement preparation with the molecular formula c2532h3854n672o711s16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 27t56c7kk0, more generally known as alglucerase. european medicines agency schedules alglucerase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05322mig. the term alglucerase is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33. alglucerase is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alglucerase under hs 35079090 and sitc 51691. smiles:. as of q4 2014, alglucerase remains the us fda preferred term for this commodity. . alglucerase bears us nlm identifiers umls id c0102139 and nci concept code c74208.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. alglucosidase alfa. this classification denotes an enzyme replacement preparation with the molecular formula c4758h7262n1274o1369s35, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dti67o9503, more generally known as alglucosidase alfa. european medicines agency schedules alglucosidase alfa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21275. the term alglucosidase alfa is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53. most nations schedule alglucosidase alfa under hs 35079090 and sitc 51691. smiles:. as of q4 2014, alglucosidase alfa remains the us fda preferred term for this commodity. . alglucosidase alfa bears us nlm identifiers umls id c1703294 and nci concept code c65221.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. imiglucerase. this classification denotes an enzyme replacement preparation with the molecular formula c2532h3843n671o711s16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q6u6j48bwy, more generally known as imiglucerase. european medicines agency schedules imiglucerase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08148mig. the term imiglucerase is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35. imiglucerase is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imiglucerase under hs 35079090 and sitc 51691. smiles:. as of q4 2014, imiglucerase remains the us fda preferred term for this commodity. . imiglucerase bears us nlm identifiers umls id c0291139 and nci concept code c65896.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. miglustat. this classification denotes a glucosidase inhibitor with the molecular formula c10h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier adn3s497az, chemically known as 3,4,5-piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2r,3r,4r,5s)- but generally known as miglustat, which bears us nih compound identifier 51634. european medicines agency schedules miglustat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20049. the term miglustat is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). world health organization schedules miglustat in its anatomical therapeutic chemical (atc) classification. most nations schedule miglustat under hs 29333999 and sitc 51574. as of q4 2014, miglustat remains the us fda preferred term for this commodity. miglustat bears us nlm identifiers umls id c1321596 and nci concept code c1222. smiles: ccccn1c[c@@h]([c@h]([c@@h]([c@h]1co)o)o)o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ornithine oxoglurate. this classification denotes an amino acid and ketoglutaric acids with the molecular formula c10h18n2o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier urk9d85myo, chemically known as 2-oxopentanedioic acid- d-ornithine(1:1) but generally known as ornithine oxoglurate, which bears us nih compound identifier 123900. european medicines agency schedules ornithine oxoglurate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03543mig. world health organization schedules bismuth subcitrate in its anatomical therapeutic chemical (atc) classification. most nations schedule ornithine oxoglurate under hs 29224995 and sitc 51465. smiles: c(cc(c(=o)o)n)cn.c(cc(=o)o)c(=o)c(=o)o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pancrelipase. this classification denotes an adverse event associated with metabolic and laboratory abnormalities with the molecular formula c5850h8902n1606o1739s49, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fq3drg0n5k, more generally known as pancrelipase. european medicines agency schedules pancrelipase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14362mig. the term pancrelipase is an international non-proprietary name or inn. as of q4 2014, pancrelipase remains the us fda preferred term for this commodity.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. pinaverium. this classification denotes a gastrointestinal drug with the molecular formula c26h41brno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u2368vve7o, chemically known as 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-4-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium, and which bears us nih compound identifier 40704. european medicines agency schedules pinaverium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03826mig. as of q4 2014, pinaverium remains the us fda preferred term for this commodity. smiles: cc1(c2ccc(c1c2)ccocc[n+]3(ccocc3)cc4=cc(=c(c=c4br)oc)oc)c.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. sacrosidase. this classification denotes a glycoside hydrolase found primarily in plants and yeasts, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8a7f670f2y, chemically known as .beta.-fructofuranosidase but generally known as sacrosidase. european medicines agency schedules sacrosidase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub38353. world health organization schedules bismuth subcitrate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, sacrosidase remains the us fda preferred term for this commodity.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. velaglucerase alfa. this classification denotes an enzyme replacement preparation with the molecular formula c2532h3854n672o711s16, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 23hye36b0i, more generally known as velaglucerase alfa. european medicines agency schedules velaglucerase alfa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31010. the term velaglucerase alfa is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 3, 2008, list 60. most nations schedule velaglucerase alfa under hs 35079000 and sitc 51691. smiles:. as of q4 2014, velaglucerase alfa remains the us fda preferred term for this commodity. . velaglucerase alfa bears us nlm identifiers umls id c2919267 and nci concept code c87735.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. carbenoxolone. this classification denotes a hydroxysteroid dehydrogenase inhibitor with the molecular formula c34h50o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mm6384ng73, chemically known as olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, hydrogen succinate but generally known as carbenoxolone, which bears us nih compound identifier 21913. carbenoxolone comes in base, adrenochrome, and sodium forms. european medicines agency schedules carbenoxolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06123mig. the term carbenoxolone is an international non-proprietary name. world health organization schedules carbenoxolone in its anatomical therapeutic chemical (atc) classification. carbenoxolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, carbenoxolone remains the us fda preferred term for this commodity. carbenoxolone bears us nlm identifiers umls id c0006979 and nci concept code c63669. smiles: o(c1c(c2c(c3c(c4(c(=cc3=o)c3c(cc4)(ccc(c3)(c)c(=o)o)c)c)(cc2)c)(cc1)c)(c)c)c(=o)ccc(=o)o.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. ranitidine bismuth citrate. this classification denotes a histamine-2 receptor antagonist with the molecular formula c13h22n4o3s.c6h5o7.bi, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7aj51i17kg, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, bismuth(3(+)) salt (1:1), compd. with n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n-methyl-2-nitro-1,1-ethenediamine (1:1) but more generally known as ranitidine bismuth citrate, which bears us nih compound identifier 3033887. european medicines agency schedules ranitidine bismuth citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15106mig. world health organization schedules ranitidine bismuth citrate in its anatomical therapeutic chemical (atc) classification. most nations schedule ranitidine bismuth citrate under hs 29321900 and sitc 51569. as of q4 2014, ranitidine bismuth citrate remains the us fda preferred term for this commodity. ranitidine bismuth citrate bears us nlm identifiers umls id c0139919 and nci concept code c66505. smiles: cnc(=c[n+](=o)[o-])nccscc1ccc(o1)cn(c)c.c(c(=o)[o-])c(cc(=o)[o-])(c(=o)[o-])o.[bi+3].. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. rabeprazole. this classification denotes a proton pump inhibitor with the molecular formula c18h21n3o3s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 32828355ll, chemically known as 1h-benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)- but more generally known as rabeprazole, which bears u.s. nih compound identifier 5029. european medicines agency schedules rabeprazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10229mig. the term rabeprazole is an international non-proprietary name or inn (see world health organization inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules rabeprazole in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. rabeprazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. agalsidase beta. a drug indicated for use in patients with fabry disease.. "
"antiulcer and related gastrointestinal gi drugs. this classification denotes various agents with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. this has included antibiotics to treat helicobacter infections; histamine h2 antagonists to reduce gastric acid secretion; and antacids for symptomatic relief.. vestronidase alfa. vestronidase alfa is a therapy intended to replace the deficient lysosomal enzyme beta-glucuronidase to help break down the glycosaminoglycans that accumulate in the tissues of patients with mps 7.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. . "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. chenodiol or chenodeoxycholic acid or chenodeoxycholic acid sodium salt. this classification denotes a cholagogue or choleretic agent with the molecular formula c24h40o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0gei24lg0j, chemically known as cholan-24-oic acid, 3,7-dihydroxy-, (3.alpha.,5.beta.,7.beta.)- but generally known as chenodeoxycholic acid, which bears us nih compound identifier 5645. european medicines agency schedules chenodeoxycholic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07463mig. the term chenodeoxycholic acid is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules chenodeoxycholic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule chenodiol under hs 29181900 and sitc 51392. smiles: oc1c2c3c(c(cc3)c(ccc(=o)o)c)(ccc2c2(c(c1)cc(o)cc2)c)c.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. dimethyl sulfoxide. this classification denotes a sulfur compound with the molecular formula c2h6os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yow8v9698h, chemically known as sulfoxide, dimethyl but generally known as dimethyl sulfoxide, which bears us nih compound identifier 679. european medicines agency schedules dimethyl sulfoxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07176mig. the term dimethyl sulfoxide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules dimethyl sulfoxide in its anatomical therapeutic chemical (atc) classification. most nations schedule dimethyl sulfoxide under hs 29309085 and sitc 51549. as of q4 2014, dimethyl sulfoxide remains the us fda preferred term for this commodity. dimethyl sulfoxide bears us nlm identifiers umls id c0012403 and nci concept code c437. smiles: s(=o)(c)c.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. fencibutirol. this classification denotes a cholagogue or choleretic agent with the molecular formula c16h22o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h2v165956a, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy-4-phenyl-, (+-)- but generally known as fencibutirol, which bears us nih compound identifier 71170. european medicines agency schedules fencibutirol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07547mig. the term fencibutirol is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). fencibutirol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fencibutirol under hs 29181985 and sitc 51392. as of q4 2014, fencibutirol remains the us fda preferred term for this commodity. fencibutirol bears us nlm identifiers umls id c0060160 and nci concept code c65641. smiles: oc1(ccc(cc1)c1ccccc1)c(cc)c(=o)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. alibendol. this classification denotes a cholagogue or choleretic agent with the molecular formula c13h17no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a8co1vzk2z, chemically known as m-anisamide, 5-allyl-2-hydroxy-n-(2-hydroxyethyl)- (8ci) but generally known as alibendol, which bears us nih compound identifier 71916. european medicines agency schedules alibendol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05323mig. the term alibendol is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). alibendol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alibendol under hs 29242995 and sitc 51479. as of q4 2014, alibendol remains the us fda preferred term for this commodity. alibendol bears us nlm identifiers umls id c0771472 and nci concept code c74231. smiles: o(c1c(o)c(cc(cc=c)c1)c(=o)ncco)c.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. azintamide. this classification denotes a cholagogue or choleretic agent with the molecular formula c10h14cln3os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier acz6l64b41, chemically known as 2-((6-chloro-3-pyridazinyl)thio)-n,n-diethylacetamide but generally known as azintamide, which bears us nih compound identifier 71105. european medicines agency schedules azintamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05658mig. the term azintamide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). azintamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azintamide under hs 29339990 and sitc 51577. as of q4 2014, azintamide remains the us fda preferred term for this commodity. azintamide bears us nlm identifiers umls id c1321999 and nci concept code c74232. smiles: ccn(cc)c(=o)csc1=nn=c(c=c1)cl.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. cholic acid. this classification denotes a cholagogue or choleretic agent with the molecular formula c24h40o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g1jo7801ae, chemically known as 3,7,12-trihydroxycholan-24-oic acid but generally known as cholic acid, which bears us nih compound identifier 303. european medicines agency schedules cholic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13348mig. world health organization schedules cholic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule cholic acid under hs 29181900 and sitc 51392. as of q4 2014, cholic acid remains the us fda preferred term for this commodity. cholic acid bears us nlm identifiers umls id c0055568 and nci concept code c91035. smiles: oc1c2(c(c3c(c4(c(cc3o)cc(o)cc4)c)c1)ccc2c(ccc(=o)o)c)c.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. clanobutin. this classification denotes a cholagogue or choleretic agent with the molecular formula c18h18clno4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w6y945055s, chemically known as butyric acid, 4-(p-chloro-n-(p-methoxyphenyl)benzamido)- but generally known as clanobutin, which bears us nih compound identifier 35378. european medicines agency schedules clanobutin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06639mig. the term clanobutin is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). clanobutin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clanobutin under hs 29242995 and sitc 51479. as of q4 2014, clanobutin remains the us fda preferred term for this commodity. clanobutin bears us nlm identifiers umls id c0055854 and nci concept code c77837. smiles: clc1ccc(c(=o)n(cccc(=o)o)c2ccc(oc)cc2)cc1.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. cyclobutyrol. this classification denotes a cholagogue or choleretic agent with the molecular formula c10h18o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8t4l120n6m, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy- but generally known as cyclobutyrol, which bears us nih compound identifier 72065. european medicines agency schedules cyclobutyrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06851mig. the term cyclobutyrol is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules cyclobutyrol in its anatomical therapeutic chemical (atc) classification. cyclobutyrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyclobutyrol under hs 29181985 and sitc 51392. as of q4 2014, cyclobutyrol remains the us fda preferred term for this commodity. cyclobutyrol bears us nlm identifiers umls id c0056739 and nci concept code c81039. smiles: ccc(c(=o)o)c1(ccccc1)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. cynarine. this classification denotes a cholagogue or choleretic agent with the molecular formula c25h24o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 85d81u9jav, chemically known as 1,5-dicaffeoylqunic acid but generally known as cynarine, which bears us nih compound identifier 5281769. european medicines agency schedules cynarine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06870mig. the term cynarine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). most nations schedule cynarine under hs 29182980 and sitc 51394. as of q4 2014, cynarine remains the us fda preferred term for this commodity. cynarine bears us nlm identifiers umls id c0056848 and nci concept code c81041. smiles: c1c(c(c(cc1(c(=o)o)oc(=o)c=cc2=cc(=c(c=c2)o)o)oc(=o)c=cc3=cc(=c(c=c3)o)o)o)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. deoxycholic acid. this classification denotes a cholagogue or choleretic agent with the molecular formula c24h40o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 005990whzz, chemically known as 3,12-dihydroxycholan-24-oic acid but generally known as deoxycholic acid, which bears us nih compound identifier 2987. european medicines agency schedules deoxycholic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13541mig. the term deoxycholic acid is an international non-proprietary name. most nations schedule deoxycholic acid under hs 29181900 and sitc 51392. as of q4 2014, deoxycholic acid remains the us fda preferred term for this commodity. deoxycholic acid bears us nlm identifiers umls id c0011479 and nci concept code c81042. smiles: oc1c2(c(c3c(c4(c(cc3)cc(o)cc4)c)c1)ccc2c(ccc(=o)o)c)c.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. febuprol. this classification denotes a cholagogue or choleretic agent with the molecular formula c13h20o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b5rkr9y63y, chemically known as 2-propanol, 1-n-butoxy-3-phenoxy- but generally known as febuprol, which bears us nih compound identifier 71119. european medicines agency schedules febuprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07520mig. the term febuprol is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). febuprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule febuprol under hs 29094990 and sitc 51617. as of q4 2014, febuprol remains the us fda preferred term for this commodity. febuprol bears us nlm identifiers umls id c0060132 and nci concept code c65627. smiles: o(cc(o)coc1ccccc1)cccc.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. fenipentol. this classification denotes a cholagogue or choleretic agent with the molecular formula c11h16o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x3fze77o60, chemically known as 1-pentanol, 1-phenyl- but generally known as fenipentol, which bears us nih compound identifier 3338. european medicines agency schedules fenipentol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07567mig. the term fenipentol is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). fenipentol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenipentol under hs 29062900 and sitc 51235. as of q4 2014, fenipentol remains the us fda preferred term for this commodity. fenipentol bears us nlm identifiers umls id c0060173 and nci concept code c65652. smiles: ccccc(c1=cc=cc=c1)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. florantyrone. this classification denotes a cholagogue or choleretic agent with the molecular formula c20h14o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uz5lmi200p, chemically known as 8-fluoranthenebutyric acid, gamma-oxo- but generally known as florantyrone, which bears us nih compound identifier 10617. european medicines agency schedules florantyrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07648mig. the term florantyrone is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). florantyrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule florantyrone under hs 29183000 and sitc 51395. as of q4 2014, florantyrone remains the us fda preferred term for this commodity. florantyrone bears us nlm identifiers umls id c0060463 and nci concept code c74233. smiles: o=c(c1cc2c3c4c(c2cc1)cccc4ccc3)ccc(=o)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. hymecromone. this classification denotes an indicator, reagent, and coumarin with the molecular formula c10h8o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3t5ng4q468, chemically known as 2h-1-benzopyren-2-one, 7-hydroxy-4-methyl- but generally known as hymecromone, which bears us nih compound identifier 5280567. european medicines agency schedules hymecromone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08089mig. world health organization schedules hymecromone in its anatomical therapeutic chemical (atc) classification. hymecromone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, hymecromone remains the us fda preferred term for this commodity. smiles: cc1=cc(=o)oc2=c1c=cc(=c2)o.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. oxazorone. this classification denotes a cholagogue/choleretic agent with the molecular formula c14h15no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 77243b845f. european medicines agency schedules oxazorone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09509mig. the term oxazorone is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11. ). oxazorone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxazorone under hs 29349990 and sitc 51579. as of q4 2014, oxazorone remains the us fda preferred term for this commodity. oxazorone bears us nlm identifiers umls id c2825424 and nci concept code c81043. smiles: o1ccn(cc1)cc1c2c(oc(=o)c1)cc(o)cc2.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. piprozolin or piprozoline. this classification denotes a piperidine with the molecular formula c14h22n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7786w0vv8m, chemically known as ethyl 3-ethyl-4-oxo-5-piperidino-.delta.(sup2, .alpha.)-thiazolidineacetate but generally known as piprozolin, which bears us nih compound identifier 28426. european medicines agency schedules piprozolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09889mig. world health organization schedules piprozolin in its anatomical therapeutic chemical (atc) classification. piprozolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: s1c(n2ccccc2)c(=o)n(c\\1=c\\c(=o)occ)cc.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. cyclobutyrol sodium. this classification denotes the sodium form of a cholagogue or choleretic agent with the molecular formula c10h18o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8t4l120n6m, chemically known as cyclohexaneacetic acid, alpha-ethyl-1-hydroxy- but more generally known as cyclobutyrol, which bears us nih compound identifier 72065. european medicines agency schedules cyclobutyrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06851mig. the term cyclobutyrol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules cyclobutyrol in its anatomical therapeutic chemical (atc) classification. cyclobutyrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cyclobutyrol sodium under hs 29181985 and sitc 51392. as of q4 2014, cyclobutyrol sodium remains us fdas preferred term for this commodity. smiles: ccc(c(=o)[o-])c1(ccccc1)o.[na+].. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. sincalide. sincalide (inn) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas.. "
"drugs used for gallbladder disease. drugs that treat disfunction in the human storage reservoir for bile secretion.. cinnarizine + calcium dobesilate. non-proliferative diabetic retinopathy.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. . "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pitofenone or pitofenone hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c22h25no4 and c22h25no4.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers m09n8k7yjy and he1za4zbex. european medicines agency schedules pitofenone in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub09946mig and sub03880mig. the term pitofenone is an international non-proprietary name or inn. pitofenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pitofenone and its salts under hs 29333999 and sitc 51574. as of q4 2014, pitofenone remains the us fda preferred term for this commodity. pitofenone bears us nlm nci concept code c73177. smiles: o(ccn1ccccc1)c1ccc(cc1)c(=o)c1c(cccc1)c(=o)oc (base) or coc(=o)c1ccccc1c(=o)c2ccc(cc2)occn3ccccc3.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. phloroglucinol. this classification denotes an indicator, reagent, antispasmodic, and trinitrobenzene with the molecular formula c6h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dhd7ffg6ys, chemically known as 1,3,5-triol but generally known as phloroglucinol, which bears us nih compound identifier 359. european medicines agency schedules phloroglucinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14845mig. world health organization schedules phloroglucinol in its anatomical therapeutic chemical (atc) classification. as of q4 2014, phloroglucinol remains the us fda preferred term for this commodity. smiles: oc1cc(o)cc(o)c1.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. viquidil or viquidil hydrochloride. this classification denotes a quinoline and vasodilator agent with the molecular formulas c20h24n2o2.clh and c20h24n2o2, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 48t4s8667s and u6fxt2v136, the base compound being chemically known as 1-propanone, 3-(3-ethenyl-4-piperidinyl)-1-(6-methoxy-4-quinolinyl)-(3r-cis)- but generally known as viquidil, which bears us nih compound identifier 198279. european medicines agency schedules viquidil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub00081mig and sub05109mig. most nations schedule viquidil under hs 29392000 and sitc 54142. as of q4 2014, viquidil remains the us fda preferred term for this commodity. smiles: coc1=cc2=c(c=cn=c2c=c1)c(=o)ccc3ccncc3c=c (base) or coc1ccc2c(c1)c(ccn2)c(=o)cc[c@@h]3ccnc[c@@h]3c=c.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. prozapine. this classification denotes an antispasmotic agent with the molecular formula c20h25no2, chemically known as 1-(3,3-diphenylpropyl)azepane hydrochloride but generally known as prozapine hydrochloride, which bears us nih compound identifier 71127. european medicines agency schedules prozapine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10154mig. most nations schedule prozapine under hs 29339930 and sitc 51577. as of q4 2014, prozapine remains the us fda preferred term for this commodity. prozapine bears us nlm identifiers umls id c0072512 and nci concept code c73167. smiles: c1cccn(cc1)ccc(c2=cc=cc=c2)c3=cc=cc=c3.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. alverine or alverine citrate or alverine hydrochloride or alverine tartrate. this classification denotes an anticholinergic agent with the molecular formulas c20h27n, c20h27n.c6h8o7, or c20h27n.c4h6o6, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 46tir1560o, 9jfb58yk1e, 8k3r1yuz4i, and 943cl334ob, the base compound being n,n-bis(3-phenylpropyl)ethylamine but it generally known as alverine, which bears us nih compound identifier 3678. alverine most often comes in citrate and dihydrogen citrate forms. european medicines agency schedules alverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05384mig (base), sub00421mig (citrate), or sub26963 (tartrate). the term alverine is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules alverine in its anatomical therapeutic chemical (atc) classification. alverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule alverine, alverine citrate, and alverine tartrate under hs 29214980 and sitc 51454. as of q4 2014, alverine remains the us fda preferred term for this commodity. alverine bears us nlm nci c76387, c72692, and c97966. smiles: n(cccc1ccccc1)(cccc1ccccc1)cc (base), ccn(cccc1ccccc1)cccc2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o (citrate), ccn(cccc1ccccc1)cccc2ccccc2.cl (hydrochloride), ccn(cccc1ccccc1)cccc2ccccc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o (tartrate).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. adiphenine or adiphenine hydrochloride or adiphenine methyl bromide. this classification denotes an antispasmotic agent with the molecular formulas c20h25no2 or c20h25no2.clh or c21h28no2.br, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers ykg6or043q, 42b4pdy0av, 2ovu84vi37, the base of which is chemically known as 2-(diethylamino)ethyl diphenylacetate but that is generally known as adiphenine, which bears us nih compound identifier 2031. adiphenine most often comes in forms chloride, hydrochloride, and methyl bromide. european medicines agency schedules adiphenine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05272mig (base) and sub00305mig (hydrochloride). the term adiphenine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). adiphenine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule adiphenine, adiphenine hydrochloride, and adiphenine methyl bromide under hs 29221980 and sitc 51461. as of q4 2014, adiphenine remains the us fda preferred term for this commodity. adiphenine bears us nlm nci concept codes c75271 and c76456. smiles: o(ccn(cc)cc)c(=o)c(c1ccccc1)c1ccccc1 (base), ccn(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.cl (chloride and hydrochloride), and cc[n+](c)(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.[br-] (methyl bromide).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. ambucetamide or ambucetamide hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c17h28n2o2 and c17h28n2o2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 131b408rzi and 2m010v3maj, the base compound being chemically known as benzeneacetamide, alpha-(dibutylamino)-4-methoxy- (9ci) but generally known as ambucetamide, which bears us nih compound identifier 10616. european medicines agency schedules ambucetamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05400mig and sub00428mig. the term ambucetamide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). ambucetamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambucetamide and its salts under hs 29242995 and sitc 51479. as of q4 2014, ambucetamide remains the us fda preferred term for this commodity. ambucetamide bears us nlm nci c80975. smiles: o=c(n)c(n(cccc)cccc)c1ccc(oc)cc1 (base) and ccccn(cccc)c(c1ccc(cc1)oc)c(=o)n.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. amifloverine. this classification denotes an antispasmotic agent with the molecular formula c16h27no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x154dlc3ey, chemically known as 2-(3,5-diethoxyphenoxy)triethylamine but generally known as amifloverine, which bears us nih compound identifier 168913. european medicines agency schedules amifloverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05429mig. the term amifloverine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). amifloverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amifloverine under hs 29221980 and sitc 51461. as of q4 2014, amifloverine remains the us fda preferred term for this commodity. amifloverine bears us nlm identifiers umls id c2346738 and nci concept code c73165. smiles: o(ccn(cc)cc)c1cc(occ)cc(occ)c1.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. amikhelline. this classification denotes an antispasmotic agent with the molecular formula c18h21no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bd9t227f6m, chemically known as 9(2-(diethylamino)ethoxy)-4-hydroxy-7-methyl-5h-furo(3,2-g)(1)benzopyran-5-one but generally known as amikhelline, which bears us nih compound identifier 71198. european medicines agency schedules amikhelline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05432mig. the term amikhelline is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). amikhelline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amikhelline under hs 29329985 and sitc 51569. as of q4 2014, amikhelline remains the us fda preferred term for this commodity. amikhelline bears us nlm identifiers umls id c2346740 and nci concept code c73160. smiles: o(ccn(cc)cc)c1c2oc(cc(=o)c2c(o)c2c1occ2)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. aminopromazine. this classification denotes an antispasmotic agent with the molecular formula c19h25n3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s9sdd93u5u, chemically known as 1,2-propanediamine, n,n,n,n-tetramethyl-3-(10h-phenothiazin-10-yl)- but generally known as aminopromazine, which bears us nih compound identifier 19392. aminopromazine most often comes in base and fumarate forms. european medicines agency schedules aminopromazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05445mig. the term aminopromazine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). aminopromazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aminopromazine under hs 29343090 and sitc 51578. as of q4 2014, aminopromazine remains the us fda preferred term for this commodity. aminopromazine bears us nlm identifiers umls id c0521944 and nci concept code c76457. smiles: s1c2c(n(cc(n(c)c)cn(c)c)c3c1cccc3)cccc2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. aseripide. this classification denotes an antispasmotic agent with the molecular formula c26h30fn3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g2m24f1i2a, chemically known as (2r,4r)-3-(n-((3-((s)-1-carboxyethyl)phenyl)carbamoyl)glycyl)-2-(o-fluorophenyl)-4-thiazolidinecarboxylic acid, 4-tert-butylester but generally known as aseripide, which bears us nih compound identifier 179339. european medicines agency schedules aseripide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05580mig. the term aseripide is an international non-proprietary name. most nations schedule aseripide under hs 29341000 and sitc 51579. as of q4 2014, aseripide remains the us fda preferred term for this commodity. aseripide bears us nlm identifiers umls id c2346860 and nci concept code c73172. smiles: s1cc(n(c1c1c(f)cccc1)c(=o)cnc(=o)nc1cc(c(c)c(=o)o)ccc1)(c(c)(c)c)c(=o)o.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. bietamiverine or bietamiverine dihydrochloride or bietamiverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c19h30n2o2, c19h30n2o2.2clh, and c19h30n2o2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 4mgi916o6y, 3xwh8ur3ox, 646wtq0g3e, the base compound being chemically known as 1-piperidineacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride but generally known as bietamiverine, which bears us nih compound identifier 72063. european medicines agency schedules bietamiverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05825mig. the term bietamiverine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). bietamiverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bietamiverine and its salts under hs 29333999 and sitc 51574. as of q4 2014, bietamiverine remains the us fda preferred term for this commodity. bietamiverine bears us nlm nci c79555 and c73602. smiles: cl.o(c(=o)c(n1ccccc1)c1ccccc1)ccn(cc)cc (base), ccn(cc)ccoc(=o)c(c1ccccc1)n2ccccc2.cl.cl (dihydrochloride) and ccn(cc)ccoc(=o)c(c1ccccc1)n2ccccc2.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. butaverine. this classification denotes an antispasmotic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1i5o5wiu8x. european medicines agency schedules butaverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06009mig. butaverine generally arises in the molecular formula c18h27no2. the term butaverine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) butaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butaverine under hs 29333999 and sitc 51574. as of q4 2014, butaverine remains the us fda preferred term for this commodity. butaverine bears us nlm identifiers umls id c0771071 and nci concept code c73169. smiles: o(c(=o)cc(n1ccccc1)c1ccccc1)cccc.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. ciclactate. this classification denotes an antispasmotic agent with the molecular formula c12h22o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mys6082g8g, chemically known as 3,3,5-trimethylcyclohexyl lactate. but generally known as ciclactate, which bears us nih compound identifier 193969. european medicines agency schedules ciclactate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06233mig. the term ciclactate is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). ciclactate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ciclactate under hs 29181100 and sitc 51391. as of q4 2014, ciclactate remains the us fda preferred term for this commodity. ciclactate bears us nlm identifiers umls id c2825696 and nci concept code c81589. smiles: o(c1cc(cc(c1)c)(c)c)c(=o)c(o)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. darifenacin or darifenacin hydrobromide. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas c28h30n2o2 and c28h30n2o2.brh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers apg9819vlm and cr02eyq8gv, the base compound being chemically known as (s)-1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide but generally known as darifenacin, which bears us nih compound identifier 72054. european medicines agency schedules darifenacin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06913mig and sub21464. the term darifenacin is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules darifenacin in its anatomical therapeutic chemical (atc) classification. darifenacin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule darifenacin and its salts under hs 29349990 and sitc 51579. as of q4 2014, darifenacin remains the us fda preferred term for this commodity. darifenacin bears us nlm nci c65363 and c78068. smiles: o=c(n)c(c1ccn(c1)ccc1cc2c(occ2)cc1)(c1ccccc1)c1ccccc1 (base) or c1ccc(cc1)c(c2ccccc2)([c@@h]3ccn(c3)ccc4ccc5c(c4)cco5)c(=o)n.br (hydrobromide).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. denaverine or denaverine hydrochloride. this classification denotes an anticholinergic agent with the molecular formulas c24h33no3 and c24h33no3.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers o14nf38mtl and 2afk8fcd4r. european medicines agency schedules denaverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06973mig. the term denaverine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11.) denaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule denaverine and its salts under hs 29221980 and sitc 51461. as of q4 2014, denaverine remains the us fda preferred term for this commodity. denaverine bears us nlm nci c77988 and c97976. smiles: o(cc(cc)cc)c(c1ccccc1)(c1ccccc1)c(=o)occn(c)c (base) or ccc(cc)coc(c1ccccc1)(c2ccccc2)c(=o)occn(c)c.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. dexsecoverine or dexsecoverine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas c22h35no2 and c22h35no2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 3o6aux3i0j and b8042dua17. european medicines agency schedules dexsecoverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07047mig. the term dexsecoverine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) dexsecoverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dexsecoverine and its salts under hs 29225000 and sitc 51467. as of q4 2014, dexsecoverine remains the us fda preferred term for this commodity. dexsecoverine bears us nlm nci c73161 and c97977. smiles: o=c(c1ccccc1)cccn(c(cc1ccc(oc)cc1)c)cc (base) or ccn(cccc(=o)c1ccccc1)[c@@h](c)cc2ccc(cc2)oc.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. difenoximide or difenoximide hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c32h31n3o4 and c32h31n3o4.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 8ug1323c03 and 6gey4w769k, the base compound being chemically known as 4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-alpha,alpha,4-triphenyl-1-piperidinebutanenitrile but generally known as difenoximide, which bears us nih compound identifier 39481. european medicines agency schedules difenoximide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07122mig. the term difenoximide is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). difenoximide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule difenoximide and its salts under hs 29333999 and sitc 51574. as of q4 2014, difenoximide remains the us fda preferred term for this commodity. difenoximide bears us nlm nci c73162 and c77288. smiles: o(n1c(=o)ccc1=o)c(=o)c1(ccn(cc1)ccc(c1ccccc1)(c1ccccc1)c#n)c1ccccc1 (base) or c1ccc(cc1)c2(ccn(cc2)ccc(c#n)(c3ccccc3)c4ccccc4)c(=o)on5c(=o)ccc5=o.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. drofenine or drofenine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas c20h31no2 and c20h31no2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 4qwv355536 and mvb31opw05, the base compound being chemically known as cyclohexaneacetic acid, .alpha.-phenyl-, 2- (diethylamino)ethyl ester but generally known as drofenine, which bears us nih compound identifier 3166. european medicines agency schedules drofenine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub06404mig and sub01838mig. the term drofenine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). drofenine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule drofenine under hs 29221980 and sitc 51461. as of q4 2014, drofenine remains the us fda preferred term for this commodity. drofenine bears us nlm nci c65484. smiles: o(c(=o)c(c1ccccc1)c1ccccc1)ccn(cc)cc (base) or ccn(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. drotaverine or drotaverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c24h31no4 and c24h31no4.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 98qs4n58tw and 24zvh4c669. european medicines agency schedules drotaverine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub06415mig and sub01843mig. the term drotaverine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) drotaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule drotaverine under hs 29334990 and sitc 51575. as of q4 2014, drotaverine remains the us fda preferred term for this commodity. drotaverine bears us nlm nci c65489 and c97980. smiles: ccoc1=c(c=c(c=c1)c=c2c3=cc(=c(c=c3ccn2)occ)occ)occ (base) or ccoc1ccc(cc1occ)/c=c\\2/c3cc(c(cc3ccn2)occ)occ.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. elziverine. this classification denotes an antispasmotic agent with the molecular formula c32h37n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1i2bo46745, chemically known as 6,7-dimethoxy-4-((4-(o-methoxyphenyl)-1-piperazinyl)methyl)-1-veratrylisoquinoline but generally known as elziverine, which bears us nih compound identifier 65839. european medicines agency schedules elziverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06498mig. the term elziverine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). elziverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule elziverine under hs 29335995 and sitc 51576. as of q4 2014, elziverine remains the us fda preferred term for this commodity. elziverine bears us nlm identifiers umls id c2348435 and nci concept code c73163. smiles: o(c1c(n2ccn(cc2)cc2c3c(c(nc2)cc2cc(oc)c(oc)cc2)cc(oc)c(oc)c3)cccc1)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. eperisone or eperisone hydrochloride. this classification denotes an anticholinergic agent with the molecular formulas c17h25no and c17h25no.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 2m2p0551d3 and u38o8u7p6x, the base compound being chemically known as 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)- but generally known as eperisone, which bears us nih compound identifier 3236. european medicines agency schedules eperisone in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub06560mig and sub01900mig. the term eperisone is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules eperisone in its anatomical therapeutic chemical (atc) classification. eperisone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eperisone and its salts under hs 29333999 and sitc 51574. as of q4 2014, eperisone remains the us fda preferred term for this commodity. eperisone bears us nlm nci c83692 and c83693. smiles: o=c(c(cn1ccccc1)c)c1ccc(cc1)cc (base) or ccc1ccc(cc1)c(=o)c(c)cn2ccccc2.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fenoverine. this classification denotes an antispasmotic agent with the molecular formula c26h25n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n274zq6pzj, chemically known as 10h-phenothiazine, 10-((4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)acetyl)- but generally known as fenoverine, which bears us nih compound identifier 72098. european medicines agency schedules fenoverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07580mig. the term fenoverine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules fenoverine in its anatomical therapeutic chemical (atc) classification. fenoverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenoverine under hs 29343090 and sitc 51578. as of q4 2014, fenoverine remains the us fda preferred term for this commodity. fenoverine bears us nlm identifiers umls id c0060182 and nci concept code c65660. smiles: s1c2c(n(c(=o)cn3ccn(cc3)cc3cc4ococ4cc3)c3c1cccc3)cccc2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fenpipramide or fenpipramide hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c21h26n2o and c21h26n2o.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 88445508x3 and kj2v75p034, chemically known as 1-piperidinebutyramide, alpha,alpha-diphenyl- but generally known as fenpipramide, which bears us nih compound identifier 65573. european medicines agency schedules fenpipramide in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub07588mig and sub02123mig. the term fenpipramide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). fenpipramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenpipramide or its salts under hs 29333999 and sitc 51574. as of q4 2014, fenpipramide remains the us fda preferred term for this commodity. fenpipramide bears us nlm nci c65666 and c78073. smiles: o=c(n)c(ccn1ccccc1)(c1ccccc1)c1ccccc1 (base) or c1ccc(cc1)c(ccn2ccccc2)(c3ccccc3)c(=o)n.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fenpiprane or fenpiprane hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c20h25n and c20h25n.clh, and preparation that us fda regulates as active ingredients or moieties under unique ingredient identifiers s2fvb1rl5x and c20h25n.clh. european medicines agency schedules fenpiprane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07589mig. the term fenpiprane is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) fenpiprane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenpiprane and its salts under hs 29333999 and sitc 51574. as of q4 2014, fenpiprane remains the us fda preferred term for this commodity. fenpiprane bears us nlm nci c73174 and c65667. smiles: c1ccn(cc1)ccc(c2=cc=cc=c2)c3=cc=cc=c3 (base) or c1ccc(cc1)c(ccn2ccccc2)c3ccccc3.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. moxaverine or moxaverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c20h21no2 and c20h21no2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers p3p08y1xj4, chemically known as 3-ethyl-1-benzyl-6,7-dimethoxyisoquinoline but generally known as moxaverine, which bears us nih compound identifier 70882. european medicines agency schedules moxaverine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub09082mig and sub03341mig. the term moxaverine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules moxaverine in its anatomical therapeutic chemical (atc) classification. moxaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxaverine and its salts under hs 29334990 and sitc 51575. as of q4 2014, moxaverine remains the us fda preferred term for this commodity. moxaverine bears us nlm nci c66209. smiles: o(c1cc2c(nc(cc2cc1oc)cc)cc1ccccc1)c (base) and ccc1cc2cc(c(cc2c(n1)cc3ccccc3)oc)oc.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fesoterodine or fesoterodine fumarate. this classification denotes an anticholinergic agent with the molecular formulas c26h37no3 and c26h37no3.c4h4o4, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 621g617227 and eos72165s7. european medicines agency schedules fesoterodine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25383. the term fesoterodine is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46.) most nations schedule fesoterodine and its salts under hs 29225000 and sitc 51467. as of q4 2014, fesoterodine remains the us fda preferred term for this commodity. fesoterodine bears us nlm nci c74138 and c72779. smiles: cc(c)c(=o)oc1=c(c=c(c=c1)co)c(ccn(c(c)c)c(c)c)c2=cc=cc=c2 (base) or cc(c)c(=o)oc1ccc(cc1[c@h](ccn(c(c)c)c(c)c)c2ccccc2)co.c(=c/c(=o)o)\\c(=o)o (fumarate).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. flopropione. this classification denotes an antispasmotic agent with the molecular formula c9h10o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 05v5nvb5y1, chemically known as 2,4,6-trihydroxypropiophenone but generally known as flopropione, which bears us nih compound identifier 3362. european medicines agency schedules flopropione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07647mig. the term flopropione is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). flopropione is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flopropione under hs 29145000 and sitc 51629. as of q4 2014, flopropione remains the us fda preferred term for this commodity. flopropione bears us nlm identifiers umls id c0060462 and nci concept code c65694. smiles: oc1c(c(=o)cc)c(o)cc(o)c1.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. heptaverine. this classification denotes an antispasmotic agent with the molecular formula c18h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0035h8m4yl, chemically known as n,n-dimethyl-n-(3-(8,9,10-trinorbornan-2-yliden)-3-phenylpropyl)amin but generally known as heptaverine, which bears us nih compound identifier 3038460. european medicines agency schedules heptaverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08017mig. the term heptaverine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). heptaverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule heptaverine under hs 29214980 and sitc 51454. as of q4 2014, heptaverine remains the us fda preferred term for this commodity. heptaverine bears us nlm identifiers umls id c2348955 and nci concept code c73166. smiles: n(cc/c(=c1/c2cc(cc2)c1)c1ccccc1)(c)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. meladrazine or meladrazine tartrate. this classification denotes an antispasmotic agent with the molecular formulas c11h23n7 and c11h23n7.c4h6o6, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 2v6z0jg2x0 and 7f3dyq3h7h, the base compound being chemically known as 1,3,5-triazin-2(1h)-one, 4,6-bis(diethylamino)-, hydrazone (9ci) but generally known as meladrazine, which bears us nih compound identifier 71679. european medicines agency schedules meladrazine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub08717mig and sub03125mig. the term meladrazine is an international non-proprietary name. world health organization schedules meladrazine in its anatomical therapeutic chemical (atc) classification. meladrazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule meladrazine and its salts under hs 29336980 and sitc 51576. as of q4 2014, meladrazine remains the us fda preferred term for this commodity. meladrazine bears us nlm nci c66076. smiles: ccn(cc)c1=nc(=nc(=n1)nn)n(cc)cc (base) or ccn(cc)c1[nh]/c(=n\\n)/nc(n1)n(cc)cc.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o (tartrate).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. metaxalone. this classification denotes a muscle relaxant with the molecular formula c12h15no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1nma9j598y, chemically known as 5-((3,5-xylyloxy)methyl)-2-oxazolidinone but generally known as metaxalone, which bears us nih compound identifier 15459. european medicines agency schedules metaxalone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08817mig. the term metaxalone is an international non-proprietary name. metaxalone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule metaxalone under hs 29349990 and sitc 51579. as of q4 2014, metaxalone remains the us fda preferred term for this commodity. metaxalone bears us nlm identifiers umls id c0163055 and nci concept code c47606. smiles: cc1=cc(=cc(=c1)occ2cnc(=o)o2)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. methylchromone or tricromyl. this classification denotes an antispasmotic agent with the molecular formula c10h8o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kj0091kaah, chemically known as 4h-1-benzopyran-4-one, 3-methyl- but generally known as methylchromone, which bears us nih compound identifier 66569. european medicines agency schedules methylchromone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08864mig. the term methylchromone is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). methylchromone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. methylchromone or tricromyl bears us nlm identifiers umls id c1881805 and nci concept code c66121. smiles: o1c2c(c(=o)c(c1)c)cccc2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. milverine. this classification denotes an antispasmotic agent with the molecular formula c20h20n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 83b517yuvm, chemically known as 4-((3,3-diphenylpropyl)amino)pyridine but generally known as milverine, which bears us nih compound identifier 71139. european medicines agency schedules milverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08970mig. the term milverine is an international non-proprietary name. milverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule milverine under hs 29333999 and sitc 51574. as of q4 2014, milverine remains the us fda preferred term for this commodity. milverine bears us nlm identifiers umls id c0628924 and nci concept code c66155. smiles: n(ccc(c1ccccc1)c1ccccc1)c1ccncc1.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. mofloverine. this classification denotes an antispasmotic agent with the molecular formula c16h23no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l1g37n4ebs, chemically known as 2,4,6-trimethoxybenzoic acid 2-morpholinoethyl ester but generally known as mofloverine, which bears us nih compound identifier 172304. european medicines agency schedules mofloverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09036mig. the term mofloverine is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). mofloverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mofloverine under hs 29349990 and sitc 51579. as of q4 2014, mofloverine remains the us fda preferred term for this commodity. mofloverine bears us nlm identifiers umls id c1881880 and nci concept code c66177. smiles: o1ccn(cc1)ccoc(=o)c1c(oc)cc(oc)cc1oc.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pramiverin or pramiverine. this classification denotes an antispasmotic agent with the molecular formula c21h27n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 157ny06g9t, chemically known as 4,4-diphenyl-n-isopropylcyclohexylamine but generally known as pramiverin, which bears us nih compound identifier 71681. european medicines agency schedules pramiverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09992mig. the term pramiverine is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). pramiverin or pramiverine bears us nlm identifiers umls id c0663384 and nci concept code c73175. smiles: cc(c)nc1ccc(cc1)(c2=cc=cc=c2)c3=cc=cc=c3.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. ciclonium or ciclonium bromide or ciclonium iodide or cyclonium or oxapium. this classification denotes an anticholinergic agent with the molecular formulas c22h34no2, c22h34no.br, and c22h34no.i, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 682380cg4n, 72r7f44611, and 682380cg4n, the base compound being chemically known as 2-cyclohexyl-2-phenyl-4-piperidinomethyl-dioxolane-1,3 but generally known as ciclonium, which bears us nih compound identifier 168884. european medicines agency schedules ciclonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01293mig, sub06244mig, and sub09499mig. the term ciclonium is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). ciclonium bears us nlm nci c90694. smiles: c[n+]1(ccccc1)cc2coc(o2)(c3ccccc3)c4=cc=cc=c4.[i-] (base) or cc[n+](c)(cc)ccoc(c)(c1ccccc1)c2cc3cc2c=c3.[br-] (bromide).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. oxyphencyclimine or oxyphencyclimine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas c20h28n2o3 and c20h28n2o3.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 4v44h1o8xi and gwo1432wou, the base compound being chemically known as 1,4,5,6-tetrahydro-1-methyl-2-pyrimidinylmethyl alpha-cyclohexyl-alpha-phenylglycolat but generally known as oxyphencyclimine, which bears us nih compound identifier 4642. european medicines agency schedules oxyphencyclimine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub09573mig and sub03594mig. the term oxyphencyclimine is an international non-proprietary name. world health organization schedules oxyphencyclimine in its anatomical therapeutic chemical (atc) classification. oxyphencyclimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxyphencyclimine and its salts under hs 29335995 and sitc 51576. as of q4 2014, oxyphencyclimine remains the us fda preferred term for this commodity. oxyphencyclimine bears us nlm nci c66283 and c66284. smiles: oc(c1ccccc1)(c1ccccc1)c(=o)occ1=ncccn1c (base) or cn1cccn=c1coc(=o)c(c2ccccc2)(c3ccccc3)o.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pargeverine or pargeverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c21h23no3 and c21h23no3.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers uc61hm8fx0 and xt63p694cj, the base compound being chemically known as benzeneacetic acid, alpha-phenyl-alpha-(2-propynyloxy)-, 2-(dimethylamino)ethyl ester but generally known as pargeverine, which bears us nih compound identifier 17700. european medicines agency schedules pargeverine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub12425mig and sub22269. the term pargeverine is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). pargeverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pargeverine and its salts under hs 29221980 and sitc 51461. as of q4 2014, pargeverine remains the us fda preferred term for this commodity. pargeverine bears us nlm nci c66320. smiles: o(c(c1ccccc1)(c1ccccc1)c(=o)occn(c)c)cc#c (base) or cn(c)ccoc(=o)c(c1ccccc1)(c2ccccc2)occ#c.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pimetremide. this classification denotes an antispasmotic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3vy58mwl7j. european medicines agency schedules pimetremide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09842mig. pimetremide generally arises in the molecular formula c16h18n2o2. the term pimetremide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) pimetremide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pimetremide under hs 29333999 and sitc 51574. as of q4 2014, pimetremide remains the us fda preferred term for this commodity. pimetremide bears us nlm identifiers umls id c1882381 and nci concept code c66386. smiles: occ(c(=o)n(cc1cccnc1)c)c1ccccc1.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. treptilamine. this classification denotes an antispasmotic agent with the molecular formula c20h27no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1urw272384, chemically known as ethanamine, n,n-diethyl-2-(phenyltricyclo(2.2.1.02,6)heptylidenemethoxy)-, hydrochloride but generally known as treptilamine, which bears us nih compound identifier 3036965. european medicines agency schedules treptilamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11239mig. the term treptilamine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). treptilamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule treptilamine under hs 29221980 and sitc 51461. as of q4 2014, treptilamine remains the us fda preferred term for this commodity. treptilamine bears us nlm identifiers umls id c0076961 and nci concept code c66625. smiles: cl.o(/c(=c1/c2c3c2cc1c3)c1ccccc1)ccn(cc)cc.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. propiverine or propiverine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formulas c23h29no3 and c23h29no3.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers 468ge2241l and dc4gzd10h3, the base compound being chemically known as 1-methyl-4-piperidyl 2,2-diphenyl-2-propoxyacetate but generally known as propiverine, which bears us nih compound identifier 4942. european medicines agency schedules propiverine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub10114mig and sub04087mig. the term propiverine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules propiverine in its anatomical therapeutic chemical (atc) classification. propiverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propiverine and its salts under hs 29333999 and sitc 51574. as of q4 2014, propiverine remains the us fda preferred term for this commodity. propiverine bears us nlm nci 66491. smiles: o(c1ccn(cc1)c)c(=o)c(occc)(c1ccccc1)c1ccccc1 (base) or cccoc(c1ccccc1)(c2ccccc2)c(=o)oc3ccn(cc3)c.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. rociverine. this classification denotes an antispasmotic agent with the molecular formula c20h37no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vi08ks44v0, chemically known as (1,1-bicyclohexyl)-2-carboxylic acid, 1-hydroxy-, 2-(diethylamino)-1-methylethyl ester but generally known as rociverine, which bears us nih compound identifier 68705. european medicines agency schedules rociverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10352mig. the term rociverine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules rociverine in its anatomical therapeutic chemical (atc) classification. rociverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rociverine under hs 29221980 and sitc 51461. as of q4 2014, rociverine remains the us fda preferred term for this commodity. rociverine bears us nlm identifiers umls id c0073547 and nci concept code c90767. smiles: oc1(c2ccccc2)c(cccc1)c(=o)oc(cn(cc)cc)c.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. stilonium. this classification denotes an antispasmodic with the molecular formula c22h30no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4l5v8z34jm, chemically known as ethanaminium, n,n,n-triethyl-2-(4-(2-phenylethenyl)phenoxy)- but generally known as stilonium, which bears us nih compound identifier 5824382. as of q4 2014, stilonium remains the us fda preferred term for this commodity. stilonium bears us nlm identifiers umls id c2828261 and nci concept code c87314. smiles: cc[n+](cc)(cc)ccoc1=cc=c(c=c1)c=cc2=cc=cc=c2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. talnetant. this classification denotes an antispasmotic agent with the molecular formula c25h22n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cz3t9t146k, chemically known as 4-quinolinecarboxamide, 3-hydroxy-2-phenyl-n-(1-phenylpropyl)-, (s)- but generally known as talnetant, which bears us nih compound identifier 133090. european medicines agency schedules talnetant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub34015. the term talnetant is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). most nations schedule talnetant under hs 29334990 and sitc 51575. as of q4 2014, talnetant remains the us fda preferred term for this commodity. talnetant bears us nlm identifiers umls id c1701942 and nci concept code c76464. smiles: oc1c(c(=o)nc(cc)c2ccccc2)c2c(nc1c1ccccc1)cccc2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. tiropramide or tiropramide hydrochloride. this classification denotes a parasympatholytic and tyrosine analog with the molecular formulas c28h41n3o3 and c28h41n3o3.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers r7s0904cn2 and 9523013y6r, the base compound being chemically known as dl-alpha-benzamido-para-(2-(diethylamino)ethoxy)-n,n-dipropylhydrocinnamamide but generally known as tiropramide, which bears us nih compound identifier 42262. european medicines agency schedules tiropramide in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub11119mig and sub15577mig. world health organization schedules tiropramide in its anatomical therapeutic chemical (atc) classification. tiropramide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiropramide and its salts under hs 29242995 and sitc 51479. as of q4 2014, tiropramide remains the us fda preferred term for this commodity. smiles: o=c(n(ccc)ccc)c(nc(=o)c1ccccc1)cc1ccc(occn(cc)cc)cc1 (base) and cccn(ccc)c(=o)c(cc1ccc(cc1)occn(cc)cc)nc(=o)c2ccccc2.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. trepibutone. this classification denotes an antispasmotic agent with the molecular formula c16h22o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h1187lu49q, chemically known as 2,4,5-triethoxy-gamma-oxobenzenebutanoic acid but generally known as trepibutone, which bears us nih compound identifier 5536. european medicines agency schedules trepibutone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11236mig. the term trepibutone is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules trepibutone in its anatomical therapeutic chemical (atc) classification. trepibutone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trepibutone under hs 29189900 and sitc 51396. as of q4 2014, trepibutone remains the us fda preferred term for this commodity. trepibutone bears us nlm identifiers umls id c0094813 and nci concept code c66623. smiles: o(c1c(cc(occ)c(occ)c1)c(=o)ccc(=o)o)cc.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. trospium. this classification denotes an antimuscarinic agent with the molecular formula c25h30no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t4y8ork057, chemically known as 6,10-ethano-5-azoniaspiro(4.5)decan-8-ol, chloride, benzilate but generally known as trospium, which bears us nih compound identifier 107979. european medicines agency schedules trospium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05000mig. world health organization schedules trospium in its anatomical therapeutic chemical (atc) classification. trospium is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, trospium remains the us fda preferred term for this commodity. trospium bears us nlm identifiers umls id c0772089 and nci concept code c78080. smiles: cl.o(c1cc2[n]3(c(cc2)c1)cccc3)c(=o)c(o)(c1ccccc1)c1ccccc1. .. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. vetrabutine or vetrabutine hydrochloride. this classification denotes an antispasmotic agent with the molecular formulas c20h27no2 and c20h27no2.clh, preparations that us fda regulates as active ingredients or moieties under unique ingredient identifiers i3e2j32f37 and 54if66rp20, the base comppound being chemically known as 1-(3,4-dimethoxyphenyl)-1-dimethylamino-4-phenylbutane but generally known as vetrabutine, which bears us nih compound identifier 111122. european medicines agency schedules vetrabutine in its extended eudravigilance medicinal product dictionary or xevmpd under indices sub00046mig and sub05093mig. the term vetrabutine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). vetrabutine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vetrabutine and its salts under hs 29222900 and sitc 51462. as of q4 2014, vetrabutine remains the us fda preferred term for this commodity. vetrabutine bears us nlm nci c73164. smiles: o(c1cc(c(n(c)c)cccc2ccccc2)ccc1oc)c (base) or cn(c)c(cccc1ccccc1)c2ccc(c(c2)oc)oc.cl (hydrochloride).. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. anethole trithione or anetholetrithione. this classification denotes a phase ii enzymes inducer with the molecular formula c10h8os3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier quy32964dj, chemically known as 5-(p-methoxyphenyl)-3h-1,2-dithiole-3-thione but generally known as anethole trithione, which bears us nih compound identifier 2194. european medicines agency schedules anethole trithione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12902mig. world health organization schedules anethole trithione in its anatomical therapeutic chemical (atc) classification. smiles: coc1=cc=c(c=c1)c2=cc(=s)ss2.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. adiphenine hydrochloride. this classification denotes an antimuscarinic agent with the molecular formula c20h25no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42b4pdy0av, chemically known as trasentine, hydrochloride but more generally known as adiphenine hydrochloride, which bears us nih compound identifier 2031. european medicines agency schedules adiphenine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00305mig. most nations, for tariff and trade purposes, schedule adiphenine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, adiphenine hydrochloride remains us fdas preferred term for this commodity. adiphenine hydrochloride bears us nlm nci c75271. smiles: ccn(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. adiphenine methyl bromide. this classification denotes an antispasmotic agent with the molecular formula c21h28no2.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2ovu84vi37, chemically known as acetic acid, diphenyl-, ester with diethyl(2-hydroxyethyl)methylammonium bromide, but more generally known as adiphenine methyl bromide, which bears us nih compound identifier 197841. european medicines agency schedules adiphenine methyl bromide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05272mig. most nations, for tariff purposes, schedule adiphenine methyl bromide under hs 29221980. smiles: cc[n+](c)(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.[br-].. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. alverine citrate. this classification denotes an antispasmotic agent and anticholinergic agent with the molecular formula c20h27n.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9jfb58yk1e, chemically known as n,n-bis(3-phenylpropyl)ethylamine but more generally known as alverine citrate, which bears us nih compound identifier 3678. european medicines agency schedules alverine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00421mig. most nations, for tariff and trade purposes, schedule alverine citrate under hs 29214980 and sitc 51454. as of q4 2014, alverine citrate remains us fdas preferred term for this commodity. alverine citrate bears us nlm nci c72692. smiles: ccn(cccc1ccccc1)cccc2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. alverine hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c20h27n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8k3r1yuz4i. most nations, for tariff and trade purposes, schedule alverine hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, alverine hydrochloride remains us fdas preferred term for this commodity. alverine hydrochloride bears us nlm nci c97966. smiles: ccn(cccc1ccccc1)cccc2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. alverine tartrate. this classification denotes an anticholinergic agent c20h27n.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 943cl334ob, chemically known as dipropylamine, n-ethyl-3,3-diphenyl-, tartrate, but more generally known as alverine tartrate, which bears us nih compound identifier 72941455. european medicines agency schedules alverine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26963. most nations, for tariff and trade purposes, schedule alverine tartrate under hs 29214980 and sitc 51454. as of q4 2014, alverine tartrate remains us fdas preferred term for this commodity. smiles: ccn(cccc1ccccc1)cccc2ccccc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. ambucetamide hydrochloride. this classification denotes an antispasmotic agent with the molecular formula c17h28n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2m010v3maj. european medicines agency schedules ambucetamide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00428mig. most nations, for tariff and trade purposes, schedule ambucetamide hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, ambucetamide hydrochloride remains us fdas preferred term for this commodity. smiles: ccccn(cccc)c(c1ccc(cc1)oc)c(=o)n.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. bietamiverine dihydrochloride. this classification denotes an antispasmotic agent with the molecular formula c19h30n2o2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3xwh8ur3ox, chemically known as bietamiverine dihydrochloride, (+/-)-, but more generally known as bietamiverine dihydrochloride, which bears us nih compound identifier 197773. european medicines agency schedules bietamiverine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05825mig. most nations, for tariff purposes, schedule bietamiverine dihydrochloride under hs 29333999. smiles: ccn(cc)ccoc(=o)c(c1ccccc1)n2ccccc2.cl.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. bietamiverine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formula c19h30n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 646wtq0g3e, chemically known as 1-piperidineacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride but more generally known as bietamiverine hydrochloride, which bears us nih compound identifier 72063. most nations, for tariff and trade purposes, schedule bietamiverine hydrochloride under hs 29333999. as of q4 2014, bietamiverine hydrochloride remains us fdas preferred term for this commodity. bietamiverine hydrochloride bears us nlm nci c73602. smiles: ccn(cc)ccoc(=o)c(c1ccccc1)n2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. ciclonium bromide. this classification denotes an anticholinergic agent with the molecular structure c22h34no.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 72r7f44611 chemically known as ethanaminium, 2-(1-bicyclo(2.2.1)hept-5-en-2-yl-1-phenylethoxy)-n,n-diethyl-n-methyl-, bromide (1:1), but more commonly known as ciclonium bromide, which bears us nih compound identifier 34625. european medicines agency schedules ciclonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06244mig. the term ciclonium bromide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8. ). most nations, for tariff and trade purposes, schedule ciclonium bromide under hs 29239000. as of q4 2014, ciclonium bromide remains us fdas preferred term for this commodity. ciclonium bromide bears us nlm nci c90694. smiles: cc[n+](c)(cc)ccoc(c)(c1ccccc1)c2cc3cc2c=c3.[br-].. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. darifenacin hydrobromide. this classification denotes an antimuscarinic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cr02eyq8gv. european medicines agency schedules darifenacin hydrobromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21464. darifenacin hydrobromide generally arises in the molecular formula c28h31brn2o2. the term darifenacin hydrobromide is a united states adopted name designation. most nations, for tariff and trade purposes, schedule darifenacin hydrobromide under hs 29349990 and sitc 51579. as of q4 2014, darifenacin hydrobromide remains us fdas preferred term for this commodity. darifenacin hydrobromide bears us nlm nci c78068. smiles: c1ccc(cc1)c(c2ccccc2)([c@@h]3ccn(c3)ccc4ccc5c(c4)cco5)c(=o)n.br.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. denaverine hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c24h33no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2afk8fcd4r, chemically known as benzeneacetic acid, alpha-(2-ethylbutoxy)-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hcl but more generally known as denaverine hydrochloride, which bears us nih compound identifier 18726. european medicines agency schedules denaverine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01583mig. most nations, for tariff and trade purposes, schedule denaverine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, denaverine hydrochloride remains us fdas preferred term for this commodity. denaverine hydrochloride bears us nlm nci c97976. smiles: ccc(cc)coc(c1ccccc1)(c2ccccc2)c(=o)occn(c)c.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. dexsecoverine hydrochloride. this classification denotes the hydrochloride form of an antispasmotic agent and antimuscarinic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3o6aux3i0j. european medicines agency schedules dexsecoverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07047mig. dexsecoverine generally arises in the molecular formula c22h35no2. the term dexsecoverine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25.) dexsecoverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dexsecoverine hydrochloride under hs 29225000 and sitc 51467. as of q4 2014, dexsecoverine hydrochloride remains us fdas preferred term for this commodity. dexsecoverine hydrochloride bears us nlm nci c97977. smiles: ccn(cccc(=o)c1ccccc1)[c@@h](c)cc2ccc(cc2)oc.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. difenoximide hydrochloride. this classification denotes an antispasmotic agent with the molecular formula c32h31n3o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6gey4w769k, chemically known as 1-piperidinebutanenitrile, 4-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-alpha,alpha,4-triphenyl-, monohydrochloride but more generally known as difenoximide hydrochloride, which bears us nih compound identifier 71431. most nations, for tariff and trade purposes, schedule difenoximide hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, difenoximide hydrochloride remains us fdas preferred term for this commodity. difenoximide hydrochloride bears us nlm nci c77288. smiles: c1ccc(cc1)c2(ccn(cc2)ccc(c#n)(c3ccccc3)c4ccccc4)c(=o)on5c(=o)ccc5=o.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. drofenine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formula c20h31no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mvb31opw05, chemically known as cyclohexaneacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride but more generally known as drofenine hydrochloride, which bears us nih compound identifier 92806. european medicines agency schedules drofenine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01838mig. most nations, for tariff and trade purposes, schedule drofenine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, drofenine hydrochloride remains us fdas preferred term for this commodity. smiles: ccn(cc)ccoc(=o)c(c1ccccc1)c2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. drotaverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formula c24h31no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 24zvh4c669, chemically known as 1-benzyl-3,4,6,7-tetraethoxy-1,2,3,4-tetrahydroisoquinoline but more generally known as drotaverine hydrochloride, which bears us nih compound identifier 1712095. european medicines agency schedules drotaverine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01843mig. most nations, for tariff and trade purposes, schedule drotaverine hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, drotaverine hydrochloride remains us fdas preferred term for this commodity. drotaverine hydrochloride bears us nlm nci c97980. smiles: ccoc1ccc(cc1occ)/c=c\\2/c3cc(c(cc3ccn2)occ)occ.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. eperisone hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c17h25no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u38o8u7p6x, chemically known as 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, hydrochloride but more generally known as eperisone hydrochloride, which bears us nih compound identifier 123698. european medicines agency schedules eperisone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01900mig. most nations, for tariff and trade purposes, schedule eperisone hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, eperisone hydrochloride remains us fdas preferred term for this commodity. eperisone hydrochloride bears us nlm nci c83693. smiles: ccc1ccc(cc1)c(=o)c(c)cn2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fenpipramide hydrochloride. this classification denotes an antimuscarinic agent with the molecular formula c21h26n2o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kj2v75p034, chemically known as alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride but more generally known as fenpipramide hydrochloride, which bears us nih compound identifier 166974. european medicines agency schedules fenpipramide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02123mig. most nations, for tariff and trade purposes, schedule fenpipramide hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, fenpipramide hydrochloride remains us fdas preferred term for this commodity. fenpipramide hydrochloride bears us nlm nci c78073. smiles: c1ccc(cc1)c(ccn2ccccc2)(c3ccccc3)c(=o)n.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fenpiprane hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c20h25n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 684n1bf96b, chemically known as 3-piperidino-1,1-diphenylpropane hydrochloride but more generally known as fenpiprane hydrochloride, which bears us nih compound identifier 197784. most nations, for tariff and trade purposes, schedule fenpiprane hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, fenpiprane hydrochloride remains us fdas preferred term for this commodity. fenpiprane hydrochloride bears us nlm nci c65667. smiles: c1ccc(cc1)c(ccn2ccccc2)c3ccccc3.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. fesoterodine fumarate. this classification denotes an anticholinergic agent c26h37no3.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eos72165s7, chemically known as propanoic acid,2-methyl ,2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester,(2e)-2-butenedioate (1:1)(salt), but more generally known as fesoterodine fumarate, which bears us nih compound identifier 9849808. most nations, for tariff and trade purposes, schedule fesoterodine fumarate under hs 29225000 and sitc 51467. as of q4 2014, fesoterodine fumarate remains us fdas preferred term for this commodity. fesoterodine fumarate bears us nlm nci c72779. smiles: cc(c)c(=o)oc1ccc(cc1[c@h](ccn(c(c)c)c(c)c)c2ccccc2)co.c(=c/c(=o)o)\\c(=o)o.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. meladrazine tartrate. this classification denotes an antispasmotic agent with the molecular formula c11h23n7.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7f3dyq3h7h. european medicines agency schedules meladrazine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03125mig. most nations, for tariff and trade purposes, schedule meladrazine tartrate under hs 29336980 and sitc 51576. as of q4 2014, meladrazine tartrate remains us fdas preferred term for this commodity. smiles: ccn(cc)c1[nh]/c(=n\\n)/nc(n1)n(cc)cc.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. moxaverine hydrochloride. this classification denotes an antispasmotic agent c20h21no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6r0i0e99cn, chemically known as 1-benzyl-6,7-dimethoxy-3-ethylisoquinoline hydrochloride, but more generally known as moxaverine hydrochloride, which bears us nih compound identifier 70881. european medicines agency schedules moxaverine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03341mig. most nations, for tariff and trade purposes, schedule moxaverine hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, moxaverine hydrochloride remains us fdas preferred term for this commodity. smiles: ccc1cc2cc(c(cc2c(n1)cc3ccccc3)oc)oc.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. oxyphencyclimine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formula c20h28n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gwo1432wou, chemically known as 1,4,5,6-tetrahydro-1-methyl-2-pyrimidinylmethyl alpha-cyclohexyl-alpha-phenylglycolat but more generally known as oxyphencyclimine hydrochloride, which bears us nih compound identifier 4642. european medicines agency schedules oxyphencyclimine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03594mig. most nations, for tariff and trade purposes, schedule oxyphencyclimine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, oxyphencyclimine hydrochloride remains us fdas preferred term for this commodity. oxyphencyclimine hydrochloride bears us nlm nci c66284. smiles: cn1cccn=c1coc(=o)c(c2ccccc2)(c3ccccc3)o.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pargeverine hydrochloride. this classification denotes an antispasmotic agent with the molecular formula c21h23no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xt63p694cj. european medicines agency schedules pargeverine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22269. the term pargeverine hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule pargeverine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, pargeverine hydrochloride remains us fdas preferred term for this commodity. pargeverine hydrochloride bears us nlm nci c97987. smiles: cn(c)ccoc(=o)c(c1ccccc1)(c2ccccc2)occ#c.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. pitofenone hydrochloride. this classification denotes an antispasmotic agent with the molecular formula c22h25no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier he1za4zbex. european medicines agency schedules pitofenone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03880mig. the term pitofenone hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule pitofenone hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, pitofenone hydrochloride remains us fdas preferred term for this commodity. smiles: coc(=o)c1ccccc1c(=o)c2ccc(cc2)occn3ccccc3.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. propiverine hydrochloride. this classification denotes an antispasmotic agent and antimuscarinic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dc4gzd10h3. european medicines agency schedules propiverine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04087mig. propiverine hydrochloride generally arises in the molecular formula c23h29no3.clh. the term propiverine hydrochloride is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule propiverine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, propiverine hydrochloride remains us fdas preferred term for this commodity. smiles: cccoc(c1ccccc1)(c2ccccc2)c(=o)oc3ccn(cc3)c.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. stilonium iodide. this classification denotes an antispasmotic agent with the molecular formula c22h30no.i, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19b3530kq6, chemically known as n,n,n-triethyl-n-(2-(4-styrylphenoxy)ethyl)ammonium iodide but more generally known as stilonium iodide, which bears us nih compound identifier 6433339. european medicines agency schedules stilonium iodide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10652mig. the term stilonium iodide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). most nations, for tariff and trade purposes, schedule stilonium iodide under hs 29239000 and sitc 51481. as of q4 2014, stilonium iodide remains us fdas preferred term for this commodity. stilonium iodide bears us nlm identifiers umls id c2348540 and nci concept code c73168. smiles: cc[n+](cc)(cc)ccoc1ccc(cc1)/c=c/c2ccccc2.[i-].. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. tiropramide hydrochloride. this classification denotes a parasympatholytic and tyrosine analog c28h41n3o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9523013y6r, chemically known as benzenepropanamide, alpha-(benzoylamino)-4-(2-(diethylamino)ethoxy)- n,n-dipropyl-, hydrochloride, (+/-)-, but more generally known as tiropramide hydrochloride, which bears us nih compound identifier 134448. european medicines agency schedules tiropramide hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15577mig. most nations, for tariff and trade purposes, schedule tiropramide hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, tiropramide hydrochloride remains us fdas preferred term for this commodity. smiles: cccn(ccc)c(=o)c(cc1ccc(cc1)occn(cc)cc)nc(=o)c2ccccc2.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. vetrabutine hydrochloride. this classification denotes an antispasmotic agent c20h27no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 54if66rp20, chemically known as n,n-dimethyl-alpha-(3-phenylpropyl)veratrylamine hydrochloride, but more generally known as vetrabutine hydrochloride, which bears us nih compound identifier 111121. european medicines agency schedules vetrabutine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05093mig. most nations, for tariff and trade purposes, schedule vetrabutine hydrochloride under hs 29222900 and sitc 51462. as of q4 2014, vetrabutine hydrochloride remains us fdas preferred term for this commodity. smiles: cn(c)c(cccc1ccccc1)c2ccc(c(c2)oc)oc.cl.. "
"antispasmodics. this classification denotes agents that inhibit the actions of the parasympathetic nervous system. the major group of drugs used therapeutically for this purpose is the muscarinic antagonists.. viquidil hydrochloride. this classification denotes a quinoline and vasodilator agent with the molecular formula c20h24n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u6fxt2v136, chemically known as 1-propanone, 3-(3-ethenyl-4-piperidinyl)-1-(6-methoxy-4-quinolinyl)-, monohydrochloride, (3r-cis)- but more generally known as viquidil hydrochloride, which bears us nih compound identifier 198279. european medicines agency schedules viquidil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05109mig. most nations, for tariff and trade purposes, schedule viquidil hydrochloride under hs 29392000 and sitc 54142. as of q4 2014, viquidil hydrochloride remains us fdas preferred term for this commodity. smiles: coc1ccc2c(c1)c(ccn2)c(=o)cc[c@@h]3ccnc[c@@h]3c=c.cl.. "
"drugs that treat interstitial cystitis. drugs that treat a condition with recurring discomfort or pain in the urinary bladder and the surrounding pelvic region without an identifiable disease, an affliction in which pain varies greatly and often is accompanied by increased urination frequency and urgency.. . "
"drugs that treat interstitial cystitis. drugs that treat a condition with recurring discomfort or pain in the urinary bladder and the surrounding pelvic region without an identifiable disease, an affliction in which pain varies greatly and often is accompanied by increased urination frequency and urgency.. pentosan polysulfate sodium. this classification denotes an anticoagulant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 914032762y. european medicines agency schedules pentosan polysulfate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14801mig. pentosan polysulfate sodium generally arises in the molecular formula (c5h6na2o10s2)n. the term pentosan polysulfate sodium is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) as of q4 2014, pentosan polysulfate sodium remains the us fda preferred term for this commodity. pentosan polysulfate sodium bears us nlm identifiers umls id c0524684 and nci concept code c946. smiles: c1c(c(c(c(o1)oc2coc(c(c2os(=o)(=o)o)os(=o)(=o)o)o)os(=o)(=o)o)os(=o)(=o)o)o.. "
"drugs that treat interstitial cystitis. drugs that treat a condition with recurring discomfort or pain in the urinary bladder and the surrounding pelvic region without an identifiable disease, an affliction in which pain varies greatly and often is accompanied by increased urination frequency and urgency.. butaphosphan. this classification denotes a phosphorous supplement with the molecular formula c7h17no2p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3q2lq1149l, chemically known as 2-(butylamino)propan-2-yl-hydroxy-oxophosphanium but generally known as casanthranol, which bears us nih compound identifier 6328684. butaphosphan, as butafosfan, is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. european medicines agency schedules butaphosphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05997mig. smiles: ccccnc(c)(c)[p+](=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. . "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. deferoxamine. this classification denotes a metal chelator with the molecular formula c25h48n6o8, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier j06y7mxw4d, chemically known as 3,9,14,20,25-pentaazatriacontane-2,10,13,21,24-pentone, 30-amino-3,14,25-trihydroxy- but more generally known as deferoxamine, which bears u.s. national institutes of health compound identifier 2973. european medicines agency schedules deferoxamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06942mig. world health organization schedules deferoxamine in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. deferoxamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. digoxin immune fab. this classification denotes an antitdote for digitalis overdose with the molecular formula c6394h9908n1698o2011s58, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yb12nqz1yn.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. dimercaprol. this classification denotes a metal chelator with the molecular formula c3h8os2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0cpp32s55x, chemically known as 2,3-mercaptopropanol but generally known as dimercaprol, which bears us nih compound identifier 3080. european medicines agency schedules dimercaprol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07165mig. the term dimercaprol is an international non-proprietary name. world health organization schedules dimercaprol in its anatomical therapeutic chemical (atc) classification. dimercaprol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dimercaprol under hs 29309085 and sitc 51549. as of q4 2014, dimercaprol remains the us fda preferred term for this commodity. dimercaprol bears us nlm identifiers umls id c0012383 and nci concept code c47494. smiles: sc(cs)co.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. edetate disodium. this classification denotes a chelating agent with the molecular formula c10h12n2o8.2h+.2na.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7fld91c86k, chemically known as 3,6-diazaoctanedioic acid, 3,6-bis(carboxymethyl)- but generally known as disodium edetate, which bears us nih compound identifier 6049. european medicines agency schedules disodium edetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11914mig. as of q4 2014, edetate disodium remains the us fda preferred term for this commodity. edetate disodium bears us nlm identifiers umls id c0012695 and nci concept code c61741. smiles: oc(=o)cn(ccn(cc(=o)o)cc(=o)o)cc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. protamine sulfate. this classification denotes a protective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0de9724ihc. european medicines agency schedules protamine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04105mig. protamine sulfate generally arises in the molecular formula h2o4s. the term protamine sulfate is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) most nations schedule protamine sulfate under hs 35040000 and sitc 59225. as of q4 2014, protamine sulfate remains the us fda preferred term for this commodity. protamine sulfate bears us nlm identifiers umls id c0033602 and nci concept code c84123. smiles: none.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sodium polystyrene sulfonate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1699g8679z. european medicines agency schedules sodium polystyrene sulfonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15321mig. sodium polystyrene sulfonate generally arises in the molecular formula (c8h8(c2h3)xl)n.(c8h8o3s)n.na. the term sodium polystyrene sulfonate is an fda designation. as of q4 2014, sodium polystyrene sulfonate remains the us fda preferred term for this commodity. sodium polystyrene sulfonate bears us nlm identifiers umls id c0142915 and nci concept code c29461. smiles: c=cc1=cc=cc=c1s(=o)(=o)[o-].[ca+2].. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. trientine. this classification denotes a metal chelator with the molecular formula c6h18n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sj76y07h5f, chemically known as 1,4,7,10-tetraazadecane but generally known as trientine, which bears us nih compound identifier 5565. european medicines agency schedules trientine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11281mig. the term trientine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). trientine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trientine under hs 29212900 and sitc 51452. as of q4 2014, trientine remains the us fda preferred term for this commodity. trientine bears us nlm identifiers umls id c0040976 and nci concept code c66633. smiles: n(ccnccn)ccn.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. methylene blue or methylthioninium chloride. this classification denotes a dye with the molecular formula c16h18n3s.cl.3h2o, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier t42p99266k, chemically known as 3,7-bis(dimethylamino)phenothiazin-5-ium chloride but more generally known as basic blue 9, which bears us nih compound identifier 6099. european medicines agency schedules methylene blue in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21957. methylene blue bears us nlm identifiers umls id c0025746 and nci concept code c644. smiles: s1c2c(nc3c1cc(n(c)c)cc3)ccc(=[n](\\c)c)/c2.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. antivenins. this classification denotes antisera used to counteract poisoning by animal venoms, especially snake venoms.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. folinic acid or leucovorin. this classification denotes a folic acid derivative with the molecular formula c20h23n7o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q573i9dvlp, chemically known as (+)-l-folinic acid, calcium salt but generally known as calcium folinate, which bears us nih compound identifier 143. european medicines agency schedules calcium folinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06052mig. the term leucovorin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules calcium folinate in its anatomical therapeutic chemical (atc) classification. folinic acid or leucovorin bears us nlm identifiers umls id c0023413 and nci concept code c71631.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. activated carbon or activated charcoal for medical use. this classification denotes an element or isotope with the molecular formula c, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2p3vwu3h10, chemically known as 1,3-dichloro-propan-2-one but generally known as activated charcoal, which bears us nih compound identifier 297. european medicines agency schedules carbon in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13242mig. world health organization schedules activated charcoal in its anatomical therapeutic chemical (atc) classification. smiles: c.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. edetate calcium disodium. this classification denotes a chelating agent with the molecular formula c10h12n2o8.ca.2na.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 25ih6r4sgf. the term calcium disodium edetate hydrate is a japanese accepted name designation. as of q4 2014, edetate calcium disodium remains the us fda preferred term for this commodity. edetate calcium disodium bears us nlm identifiers umls id c0006692 and nci concept code c334. smiles: c(cn(cc(=o)o)cc(=o)[o-])n(cc(=o)o)cc(=o)[o-].[na+].[na+].. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. fomepizole. this classification denotes an enzyme inhibitor with the molecular formula c4h6n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 83lcm6l2by, chemically known as 1h-pyrazole, 4-methyl- but generally known as fomepizole, which bears us nih compound identifier 3406. european medicines agency schedules fomepizole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07775mig. the term fomepizole is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules fomepizole in its anatomical therapeutic chemical (atc) classification. fomepizole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fomepizole under hs 29331990 and sitc 51571. as of q4 2014, fomepizole remains the us fda preferred term for this commodity. fomepizole bears us nlm identifiers umls id c0048504 and nci concept code c47538. smiles: [nh]1ncc(c1)c.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. pralidoxime. this classification denotes a cholinergic agonist with the molecular formula c7h9n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p7mu9utp52, chemically known as pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, iodide but generally known as pralidoxime, which bears us nih compound identifier 5353894. european medicines agency schedules pralidoxime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04002mig. world health organization schedules pralidoxime in its anatomical therapeutic chemical (atc) classification. pralidoxime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, pralidoxime remains the us fda preferred term for this commodity. pralidoxime bears us nlm identifiers umls id c0071808 and nci concept code c78131. smiles: o=[nh]/c=c1/n(cccc1)c.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sodium thiosulfate or thiosulfate or thiosulphate. this classification denotes a protective agent with the molecular formula 2na.o3s2.5h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hx1032v43m, chemically known as thiosulfuric acid (h2s2o3), disodium salt but generally known as sodium thiosulfate, which bears us nih compound identifier 24477. european medicines agency schedules sodium thiosulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15332mig. smiles: [o-]s(=o)(=s)[o-].[na+].[na+].. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. dimercaptosuccinic acid or succimer. this classification denotes a metal chelator with the molecular formula c4h6o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dx1u2629qe, chemically known as 2,3-dithio-meso-tartaric acid but generally known as succimer, which bears us nih compound identifier 9354. european medicines agency schedules succimer in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10663mig. the term succimer is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). succimer is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. dimercaptosuccinic acid or succimer bears us nlm identifiers umls id c0012384 and nci concept code c61953. smiles: c(c(c(=o)o)s)(c(=o)o)s.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. copper sulfate. this classification denotes an emetic and antidote with the molecular formula cu.o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kuw2q3u1vv, chemically known as vanadium sulfate, vso4 but generally known as copper sulfate, which bears us nih compound identifier 1118. european medicines agency schedules copper sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13460mig. world health organization schedules copper sulfate in its anatomical therapeutic chemical (atc) classification. smiles: [o-]s(=o)(=o)[o-].[cu+2].. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. carglumic acid. this classification denotes an agent affecting blood and body fluid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5l0hb4v1ew. european medicines agency schedules carglumic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20051. carglumic acid generally arises in the molecular formula c6h10n2o5. the term carglumic acid is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46.) most nations schedule carglumic acid under hs 29241900 and sitc 51471. as of q4 2014, carglumic acid remains the us fda preferred term for this commodity. carglumic acid bears us nlm identifiers umls id c1318649 and nci concept code c76884. smiles: c(cc(=o)o)c(c(=o)o)nc(=o)n.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. cysteamine or mercaptamine. this classification denotes an anti-ulcer agent with the molecular formula c2h7ns, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ux2sd1ke2, chemically known as 2-mercaptoethylamine, polymer-bound but generally known as cysteamine, which bears us nih compound identifier 6058. european medicines agency schedules cysteamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08770mig. the term cysteamine is an international non-proprietary name. world health organization schedules cysteamine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, cysteamine remains the us fda preferred term for this commodity. cysteamine bears us nlm identifiers umls id c0010648 and nci concept code c61696. smiles: c(cs)n.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. deferasirox. this classification denotes a metal chelator with the molecular formula c21h15n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v8g4mof2v9, chemically known as 4-(3,5-bis-(hydroxy-phenyl)-1,2,4)triazol-1-yl)-benzoic acid but generally known as deferasirox, which bears us nih compound identifier 5493381. european medicines agency schedules deferasirox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21981. the term deferasirox is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48). world health organization schedules deferasirox in its anatomical therapeutic chemical (atc) classification. most nations schedule deferasirox under hs 29339990 and sitc 51577. as of q4 2014, deferasirox remains the us fda preferred term for this commodity. deferasirox bears us nlm identifiers umls id c1619629 and nci concept code c48384. smiles: o=c1/c(=c2/n([nh]/c(=c3\\c(=o)c=cc=c3)[nh]2)c2ccc(cc2)c(=o)o)c=cc=c1.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. deferiprone. this classification denotes a cancer tnm vessel invasion finding category with the molecular formula c7h9no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2bty8kh53l, chemically known as 1,2-dimethyl-3-hydroxypyrid-4-one but generally known as deferiprone, which bears us nih compound identifier 2972. european medicines agency schedules deferiprone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06941mig. the term deferiprone is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). world health organization schedules deferiprone in its anatomical therapeutic chemical (atc) classification. deferiprone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule deferiprone under hs 29333999 and sitc 51574. as of q4 2014, deferiprone remains the us fda preferred term for this commodity. deferiprone bears us nlm identifiers umls id c0043832 and nci concept code c73030. smiles: oc1c(n(ccc1=o)c)c.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. dicobalt edetate. this classification denotes a protective agent with the molecular formula c10h12n2o8.2co, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ukc6gh80qr, chemically known as cobaltate(2-), ((n,n-1,2-ethanediylbis(n-(carboxymethyl)glycinato))(4-)-n,n,o,o,o(sup n), o(sup n))-, cobalt(2+) (1:1), (oc-6-21) but generally known as dicobalt edetate, which bears us nih compound identifier 71942. european medicines agency schedules dicobalt edetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13569mig. the term dicobalt edetate is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). most nations schedule dicobalt edetate under hs 29224995 and sitc 51465. as of q4 2014, dicobalt edetate remains the us fda preferred term for this commodity. dicobalt edetate bears us nlm identifiers umls id c0950483 and nci concept code c81167. smiles: c(cn(cc(=o)[o-])cc(=o)[o-])n(cc(=o)[o-])cc(=o)[o-].[co+2].[co+2].. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. glucarpidase. this classification denotes an enzyme replacement preparation, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2gfp9bjd79. european medicines agency schedules glucarpidase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25203. glucarpidase generally arises in the molecular formula 4zn. the term glucarpidase is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 3, 2005, list 54.) most nations schedule glucarpidase under hs 35079090 and sitc 51691. as of q4 2014, glucarpidase remains the us fda preferred term for this commodity. glucarpidase bears us nlm identifiers umls id c0007072 and nci concept code c346. smiles: none.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. mesna. this classification denotes a uroprotective agent with the molecular formula c2h5o3s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nr7o1405q9, chemically known as ethanesulfonic acid, 2-mercapto-, monosodium salt but generally known as mesna, which bears us nih compound identifier 598. european medicines agency schedules mesna in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08784mig. the term mesna is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules mesna in its anatomical therapeutic chemical (atc) classification. mesna is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mesna under hs 29309085 and sitc 51549. as of q4 2014, mesna remains the us fda preferred term for this commodity. mesna bears us nlm identifiers umls id c0000294 and nci concept code c192. smiles: s(=o)(=o)(o)ccs.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. pentetic acid. this classification denotes a metal chelator with the molecular formula c14h23n3o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7a314hqm0i, chemically known as 1,1,4,7,7-diethylenetriaminepentaacetic acid but generally known as pentetic acid, which bears us nih compound identifier 3053. european medicines agency schedules pentetic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09689mig. the term pentetic acid is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). most nations schedule pentetic acid under hs 29224995 and sitc 51465. as of q4 2014, pentetic acid remains the us fda preferred term for this commodity. pentetic acid bears us nlm identifiers umls id c0013254 and nci concept code c460. smiles: oc(=o)cn(ccn(cc(=o)o)cc(=o)o)ccn(cc(=o)o)cc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sodium edetate. this classification denotes a chelating agent with the molecular formula c10h12n2o8.4na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mp1j8420lu, chemically known as tetrasodium ethylenediamine-n,n,n,n-tetraacetate but generally known as edetate sodium, which bears us nih compound identifier 6144. european medicines agency schedules edetate sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub37153. world health organization schedules edetate sodium in its anatomical therapeutic chemical (atc) classification. most nations schedule sodium edetate under hs 29224990 and sitc 51465. smiles: [na].[na].[na].[na].oc(=o)cn(ccn(cc(=o)o)cc(=o)o)cc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sodium lactate. this classification denotes an electrolyte replacement agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tu7hw0w0qt. european medicines agency schedules sodium lactate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15300mig. sodium lactate generally arises in the molecular formula c3h6o3.na. the term sodium lactate is a united states homeopathic pharmacopoeia name designation. most nations schedule sodium lactate under hs 29181100 and sitc 51391. as of q4 2014, sodium lactate remains the us fda preferred term for this commodity. sodium lactate bears us nlm identifiers umls id c0142874 and nci concept code c47726. smiles: oc(c)c(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sugammadex. this classification denotes a protective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 361lpm2t56. european medicines agency schedules sugammadex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26695. sugammadex generally arises in the molecular formula c72h112o48s8. the term sugammadex is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 3, 2005, list 54.) most nations schedule sugammadex under hs 29329985 and sitc 51569. as of q4 2014, sugammadex remains the us fda preferred term for this commodity. sugammadex bears us nlm identifiers umls id c1700695 and nci concept code c80629. smiles: c(cscc1c2c(c(c(o1)oc3c(oc(c(c3o)o)oc4c(oc(c(c4o)o)oc5c(oc(c(c5o)o)oc6c(oc(c(c6o)o)oc7c(oc(c(c7o)o)oc8c(oc(c(c8o)o)oc9c(oc(o2)c(c9o)o)csccc(=o)o)csccc(=o)o)csccc(=o)o)csccc(=o)o)csccc(=o)o)csccc(=o)o)csccc(=o)o)o)o)c(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. trientine dihydrochloride. this classification denotes a metal chelator, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hc3nx54582. european medicines agency schedules trientine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04953mig. trientine dihydrochloride generally arises in the molecular formula c6h18n4.2clh. the term trientine dihydrochloride is a united states adopted name designation. most nations schedule trientine dihydrochloride under hs 29212900 and sitc 51452. smiles: cl.cl.n(ccnccn)ccn.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. exopeptidase g2. this classification denotes an enzyme with the molecular formula c31h38n4o7s, chemically known as 4-[[1-[[1-[2-[(1-benzylsulfanyl-1-oxo-3-phenylpropan-2-yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid but generally known as exopeptidase g2, which bears us nih compound identifier 3289209. smiles: cc(c(=o)nc(c)c(=o)n1cccc1c(=o)nc(cc2=cc=cc=c2)c(=o)scc3=cc=cc=c3)nc(=o)ccc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. ethylenediaminetetraacetic acid (edta). this classification denotes a chelating agent and anticoagulant agent with the molecular formula c10h16n2o8, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 9g34hu7rv0. the european medicines agency schedules edta in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16095mig. the term edetic acid is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3. ). smiles: oc(=o)cn(ccn(cc(=o)o)cc(=o)o)cc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. acetohydroxamic acid. this classification denotes a chelating agent with the molecular formula c2h5no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4rz82l2gy5, chemically known as hydroxylamine, n-acetyl- but generally known as acetohydroxamic acid, which bears us nih compound identifier 1990. european medicines agency schedules acetohydroxamic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05224mig. the term acetohydroxamic acid is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). world health organization schedules acetohydroxamic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule acetohydroxamic acid under hs 29280090 and sitc 51486. as of q4 2014, acetohydroxamic acid remains the us fda preferred term for this commodity. acetohydroxamic acid bears us nlm identifiers umls id c0050451 and nci concept code c47381. smiles: cc(=o)no.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sugammadex sodium. this classification denotes a protective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier erj6x2mxv7. european medicines agency schedules sugammadex sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32205. sugammadex sodium generally arises in the molecular formula c72h104o48s8.8na. the term sugammadex sodium is a united states adopted name designation. most nations, for tariff and trade purposes, schedule sugammadex sodium under hs 29329985 and sitc 51569. sugammadex sodium bears us nlm identifiers umls id c2350811 and nci concept code c78123. smiles: as of q4 2014, sugammadex sodium remains us fdas preferred term for this commodity.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. trientine hydrochloride. this classification denotes a metal chelator, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hc3nx54582. european medicines agency schedules trientine dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04953mig. trientine hydrochloride generally arises in the molecular formula c6h18n4.2clh. the term trientine hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule trientine hydrochloride under hs 29212900. as of q4 2014, trientine hydrochloride remains us fdas preferred term for this commodity. trientine hydrochloride bears us nlm identifiers umls id c0770325 and nci concept code c61987. smiles: c(cnccnccn)n.cl.cl.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. gadopenamide. this classification denotes a gadolinium-chelate with the molecular formula c22h34n5o10.gd, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vc7m3xd17l, chemically known as (n,n-bis(2-((carboxymethyl)((morpholinocarbonyl)methyl)amino)ethyl)glycinato(3-))gadolinium but more generally known as gadopenamide, which bears us nih compound identifier 3034033. european medicines agency schedules gadopenamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07863mig. the term gadopenamide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 3, no. 3, 1989, list 29). gadopenamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: [gd].o1ccn(cc1)c(=o)cn(ccn(ccn(cc(=o)n1ccocc1)cc(=o)o)cc(=o)o)cc(=o)o.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. levoleucovorin. levoleucovorin injection is a folate indicated for rescue after high-dose methotrexate therapy in osteosarcoma and diminishing the toxicity and counteracting the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. linaclotide. an oligo-peptide agonist of guanylate cyclase 2c. it was approved by the fda in august 2012 and by the european medicines agency[4] for the treatment in adults of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation.. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. naloxegol. an opioid antagonist indicated for the treatment of opioid-induced constipation (oic) in adultpatients with chronic non-cancer pain. "
"antidotes and emetics. this classification denotes agents counteracting or neutralizing the action of poisons.. sodium thiosulfate pentahydrate. a medication used as an antidote in cases of cyanide poisoning.  thiosulfate acts as a sulfur donor to produce the conversion of cyanide to thiocyanate, which can then be safely excreted through urine, that conversion is catalyzed by the enzyme rhodamine (rhodanase). it has also been used as a treatment for calciphylaxis in patients undergoing hemodialysis, who have chronic kidney disease. it is also used in the management of extravasation of urine in chemotherapy. sodium thiosulfate prevents alkylation and tissue destruction, providing a substrate for the alkylating agents that have invaded the subcutaneous tissues. it is also used in foot baths for the prophylaxis of dermatophytosis and as a topical antifungal agent for pityriasis versicolor.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. . "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium hydroxide/magnesium trisilicate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga103. this va drug class (ga103) classifies this compound as belonging to the group aluminum/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. acidophilus/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. alginic acid/aluminum hydroxide/calcium stearate/magnesium trisilicate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga109. this va drug class (ga109) classifies this compound as belonging to the group magnesium/sodium bicarbonate containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. alginic acid/aluminum hydroxide/magnesium trisilicate/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. alginic acid/calcium carbonate/magnesium trisilicate/sodium bica. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. alginic acid/carboxymethylcellulose sodium/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/calcium carbonate/magnesium hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga102. this va drug class (ga102) classifies this compound as belonging to the group aluminum/calcium/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium carbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga103. this va drug class (ga103) classifies this compound as belonging to the group aluminum/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium carbonate/sodium alginate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga103. this va drug class (ga103) classifies this compound as belonging to the group aluminum/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/papain. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium hydroxide/simethicone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aluminum hydroxide/magnesium trisilicate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga103. this va drug class (ga103) classifies this compound as belonging to the group aluminum/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/atropine/cellulase/hyoscyamine/lipase/phenobarbital/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/atropine/lipase/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/bile salts/dehydrocholic acid/lipase/pepsin/proteolytic. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/cellulase/homatropine/phenobarbital/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/cellulase/hyoscyamine/lipase/phenyltoloxamine/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/dehydrocholic acid/desoxycholic acid/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. amylase/dehydrocholic/desoxycholic/homatropine/phenobarbital/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/kaolin/opium/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. asafetida/magnesia. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. aspirin/citric acid/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga110. this va drug class (ga110) classifies this compound as belonging to the group sodium bicarbonate containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. atropine/butabarbital/hyoscyamine/ox bile/pepsin/scopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. atropine/difenoxin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. atropine/diphenoxylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. atropine/hyoscyamine/kaolin/pectin/scopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. atropine/kaolin/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/bile salts/pancreatin/pepsin/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/dehydrocholic acid/lipase/ox bile/pancreatin/pepsin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subcarbonate/kaolin/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/kaolin/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/kaolin/pectin/sodium benzoate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. belladonna/kaolin/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. benzocaine/bismuth subnitrate/cerium oxalate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. benzocaine/calcium carbonate/magnesium carbonate/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. betaine/protease. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bile salts/dehydrocholic acid/pancreatin/pepsin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth hydroxide/kaolin/opium/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subcarbonate/kaolin/opium/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/famotidine/magnesium hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subcarbonate/morphine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subgallate/kaolin/opium/pectin/zinc phenosulfonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subnitrate/calcium carbonate/magnesium carbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subsalicylate/calcium carbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subsalicylate/codeine/kaolin/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subsalicylate/kaolin/opium/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth subsalicylate/magnesium silicate/salicylic acid/sodium s. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth/calcium/opium/pectin/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. bismuth/kaolin/opium/pectin/potassium/salol/zinc. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/folic acid/magnesium carbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga106. this va drug class (ga106) classifies this compound as belonging to the group calcium/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/glycine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga105. this va drug class (ga105) classifies this compound as belonging to the group calcium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium carbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga106. this va drug class (ga106) classifies this compound as belonging to the group calcium/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium carbonate/magnesium oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga106. this va drug class (ga106) classifies this compound as belonging to the group calcium/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium carbonate/sodium alginate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium hydroxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga106. this va drug class (ga106) classifies this compound as belonging to the group calcium/magnesium containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium hydroxide/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/magnesium hydroxide/simethicone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/nux vomica/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. homatropine/hyoscyamine/pancreatin/pepsin/phenobarbital/scopolam. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. homatropine/hyoscyamine/pancreatin/pepsin/phenobarbital/scopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. calcium carbonate/simethicone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. choline/dexpanthenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. citric acid/simethicone/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class dx900. this va drug class (dx900) classifies this compound as belonging to the group diagnostics, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. dehydrocholic acid/homatropine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. dehydrocholic acid/homatropine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. dehydrocholic acid/pancreatin/pepsin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. pancreatin/pyridoxine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. homatropine/opium/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. isopropamide/prochlorperazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. kaolin/paregoric/pectin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. kaolin/pectin/zinc phenolsulfonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. lansoprazole/naproxen. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. loperamide/simethicone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga208. this va drug class (ga208) classifies this compound as belonging to the group antidiarrheal agents.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. magaldrate/simethicone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga199. this va drug class (ga199) classifies this compound as belonging to the group antacids, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. nux vomica/pancreatin/papain/pepsin/phenobarbital/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga500. this va drug class (ga500) classifies this compound as belonging to the group digestants.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. omeprazole/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga900. this va drug class (ga900) classifies this compound as belonging to the group gastric medications, other.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. potassium bicarbonate/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga110. this va drug class (ga110) classifies this compound as belonging to the group sodium bicarbonate containing antacids.. "
"combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations. this classification denotes combination drugs that consist of various combined preparations that are a) substances that counteract or neutralize acidity of the gastrointestinal tract, substances generally known as antacids; b) miscellaneous agents found useful in the symptomatic treatment of that condition which evinces outward symptom of an increased liquidity or decreased consistency of feces, such as running stool, a condition called diarrhea, hence the term antidiarrheal or antidiarrheals; c) agents used to prevent the formation of foam or to treat bloat, or flatulence, hence the term anti-flatulence preparations or anti-flatulents; d) preparations that treat dysfunction of that group of organs stretching from the mouth to the anus, serving to breakdown foods, assimilate nutrients, and eliminate waste, commonly called the digestive system, hence the term digestive preparations; and/or e) preparations that operate to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion in the gastrointestinal system, hence the term gastric preparations. typical combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric constituents are bismuth subcarbonate, calcium carbonate, potassium bicarbonate, sodium bicarbonate, etc.. sodium bicarbonate/sodium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga110. this va drug class (ga110) classifies this compound as belonging to the group sodium bicarbonate containing antacids.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. . "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. amyl nitrite/sodium nitrite/sodium thiosulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad200. this va drug class (ad200) classifies this compound as belonging to the group cyanide antidotes.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. atropine/pralidoxime. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad900. this va drug class (ad900) classifies this compound as belonging to the group antidotes/deterrents, other.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. charcoal/ipecac. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad900. this va drug class (ad900) classifies this compound as belonging to the group antidotes/deterrents, other.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. charcoal/sorbitol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad900. this va drug class (ad900) classifies this compound as belonging to the group antidotes/deterrents, other.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. chlorpheniramine/epinephrine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad900. this va drug class (ad900) classifies this compound as belonging to the group antidotes/deterrents, other.. "
"combination poison antidotes. this classification denotes combination drugs that counteract or neutralize the action of poisons. typical combination antidote constituents are amyl nitrite, atropine, charcoal, chlorpheniramine, sodium benzoate, sodium chloride, and sodium nitrite.. sodium chloride/sodium sulfite/sodium thiosulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ad200. this va drug class (ad200) classifies this compound as belonging to the group cyanide antidotes.. "
"combination antiemetics. this classification denotes combination drugs that prevent nausea or vomiting, antiemetics act by a wide range of mechanisms: some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors. typical antiemetic constituents are dextrose and fructose.. . "
"combination antiemetics. this classification denotes combination drugs that prevent nausea or vomiting, antiemetics act by a wide range of mechanisms: some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors. typical antiemetic constituents are dextrose and fructose.. dextrose/levulose/phosphoric acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga605. this va drug class (ga605) classifies this compound as belonging to the group antiemetics.. "
"combination antiemetics. this classification denotes combination drugs that prevent nausea or vomiting, antiemetics act by a wide range of mechanisms: some act on the medullary control centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors. typical antiemetic constituents are dextrose and fructose.. fructose/glucose/phosphoric acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga605. this va drug class (ga605) classifies this compound as belonging to the group antiemetics.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. . "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. atropine/benzoic acid/hyoscyamine/methenamine/phenyl salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. atropine/benzoic/gelsemium/hyoscyamine/methenamine/methylene/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. atropine/benzoic/hyoscyamine/methenamine/methylene/phenyl salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. atropine/hyoscyamine/phenazopyridine/scopolamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. belladonna/benzoic/gelsemium/methenamine/phenazopyridine/phenyl salicylate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. belladonna/methenamine/salicylamide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. butabarbital/hyoscyamine/phenazopyridine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. hyoscyamine/methamine/methylene blue/phenyl salicylate/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. hyoscyamine/methenamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. hyoscyamine/methenamine/methylene/phenyl salicyl/sodium phoshate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. hyoscyamus/phenazopyridine/sulfamethizole. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination antispasmodics. this classification denotes combination drugs that inhibit the actions of the parasympathetic nervous system, sometimes also called spasmolytics, or drugs which inhibit spasms, hence the term antispasmodics. typical combination antispasmodic constituents are atropine, belladonna, butabarbital, hyoscyamine, hyoscyamus, and methenamine.. methenamine/na biphospha/phenyl salicylate/methelene/hyoscyamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu209. this va drug class (gu209) classifies this compound as belonging to the group antispasmodics, urinary, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. . "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzalkonium chloride/benzocaine/zinc chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. alcohol/benzoic acid/eucalyptol/methyl salicylate/thymol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. alcohol/cetylpyridinium chloride/domiphen bromide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. alcohol/eucalyptol/menthol/methyl salicylate/thymol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. alcohol/fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. alcohol/gum benzoin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. aluminum chloride/hydroxyquinoline sulfate/tetracaine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. amyl metacresol/benzocaine/myrrh/phenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/chlorobutanol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/chlorobutanol/eugenol/peruvian balsam. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/cinnamon oil/clove oil/eucalyptus oil/phenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/clove oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/phenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. benzocaine/phenol/povidone iodine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. calcium carbonate/calcium phosphate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or200. this va drug class (or200) classifies this compound as belonging to the group dental protectants.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. camphor/menthol/phenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. camphor/parachlorophenol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. glycerin/lemon. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. carbamide peroxide/glycerol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. cetylpyridinium chloride/chlorophyl copper complex. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. cresol/formaldehyde. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. epinephrine/zinc chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. epinephrine/zinc phenolsulfonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. eucalyptol/menthol/thymol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. fluoride/phosphoric acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. glycerin/kaolin/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. potassium nitrate/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. glycerin/phenol/sodium bicarbonate/sodium borate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. hydrofluoric acid/phosphoric acid/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. hydrofluoric acid/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. hydrofluoric acid/sodium fluoride/stannous fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. hydrogen peroxide/povidone iodine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. hydrogen peroxide/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or500. this va drug class (or500) classifies this compound as belonging to the group mouthwashes.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. iodine/potassium iodide/zinc phenolsulfonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. paraformaldehyde/titanium dioxide/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or900. this va drug class (or900) classifies this compound as belonging to the group dental and oral agents, topical, other.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. phosphoric acid/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. sodium biphosphate/sodium fluoride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination cariostatics, dental or mouthwashes or oral agents. this classification denotes a) combination drugs that inhibit or arrest formation of localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation, or dental caries, hence the term cariostatics; b) combination drugs that treat diseases of the teeth, oral cavity, and associated structures; or c) combination drugs for rinsing the mouth, possessing cleansing, germicidal, or palliative properties. typical combination cariostatic, dental or oral agent, or mouthwash constituents are alcohol, aluminum chloride, amyl metacresol, benzalkonium chloride, benzocaine, calcium carbonate, camphor, carbamide peroxide, cetylpyridinium chloride, cresol, epinephrine, eucalyptol, fluoride, glycerin, hydrofluoric acid, hydrogen peroxide, iodine, paraformaldehyde, phosphoric acid, potassium nitrate, sodium biphosphate, and sodium fluoride.. sodium fluoride/sodium phosphate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class or100. this va drug class (or100) classifies this compound as belonging to the group cariostatics, topical.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. . "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. acetic acid/glycerin/oxyquinoline/ricinoleic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. acetic acid/oxyquinoline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. acetic acid/oxyquinoline/ricinoleic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. cystine/inositol/methionine/sodium propionate/urea. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. dutasteride/tamsulosin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. eucalyptus oil/menthol/methyl salicylate/phenol/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. lactic acid/methyl salicylate/octoxynol 9/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination genito-urinary agents. this classification denotes combination drugs and preparations that treat diseases and disorders of the organs involved in reproduction and the formation and release of urine, which include the genitals, hence the term genito-urinary agents. typical combination genito-urinary agent constituents are boric, glycerin, inositol, menthol, methyl salicylate, octoxynol 9, oxyquinoline, sodium acid pyrophosphate, sodium citrate, and tamsulosin.. lactic acid/octoxynol 9/sodium lactate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class gu900. this va drug class (gu900) classifies this compound as belonging to the group genito-urinary agents, other.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. . "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. benzocaine/bismuth subgallate/phenylmecuric nitrate/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. benzocaine/camphor/ephedrine/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. benzyl benzoate/bismuth/calcium/coconut oil/vegetable oil/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. benzyl benzoate/bismuth/peruvian balsam/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. bismuth subgallate/boric acid/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. camphor/ephedrine/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. hemorrhoidal/hydrocortisone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs202. this va drug class (rs202) classifies this compound as belonging to the group hemorrhoidal preparations with steroid.. "
"combination hemorrhoidal preparations. this classification denotes combination drugs and preparations that treat or alleviate symptoms of swollen veins in the lower part of the rectum or anus. typical combination hemorrhoidal preparation constituents are ismuth, bismuth subgallate, boric acid, camphor, ephedrine, hydrocortisone, lidocaine, pramoxine, and zinc oxide.. pramoxine/zinc oxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs201. this va drug class (rs201) classifies this compound as belonging to the group hemorrhoidal preparations without steroid.. "
"combination histamine antagonists. this classification denotes combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. typical combination histamine antagonist constituents are dextrose and sodium chloride.. . "
"combination histamine antagonists. this classification denotes combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. typical combination histamine antagonist constituents are dextrose and sodium chloride.. cimetidine/dextrose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga301. this va drug class (ga301) classifies this compound as belonging to the group histamine antagonists.. "
"combination histamine antagonists. this classification denotes combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. typical combination histamine antagonist constituents are dextrose and sodium chloride.. cimetidine/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga301. this va drug class (ga301) classifies this compound as belonging to the group histamine antagonists.. "
"combination histamine antagonists. this classification denotes combination drugs containing preparations that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists, thus the term antihistamines, and which thereby act in the bronchi, capillaries, and other smooth muscles to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. typical combination histamine antagonist constituents are dextrose and sodium chloride.. ranitidine/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga301. this va drug class (ga301) classifies this compound as belonging to the group histamine antagonists.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. . "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/magnesium citrate/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. aloe/cascara sagrada. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga204. this va drug class (ga204) classifies this compound as belonging to the group stimulant laxatives.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. asafetida/capsicum/cascara sagrada/ginger/nux vomica. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bagenema/bisacodyl/castile soap/castor oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. benzocaine/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs300. this va drug class (rs300) classifies this compound as belonging to the group laxatives, rectal.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/castor oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/docusate/senna concentrate/senna extract/sucrose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/electrolytes/peg-3350. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/magnesium citrate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/magnesium citrate/magnesium sulfate/senna/sucrose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. carboxymethylcellulose/docusate/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/phospho soda. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bisacodyl/tannic acid. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs300. this va drug class (rs300) classifies this compound as belonging to the group laxatives, rectal.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. bryonia/hydrastis/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga204. this va drug class (ga204) classifies this compound as belonging to the group stimulant laxatives.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. calcium pantothenate/danthron. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. calcium pantothenate/danthron/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. capsicum/cascara sagrada/ginger/nux vomica. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. carboxymethylcellulose/casanthranol/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. carboxymethylcellulose/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. magnesium hydroxide/mineral oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. casanthranol/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. cascara/mineral oil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. danthron/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. dehydrocholic acid/docusate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. dehydrocholic acid/docusate/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. docusate/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. docusate/sennosides. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga204. this va drug class (ga204) classifies this compound as belonging to the group stimulant laxatives.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. galactose/lactose/lactulose. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga202. this va drug class (ga202) classifies this compound as belonging to the group hyperosmotic laxatives.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. magnesium citrate/phenolphthalein/potassium bitartrate/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. magnesium sulfate/potassium sulfate/sodium sulfate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga202. this va drug class (ga202) classifies this compound as belonging to the group hyperosmotic laxatives.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. mineral oil/phenolphthalein. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class ga209. this va drug class (ga209) classifies this compound as belonging to the group laxatives, other.. "
"combination laxatives. this classification denotes combination drugs and preparations that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation, sometimes also called purgatives, but more generally known as laxatives. typical combination laxative constituents are bisacodyl, casanthranol, docusate, electrolytes, hydrastis, lactose, and magnesium citrate.. potassium bitartrate/sodium bicarbonate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs300. this va drug class (rs300) classifies this compound as belonging to the group laxatives, rectal.. "
"combination rectal, local other. this classification denotes combination drugs and preparations which treat damaged, chafed areas. typical combination other local rectal constituients are alcloxa and pramoxine.. . "
"combination rectal, local other. this classification denotes combination drugs and preparations which treat damaged, chafed areas. typical combination other local rectal constituients are alcloxa and pramoxine.. alcloxa/pramoxine/witch hazel. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class rs900. this va drug class (rs900) classifies this compound as belonging to the group rectal, local other.. "
